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List of abbreviations
DNA  Deoxyribonucleic acid 
FSDNA  Fish sperm deoxyribonucleic acid
CTDNA  Calf thymus deoxyribonucleic acid
dsDNA            double-stranded deoxyribonucleic acid
ssDNA            single-stranded deoxyribonucleic acid
MOPS  3-(N-morpholino) propanesulfonic acid
DMSO Dimethyl sulfoxide
TRIS Tris(hydroxymethyl)aminomethane
UV Ultra-violet
vis Visible
A                  Absorbance
a.u.               Arbitrary unit
λmax                     Lambda max
°C Degree Celsius
Kcal  Kilocalore
ml Millilitre
mM Millimolar
Kb Binding constant
n Binding site size in base pairs
Kagg                   Aggregation constant
∆Hagg             Change in enthalpy of aggregation
vSummary
This thesis presents biophysical studies of new optoelecronically active DNA-binders.
Chapter one gives a brief overview of the importance of DNA in medicine, of DNA 
structure and of the mode of interactions of small molecules with double-stranded 
DNA, including electrostatic, intercalation and groove interactions. Various examples 
of small-molecule binding to DNA are discussed. Additionally, this chapter briefly 
describes the biophysical techniques which can be exploited to quantify the 
interaction between small-molecules and duplex DNA.
Chapter two describes the results of studies of the interactions of a group of 1,8-
naphthalimide derivatives with double-stranded DNA using a variety of techniques 
viz. spectroscopy, calorimetry, viscosity and molecular docking studies. Additionally, 
this chapter also presents sequence selectivity studies of this group of compounds for 
specific sequences (dAdT)12●(dAdT)12 and (dGdC)12●(dGdC)12 through UV-visible 
spectroscopy. The 1,8-napthtalimide unit is shown to be a useful element for inducing 
DNA-binding.
Chapter three describes studies of the interactions of a family of dendrimeric
compounds with double-stranded DNA, again using spectroscopy, calorimetry, 
viscosity and molecular docking studies. Furthermore, this chapter includes sequence 
selectivity studies of this group of compounds for (dAdT)12●(dAdT)12 and 
(dGdC)12●(dGdC)12 via UV-visible spectroscopy. The charge and the length of the 
dendritic structures is shown to strongly affect nucleic acid affinities of this series of 
molecules.
Chapter four describes the results of studies of the interactions of miscellaneous
compounds with double-stranded DNA using variety of techniques viz. spectroscopy, 
calorimetry, viscosity and molecular docking studies. In addition, this chapter 
displays sequence selectivity studies of this group of compounds for specific 
sequences (dAdT)12●(dAdT)12 and (dGdC)12●(dGdC)12 via UV-visible spectroscopy.
Chapter five gives an overview and general conclusions about the DNA binding 
studies presented in Chapters 2, 3 & 4 and finishes with suggestions for future work.
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Abstract
Since the importance of DNA has been revealed in the field of medicine, binding of a 
compound with selectivity for a specific DNA sequence is of significant interest in 
medical and pharmaceutical respects. The first part of Chapter 1 gives a brief 
overview of the importance of DNA in the medicine, of DNA structure and of the mode 
of interactions of small molecules with double-stranded DNA, including electrostatic, 
intercalation and groove interactions. Various examples of small-molecule binding to 
DNA are discussed. Additionally, this chapter briefly describes the biophysical 
techniques which can be exploited to quantify the interaction between small-
molecules and duplex DNA, such as UV-visible and CD spectroscopy, isothermal 
titration calorimetry, and viscometry.  
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1.1 General introduction of the thesis
DNA, the molecule of life, plays an important role in living organisms and it is the 
long-term storage of hereditary information. Compounds binding to DNA have 
interested scientists and researchers ever since the importance of DNA has been 
revealed. The study of small molecules that bind to DNA is a promising field, and 
could lead to the discovery of new medicines to control genetic and other diseases; the 
mode of action of several drugs in clinical use for the treatment of diseases is based 
on their binding to DNA and subsequent modifications of the genetic material. For
example, cisplatin, is one of the best-known anticancer drugs that is used to treat 
various types of cancer.1 However here we focus on how to exploit DNA-binders as
components to enhance DNA detection in genosensors.2, 3
Underpinning the use of optoelectronically active compounds in genosensors, is 
understanding how these compounds interact with DNA. There are several techniques 
that can be used to study DNA binding and these include UV-visible spectroscopy, 
isothermal titration calorimetry (ITC), and circular dichroism (CD) spectroscopy. A 
brief description of these techniques is provided next in the second part of this 
chapter.
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1.2 Deoxyribonucleic acid (DNA)
The discovery of the molecule of life (DNA) in the late 1800s by the Swiss biochemist 
Friedrich Miescher inspired many scientists and researchers to study and explore the 
importance of this molecule in living organisms. DNA is a chemical depository for 
the genetic information of an organism. The genetic information, stored within DNA 
in the form of an alphabet consisting of four distinct building blocks, regulates every 
characteristic of every living species. The mechanisms of DNA functions in the cell 
cycle, such as replication and transcription, have been fully investigated.4,5
According to the “central dogma of molecular biology”, the information encoded in 
DNA in the form of three-letter codons is transferred through RNA to proteins in the 
cell. This transfer includes several important cellular processes surrounding the DNA 
such as transcription and translation. Messenger RNA (mRNA) is formed using DNA 
as a template during the transcription process. The messenger RNA is transferred to 
the ribosome in the cytoplasm where the proteins are produced through translation. 
Each of these processes is catalysed by different types of proteins called enzymes.6
The interaction of small molecules with DNA can have a great influence on the DNA 
replication process in the living cell. In the first step DNA transcribed to RNA and 
usually the transcription involves a particular protein binding to a specific site in the 
DNA framework. Thus small molecules binding to DNA can emulate or block such 
binding and lead to stop replication and/or transcription.7
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1.3 Biosensors (genosensors) 
Quantification of biological or biochemical processes is of importance for several 
applications, including medical and biotechnological applications. However, 
converting information on biological system into quantitative results is challenging 
because of the complexity of connecting electronic devices directly to biological 
environments. A biosensor is defined as an analytical device that converts a biological 
parameter into a detectable and quantifiable signal.8 In general, a biosensor consists of 
two main elements viz. a biological recognition unit (sensing element) that can 
specifically interact with an analyte and a transducer element which converts a 
biological response into a measurable electronic signal.9-12 Biosensors which utilize 
nucleic acid interactions are referred to as genosensors. The recognition process in 
genosensors is typically based on DNA hybridization (Figure 1.1), where a short 
nucleic acid (capture probe) that is immobilized on the sensor forms a receptor and 
can recognize and interact specifically with its complementary nucleic acid sequence 
in the analyte sample. Upon hybridization of the capture probe with its target nucleic 
acid sequence, any changes in optical or electronic properties which occur, can be 
transduced and amplified using different detectors, including optical and 
electrochemical detections.13, 14
Figure 1.1 General DNA biosensor design.13
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2.3.1 Detection technologies used for biosensors
2.3.1.1 Electrochemical impedance spectroscopy (EIS)
Electrochemical impedance spectroscopy (EIS) is an important detection technique
that is widely used in biosensors, particularly to detect DNA hybridization.94, 95 A 
typical DNA sensor using detection through EIS is designed as follows. A single-
stranded DNA capture probe is immobilized on an electrode, typically a gold 
electrode. Upon hybridization of a strand of the target DNA in the sample solution 
with the single-stranded DNA probe, a change in the impedance of the electrode-
solution interface occurs, i.e. the rate of charge transfer between the electrode and a
redox indicator [Fe(CN)6]3–/4– changes resulting from increasing blocking ability of 
biolayer on the electrode (Scheme 1.1).96 Thus, any change in the impedance that 
occurs as a result of the hybridization is detected and measured as a charge transfer 
resistance (Rct) by electrochemical impedance spectroscopy (EIS).
Scheme 1.1 Schematic representation of Biosensor based-EIS detection.96
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2.3.1.2 Field-effect transistor (Bio-FET)
Typical field-effect transistor based-biosensors consists of a semiconductor 
transducer, a dielectric layer (SiO2), a bio-receptor, the analyte, and a gate (Scheme 
1.2). The dielectric layer (SiO2) is used to separate the semiconductor transducer from 
the analyte solution and electrostatically connects the surface layer to the Bio-FET 
channel.93 When the analyte binds to the bio-receptor, changes in the charge 
distribution at the surface layer happen, leading to a change in the electrostatic 
potential of the semiconductor, which eventually results in a in the current flowing 
between the source (S) and the drain (D) of the field effect transistor (FET).97, 98 Thus, 
there is a relation between the amount of bound analyte and the current travelling 
between the source and drain.
Scheme 1.2 (a) Schematic representation of the Bio-FET. (b) Working principle, 
including the charge compensation in the semiconductor upon the binding of sulfate 
ions to the receptor.98
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2.3.1.3 Coulometry 
DNA biosensors-based on coulometry commonly consist of three main components.
The first part is an electrode, gold or carbon is often used, the second part is a DNA 
capture probe, that is attached to the surface of the electrode, and the third part is a 
redox active label, which are compounds that bind to a hybridized duplex DNA or are 
attached to a reporter DNA probe via covalent bonds.99, 100 When the single-stranded 
DNA capture probe hybridizes with a single-stranded target DNA strand, the redox-
active compound binds to that hybridized duplex DNA. This binding event leads to a 
current between the electrode and redox-active sensitizer and that current will be 
detected and measured through coulometry (Scheme 1.3).  
 
Scheme 1.3 Schematic representation of DNA biosensor based-coulometry.
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2.3.1.4 Fluorimetry 
DNA sensors using fluorimetry detection are typically constructed from four major 
components (Scheme 1.4), viz. 1) DNA capture probes that are immobilized on a 
solid layer, 2) fluorochrome molecules, 3) target DNA molecules in the sample and 4) 
light sources and detectors.101, 102 Upon hybridization of the single-stranded DNA 
capture probe with the single-stranded DNA target, binding of the fluorochrome to the
hybridized duplex DNA occurs. Binding of the fluorophore leads to change in its 
fluorescent properties and converts the biorecognition event into a measurable optical 
signal.103
Scheme 1.4 Schematic representation of DNA biosensor-based on fluorimetry.
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1.4 DNA structure 
The discovery that DNA is the prime molecule carrying all the hereditary information 
within chromosomes inspired several researchers to focus on its structure. The study 
of DNA structure reveals how DNA carries the genetic messages that are replicated 
when chromosomes divide to produce two identical copies of themselves. Some
research groups in the United States and in Europe in the late 1940s and early 1950s
involved in serious efforts, to understand the nature of DNA structure.15
In 1953, there appeared three papers in the journal Nature which changed our 
understanding of life. James Watson and Francis Crick first described the structure of 
DNA. According to Watson and Crick’s model, DNA is a double helix, composed of 
two antiparallel complementary strands, twisted around each other and held together 
through hydrogen bonding between the purine derivatives (adenine and guanine) and 
pyrimidine derivatives (cytosine and thymine) base pairs (Figure 1.2). Each 
nucleobase in a particular stand is linked via the glycoside bonds to the C1 of the 
deoxyribose sugar backbone. The sugar units in the backbone are joined together via 
3'-hydroxyl and 5'-hydroxyl groups by phosphodiester groups. These linker groups are 
orientated outside of the double helix to minimize repulsion between the strands, 
while the nucleotides are inside of the helix, stacking along the direction of the helix 
axis.16
Figure 1.2 Detailed chemical structure of DNA.15
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There are four nitrogen heterocyclic bases in DNA; these bases are divided into two 
classes, the purine derivatives adenine (A) and guanine (G), whilst cytosine (C) and 
thymine (T) are pyrimidine derivatives. The bases are connected to the sugar with a 
glycosidic bond, through N9 of the purine bases and N1 of the pyrimidine bases 
(Figure 1.3).
Figure 1.3 purine and pyrimidine derivatives bases.15
Base pairing, between adenine (A) and thymine (T) and between guanine (G) and 
cytosine (C), leads to a complementary relationship between the sequences of bases 
on the two intertwined chains and gives DNA its self-encoding character. 
The pairing between A and T base pairs results in forming two hydrogen bonds, while 
G and C base pairs form three hydrogen bonds, making G-C base pairs more stable 
than A-T base pairs. On the other hand, the higher stability of G-C base pairs in DNA 
is not only due to the presence of additional hydrogen interaction, but instead is due to 
stronger stacking interactions between the base pairs (i.e. along the helical stack).17 
In addition, the back bone of DNA (sugar and phosphate groups) can produce various 
torsional effects on the secondary structure of the nucleic acid, allowing double 
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stranded DNA to adopt several conformations depending on base-pairs sequences and 
conditions, viz. A-, B- and Z-DNA (Figure 1.4).18
Figure 1.4 The conformations of DNA (from left to right). (a) A-DNA (NDB ID: 
AD0003), (b) B-DNA (NDB ID: BD0003) and (c) Z-DNA (NDB ID: ZD0008).
Both A- and B-DNA have right-handed helical structures, whereas Z-DNA possesses 
left-handed helical structure. Each conformation has a different number of base pairs 
per helical turn. For A-DNA 11 base pairs with C3’-endo conformation for the sugar 
unit form a helical turn, while B-DNA contains 10.4 base pairs with C2’-endo 
conformation for the sugar unit per helical turn. One helical turn for the Z-DNA 
conformation corresponds to 12 base pairs. In addition, there are other DNA 
conformations which are well known such as G-quadruplex, triplex and i-motif
structures (Figure 1.5).
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Figure 1.5 Other DNA conformations (from left to right): a) G-quadruplex DNA 
(PDB: ID 2HY9), b) triplex DNA (NDB ID: BD0017) and c) i-motif (NDB ID: 
2N89).
1.5 DNA grooves
In B-DNA, there are two grooves, viz. major and minor grooves that are not equal in 
size to each other as a consequence of the geometry of the base pairs and the double 
helical structure of the two chains (Figure 1.6).
Figure 1.6 Major and minor grooves of DNA (NDB ID: BD0003)
As its name implies, the major groove is wider (12 Å) than the minor groove (6Å).19, 
20 These grooves provide sites for DNA binders such as small molecules and proteins 
to interact with double stranded DNA because the edges of the bases in the major and 
minor grooves are exposed at the surface of DNA.21
The major and minor grooves can be distinguished in several ways such as through
patterns of available hydrogen bond donors and acceptors, electrostatic potential, 
steric factors (Figure 1.7).
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Figure 1.7 H-bond donor and acceptor sites for the base pairs in the minor and major 
groove of DNA. The letters in red identify hydrogen bond acceptors (A), hydrogen 
bond donors (D), nonpolar hydrogens (H), and methyl groups (M).15
In the major groove, the edge of a G●C base pair displays the following chemical 
groups in the following order in the major groove: AAD, whereas the edge of C●G 
base pair in the major groove displays the reverse pattern DAA. On the other hand, 
the edges of A●T and T●A base pairs show the same hydrogen bonding patterns 
(ADA). However, the presence of the methyl group on the thymine make these bases 
lose their symmetry (ADAM) and (MADA) and can be distinguished. 
In contrast, in the minor groove, the hydrogen bonding patterns produce no difference 
between C●G and G●C base pairs or between A●T and T●A because the hydrogen 
bonding patterns for each base pair are symmetrical; i.e. for C●G and G●C base pairs 
are (ADA) pattern and for A●T and T●A are (AA) pattern.
Introduction
15
1.6 Small molecules binding to DNA
As a result of the geometry of the base pairs of DNA and the double helical structure 
of the two complementary stands, DNA can interact with small molecules and 
proteins in several different ways. Irreversible binding typically involves non-specific 
covalent bonding to the sugar or phosphate parts of the DNA backbone. Irreversible 
binding can have an influence on transcription processes, which normally ends with 
cell death or alters gene expression.22 Small molecules that bind to DNA in this way 
can bind to sites of duplex DNA either in the same strand (intrastrand) or crosslink 
from different strands i.e. complementary strands.23
In addition, drugs can attach to other sites on the DNA; for instance, the well-known 
anticancer drug cisplatin can form intrastrand bonds with the basic sites of the DNA 
helix, the drug binds to the nitrogen atom of either guanine or adenine base (Figure 
1.8)
Figure 1.8 Cisplatin interactions with DNA (NDB ID: 1A84)
A wide range of chemical species can also bind reversibly to DNA, including water, 
metal complexes, proteins, and small molecules.18 Reversible binding can occur in 
several modes such as electrostatic interactions, groove binding or intercalation 
between the base pairs (Figure 1.9) and a brief description for each mode is provided 
next.
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Figure 1.9 Examples of different reversible interactions between molecules and 
DNA, (left) minor groove binding (NDB ID: GDLB05), (right) intercalation (NDB 
ID: DD0070).
1.6.1 Electrostatic interactions
DNA molecules carry high negative charges under physiological conditions, due to 
the presence of the negatively charged phosphate groups that run along the exterior 
surface of the double helix structure of DNA.24 Thus, cationic molecules are able to 
interact with DNA by electrostatic interactions. This mode of interaction is influenced 
by size of ligand, the charge on the ligand and hydrophobicity of ligand.25-27 The 
stability of the DNA conformation usually increases upon this interaction. Cation
sizes can range from small ions for example Na+ or Mg2+ to larger cationic 
polyamines such as spermidine and spermine. The binding of these cations with DNA 
leads to neutralization of the phosphate backbone’s charge,28 therefore the binding of 
small molecules with DNA is influenced by the ionic strength of the medium.
1.6.2 Intercalations and Intercalators
The concept of intercalation was first introduced in 1961 by Lerman and was 
modified in 1966 by Pritchard. In this mode of binding, flat polycyclic aromatic ring 
molecules such as acridine dyes can intercalate between two base pairs of the DNA 
double helix. The main binding forces are provided by π-π stacking interactions and 
Van der Waals interactions between the aromatic DNA binder and the base pairs of 
DNA.29, 30 Intercalation is usually enthalpically driven, leading to significant changes 
in geometry and length of the DNA helix.25 There are many well-known intercalators 
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such as, proflavine, acridine orange, N,N-dimethyl proflavine, 9-aminoacridine and 
ethidium bromide (Figure 1.10).
Figure 1.10 Chemical formulae of intercalators, (a) proflavine, (b) acridine orange, 
(c) N,N-dimethyl proflavine, (d) 9-aminoacridine and (e) ethidium bromide.
In B-form DNA, the vertical separation of two consecutive base pairs is normally 
about 3.4 Å, this distance must be expanded noticeably to accommodate the 
considerably large aromatic ring molecule. The expansion of DNA helix can vary 
over a wide range (1.8-4.5 Å per intercalation), depending on the ligand and type of 
nucleotide involved.  
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Most intercalators have a preference for a specific binding site. Some prefer to 
intercalate between a 5ʹ-purine–pyrimidine-3ʹ base step rather than between a 5ʹ-
pyrimidine–purine-3ʹ base step (or vice versa), while, others have preference for
certain base-pair sequences (Figure 1.11).31
Figure 1.11 Structure of an acridine–DNA complex.31
According to the “neighbor exclusion principle”,26 DNA binders cannot occupy two 
successive base steps because during intercalation the conformation of neighboring 
binding sites also changes, leading to block the accommodation of a second 
intercalator between base pairs adjacent to a bound intercalator. Binding site sizes for 
intercalators are therefore typically larger than one base pair. Furthermore, those 
intercalators that carry positive charges have additional electrostatic interactions with
the anionic sugar-phosphate backbone, causing the duplex DNA to become more 
stable.
1.6.3 Groove binding (Major and Minor)
The double-helix structure of DNA exhibits the major and minor grooves as a 
consequence of the geometry of base pair formation and the double helical structure 
of the two complementary strands.15 These grooves are different in many patterns 
such as patterns of available hydrogen bond donors and acceptors, electrostatic 
potential, steric factors and sizes. Therefore, binding of DNA binders in these grooves 
can become selective.  
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Larger biomolecules, such as proteins, usually bind to duplex DNA in the major 
groove, allowing sequence-specific recognition.27 On the other hand, smaller 
molecules tend to bind with duplex DNA in the minor groove because the 
environment is more convenient in the minor groove for the smaller molecules since 
the minor groove provides more sites for interactions. Key interactions include 
hydrophobic interactions of small molecules with the hydrophobic interior walls of 
the minor groove. Typically, the minor groove is preferred by molecules with a 
hydrophobic framework linked by bonds with torsional freedom in order to enable 
these molecules to twist and adopt the curvature of the minor groove of DNA.      
The majority of minor groove binders binds selectively to A●T rather than to G●C 
rich sequences because the minor groove becomes narrower in the presence of A●T 
sequences and therefore facilitates the formation of Van der Waals interactions with 
the walls of the groove. Lower affinity for G●C rich sequences is also due to the 
existence of the NH2 group of guanine, which prevents the penetration of molecules 
into minor groove. Additionally, negative electrostatic potentials in A●T minor 
grooves are greater than in G●C minor grooves.32-34 
Classic minor groove binders, such as netropsin and distamycin, are long, flexible, 
and crescent-shaped molecules. Netropsin and distamycin possess two and three N-
methylpyrrole rings, respectively, which are linked through peptide linkage to the 
positively charged amidinium (C(NH2)(NH2)+) group at the terminal position(s).31
This class of minor groove binders served as inspiration for the so-called hairpin 
polyamides later developed by Dervan's group, who particularly focused on 
development of modular sequence-selective minor groove binders.35, 36 
The driving forces for selective binding of netropsin and distamycin to A-T rich 
regions of B-DNA (Figure 1.12) are the result of displacement of water molecules that 
hydrate the minor groove of DNA and formation of hydrogen bonds between the NH 
groups on netropsin and the nitrogen in adenine and oxygen of thymine on each 
adjacent base pair, together with electrostatic and Van der Waals interactions.37
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Figure 1.12 Structures of distamycin and netropsin.31
Binding of netropsin to DNA usually occurs in a 1:1 ratio along four consecutive A•T 
base pairs, whereas distamycin is able to bind with DNA in the minor groove in two 
different modes, viz. a 1:1 and 2:1 ratio along five base pairs (Figure 1.13).38, 39
(a) (b)   (c)
Figure 1.13 The groove binding modes of netropsin and distamycin with duplex 
DNA: 1:1 binding of netropsin to the 5’-CGCAATTGCG-3’ sequence (NDB ID: 
GDLB05) (a), 1:1 binding of distamycin to the 5’-CGCAAATTTGCG-3’ sequence 
(NDB ID: GDL003) (b) and side-by-side binding of distamycin to the 5’-
GTATATAC-3’ sequence (NDB ID: GDH060) (c).
Another familiar minor groove binder is Hoechst 33258, which has shape 
resemblances with netropsin and distamycin (i.e. they have crescent shape). Hoechst 
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33258 possesses a π-conjugated oligoheteroaromatic framework. However, the 
presence of the single bonds that link the aromatic rings allows enough rotational 
flexibility to fit into the minor groove (Figure 1.14).40
Figure 1.14 Structure of H33258 (left), the minor groove binding of H33258 to 
d(CGCAAATTTGCG)2 (NDB ID: GDL028) (right).
Binding studies of H33258 with duplex DNA show that this ligand binds to A●T-rich 
sequence of DNA in the minor groove with a binding site size between 4 and 5 base 
pairs. In addition, H33258 shows low affinity for G●C-rich sequence of DNA.41
Other minor groove binders include compounds such as chromomycin A3 and 
mithramycin, which are antitumor antibiotics extracted from Streptomyces grisius and 
Streptomyces plicatus. In contrast to A●T-rich groove-binding molecules such as 
distamycin and netropsin discussed before, chromomycin A3 and mithramycin bind to 
the G●C-rich region of the duplex DNA sequences in the minor groove with a 
stoichiometry of 2:1 (ligand/duplex) molar ratio in the presence of a divalent metal 
ion such as Mg+2 (Figure 1.15).31
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Figure 1.15 Structures of mithramycin and chromomycin A3,31 and side-by-side 
binding of chromomycin A3 to d(AAGGCCTT)2 (NDB ID: 1D83).
A very interesting class of minor groove binders is formed by Dervan’s hairpin
polyamides (DHP), which are synthetic minor groove binders inspired by natural 
sequence-selective ligands netropsin and distamycin. DHPs provide modular and 
programmable sequence recognition of duplex DNA.36, 42 However, the sequence 
recognition of DHPs for double-stranded DNA is limited for 5 base pairs because the 
polyamide curvature no longer matches the curvature of the minor groove of DNA.43
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Therefore, new developed structures of polyamides were prepared by Dervan’s group. 
The developed polyamides linked turn to turn or turn to tail which recognise extended 
DNA sequence without losing selectivity along 10 base pairs (Figure 1.16).44, 45
Turn-to-turn tandem Turn-to-tail tandem              Candy cane
Figure 1.16 Schematic representations of polyamide for binding extended DNA 
sequences.36
Another interesting class of DNA minor groove binders is provided by CC-1065 and 
its derivatives (Adozelesin, bizelesin and carzelesin) (Scheme 1.5).86, 87 These 
compounds specifically bind to AT-rich regions of the DNA minor groove, leading to 
alkylation of DNA.
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Scheme 1.5 Chemical structures of CC-1065 and its derivatives.
Duocarmycin derivatives (Scheme 1.6) are also considered a potent class of antitumor 
agents. They bind to duplex DNA through the minor groove binding and lead to 
alkylation of DNA at the N3 position of adenine.88
Scheme 1.6 Some structures of duocarmycin derivatives.
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1.7 π-Conjugated polymers and oligomers
Fundamentally, polymers are macromolecules consisting of a high but finite number 
of repeated monomer units which are linked by covalent bonds, whereas oligomers 
consist of a low numbers of repeated monomer units. With respect to repeating unit 
types, polymers could be homo-polymers (consisting of one type of monomer) or co-
polymers (composed of two or more different monomers).46 Conjugated polymers 
have characteristic of π−delocalisation along the main chain, leading to their use as 
organic semiconductors (Scheme 1.7).47, 48 In addition, π-conjugated polymers 
typically possess rigid structures and interchain forces cause them to be insoluble in 
many organic solvents and aqueous medium. Therefore, cationic or anionic charged 
side chains are typically placed onto the polymer backbone to increase their solubility.
Scheme 1.7 Chemical structures of some semiconducting polymers.47
There are many π-conjugated oligomeric systems which bind to DNA. In general, 
these π-conjugated DNA binders are either composed of several heteroaromatic rings 
linked to each other, or have extended frameworks involving alkene units for further 
conjugation. The presence of cationic functional groups in some conjugated oligomers 
has been shown to increase the driving forces for these compounds to bind with DNA 
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via electrostatic interactions with the negatively charged phosphate ester backbone of 
DNA.49 In addition, optical and electrical properties of the conjugated polymers 
change upon interaction with bio-macromolecules such as DNA. Therefore, these 
optoelectronically active bio-macromolecules binders are promising components for 
biosensors.50, 51
1.8 Optical detection of DNA
The detection and quantification of small amounts of DNA in biological samples is of 
significant interest. Leclerc and co-workers first introduced the use of cationic 
polythiophenes to study DNA-hybridisation.50 Some structures which were used in 
the detection of DNA are shown in Scheme 1.8.
Scheme 1.8
The exploitation of cationic polythiophenes in the optical detection of DNA can be 
illustrated as follows (Figure 1.18). The free cationic polythiophene is yellow in an 
aqueous solution with a maximum absorption around 400 nm due to forming a 
random-coil conformation which leads to a decrease in the effective conjugation 
length. Upon addition of a single-stranded DNA (ssDNA), the colour of the solution 
becomes red and the UV-visible spectrum shows a maximum absorption around 527 
nm (Figure 1.17), owing to the formation of a double-stranded structure (duplex) 
between the polythiophene and single-stranded DNA probe (Figure 1.18), leading to 
planarising the polythiophene backbone and an increase in the effective conjugation 
length (i.e. causes to produce a strong red-shift). When the complementary strand of 
DNA is added to the mixture of polythiophene and ssDNA, the solution becomes 
yellow again with a maximum absorption around 420 nm. This change in lambda 
maximum is presumably caused by the formation of a new complex triplex structure. 
As described before, the cationic polythiophene shows different λmax in the duplex and 
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triplex forms. This difference in λmax is attributed to the presence of different 
conformations of polythiophene. Additionally, a fluorometric detection of DNA 
hybridization is also accomplishable as the fluorescence of polythiophene is quenched 
in the planar and aggregated form i.e. in the complex with single stranded DNA.51
Figure 1.17 Conformations and corresponding UV-visible absorption spectra of 
polythiophene.50
Figure 1.18 Optical detection of DNA. Reproduced from reference 50.
Introduction
28
1.9 Electrochemical detection of DNA
Electrochemical techniques are considered one of the most attractive methods to study 
oligonucleotides since these techniques offer low instrumentation costs, high 
sensitivity, ease of miniaturization and direct electronic readout.52-56 Garnier and co-
workers first reported electrochemically detection of DNA hybridization, where they 
designed a biosensor using an electroactive polypyrrole functionalized with an 
oligonucleotide probe.57 When a grafted oligonucleotide hybridizes with its 
complementary oligonucleotide target in solution, this causes a significant 
modification in the electrochemical response of polypyrrole, leading to a sensitive 
electrical reading of the recognition process. The modifications in electronic 
properties of polypyrrole were attributed to changes in the polymer conformation as a 
result of binding of the polymer-oligonucleotide probe to the target oligonucleotide 
strand.
Based on the method proposed by Garnier and co-workers, a variety of functionalized 
polythiophenes have been used to electrochemically detect DNA hybridization.58 For 
instance, Lee et al. introduced a terthiophene-carrying a carboxyl group which can be 
electropolymerized on a glass carbon electrode (Scheme 1.9).59
Scheme 1.9
In this study, the hybridization of the target oligonucleotide with immobilized 
polythiophene-oligonucleotide probe leads to a decrease in impedance values since 
the double-stranded DNA has higher impedance than single-stranded DNA. Thus, the 
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hybridization process can be easily confirmed based on the changes in the impedance 
values before and after hybridization.
In addition, Lee et al. carried out experiments to determine the response of the 
polythiophene-oligonucleotide probe to mismatched target oligonucleotides, such as 
one-base mismatch and two-base mismatch. The results showed very limited 
difference in impedance between before and after hybridization, indicating that 
polythiophene-oligonucleotide probe constructed in this study specifically recognizes 
matched and mismatched oligonucleotide sequences.59
Recently, several advances in electrochemical detection of DNA have been achieved, 
including detection of hybridization of single-stranded DNA on surfaces using 
voltammetry or electrochemical impedance spectroscopy.60-63
Zongbing and co-workers proposed a method for enhancing electrochemical detection 
of double-stranded DNA by using a hybridization chain reaction (HCR) and 
positively charged gold nanoparticles.64 They constructed a sensor where the capture 
probe was immobilized on a gold electrode surface (Figure 1.19). A sandwich 
complex was formed between capture probe and detection probe upon addition of 
dsDNA. Then two alternating ferrocene-modified DNA hairpins (H1 and H2) in turn 
were opened by the detection probe, initiating HCR to form double-helix. Meanwhile, 
the positively charged gold nanoparticles were electrostatically absorbed onto the 
negatively charged backbone of the double-helix to magnify the electrochemical 
signal.
Figure 1.19 Scheme of the proposed method for dsDNA recognition.64 
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Another example of enhancing electrochemical detection of DNA is using a novel 
complex [Co(GA)2(aqphen)]Cl as a signal enhancer that was introduced by our 
group.65
In addition, there are other examples where peptide nucleic acids (PANs) are used as 
probes in DNA biosensing instead of conventional single-stranded DNA.66-70 Peptide
nucleic acids are DNA mimics in which the sugar-phosphate backbone is replaced by 
2-aminoethyl-glycine linkages and the nucleotide bases are attached to the PNA 
backbone by a methylene bridge and a carbonyl group. There are several advantages 
of using PNAs as probes in biosensing, such as elimination of repulsion forces 
between two hybridized strands since the PNA backbone is neutral. Furthermore, 
PNA can bind to complementary strands with a higher affinity and selectivity than 
DNA does. 
Zhang and co-workers68 introduced a novel DNA biosensor based on electrochemical 
reduced graphene oxide (EGRO) and peptide nucleic acid PNA-DNA hybridization. 
The working principle of this biosensor is as follows; firstly, the graphene oxide is 
reduced onto the glassy carbon electrode (GCE, Figure 1.20) and then a PNA probe is 
immobilized onto the graphene surface using a linker (1-pyrenebutanoic acid 
succinimidyl ester, PASE). Thus, different PNA probes can be used for hybridization 
of different target DNA sequences. Methylene blue is used as an indicator for 
monitoring the hybridization event using deferential pulse voltammetry because it 
shows different reduction signals upon interactions with PNA and dsDNA.
Figure 1.20 Schematic illustration of the electrochemical DNA biosensor.68 
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1.10 Techniques used for quantification of affinity of small molecules for DNA
DNA-small molecules interactions can be studied through a variety of techniques, 
including UV-visible and circular dichroism (CD) spectroscopy, isothermal titration
calorimetry (ITC), viscometry. These techniques will be briefly described below. 
1.10.1 UV-visible spectroscopy
UV-visible spectroscopy is a technique that measures the interaction of electromagnetic 
radiation with matter. This technique is usually applied to those molecules which are able 
to absorb radiation energy in the UV-visible range. The absorbed energy is used to excite 
electrons from the electronic ground state to an excited state. Most organic molecules with 
highly conjugated systems, and many biological macromolecules such as proteins and 
nucleic acids, can be analysed using UV-visible spectroscopy.71 
Typically, there is a linear relation between the amount of radiation that is absorbed 
by a compound and its concentration with the linear correlation valid at a defined 
wavelength, solvent type and optical path length. This linear correlation is known as 
the Lambert-Beer law. Absorption spectroscopy is therefore considered a good 
method to study ligand-DNA interactions because data can be deconvoluted to yield 
concentrations of free and bound species. As a result of interactions of molecules with 
DNA alteration in structural conformations of ligands and local medium effects occur 
and these effects can lead to changes in spectroscopic response. The change may 
correspond to an increase (hyperchromicity) or decrease (hypochromicity) in molar 
absorptivity of ligands or possibly a shift of the wavelength of maximum absorption 
to higher wavelength (red shift) or lower wavelength (blue shift). 
When several spectra are plotted in one graph we may see a point that is called 
isosbestic point, where two species have the same molar absorptivity, suggesting the 
presence of only two species viz. free and bound ligands in the equilibrium.72,73
The changes in the ligand absorption properties can be exploited to quantify the 
interaction of ligands with DNA. When a titration curve is extracted from recorded 
UV-visible data, this curve can be analysed using a binding model. A frequently used 
model is the multiple independent binding sites (MIS) model. This model can be fitted 
to the data and give binding parameters (binding constant K and binding site size N). 
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The MIS model is derived starting from the complexation equilibrium (equation 1.1) 
and the concentrations of free ligand, free DNA and bound ligand (complex) are 
related through Kbind (equation 1.2). Each binding site consists of a specific number of 
base pairs (N), which is occupied by a single ligand molecule, thus the concentration 
of binding sites can be defined as the concentration of DNA base pairs divided by N
(equation 1.3).
Kbind is defined based on the equilibrium between the free ligand, free DNA and the 
complex (1.2). Since the concentration of free ligand [L]f and free binding site [bs]f
with complex concentration [C] are related through the total ligand concentration [L]t
and total binding site concentration [bs]t (1.4), (1.5) respectively, it is possible to 
establish an overall equation describing the equilibrium (1.6). Rearrangement of 
equation (1.6) leads to a quadratic representation of the complex concentration (1.7).  
Lf + bsf Lb (1.1)
Kbind = [L]b / [L]f . [bs]f, [L]b = [C] (1.2)
[bs] = [DNA] / N (1.3)
[L]t = [L]f + [C]      [L]f = [L]t  - [C]                                                   (1.4)
[bs]t = [bs]f + [C]   [bs]f = [bs]t  - [C]                                                  (1.5)
[C] = Kbind.([bs]t - [C]).([L]t - [C])                                                                
[C] = Kbind [bs]t.[L]t – Kbind.[C].[bs]t – Kbind.[C].[L]t – Kbind.[C]2 (1.6)
Kbind [C]2 – (1 + Kbind.[bs]t + Kbind.[L]t).[C] + Kbind.[bs]t.[L]t = 0 (1.7)
The classic equation (1.8) can be used to solve the quadratic equation (1.7), thus the 
concentration of complex [C] can be expressed as a function of total ligand and 
binding site concentrations (1.9).  
(1.8)
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By adding the Beer-lambert Law ( ), modified for background 
absorbance, into Equation 1.9, the observed absorbance is given by Equation 1.10. 
This equation can be fit to a plot of absorption against total DNA concentration to 
obtain the optimal approximations for binding constant and binding site size. 
signalobsd = background + signalfree, m.[L]t + ∆binding signalm
Equation 1.10
The terms in equation 1.10 are defined as follows;
signalobsd is the observed absorbance; background is the buffer absorbance; signalfree,m 
is the product of the cuvette pathlength and molar extinction coefficient; ∆binding
signalm is the product of the cuvette path length and the change in extinction 
coefficient upon binding; K is the binding constant; [DNA] is the DNA concentration 
in terms of base pairs; [L]tot is the total ligand concentration; N is the binding site size 
in base pairs.
For weak binders, the fraction of the bound binding sites in the presence of ligand can 
be estimated using the so-called c-value as demonstrated below.
Kb.[L]f = [C] / [bs]f      for [C] << [bs]f
[bs]f [bs]t and [L]f [L]t
Therefore, Kb.[L]f [C] / [bs]t       
Define the c-value as = Kb.[L]f c-value = Kb.[L]t
Thus, c-value [C] / [bs]t c-value [bs]b / [bs]t
c-value ratio of bound binding sites to the total binding sites.
If c-value = 0.05, indicating only 5% of binding sites occupied, confirming negligible 
binding.
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1.10.2 Circular Dichroism Spectroscopy (CDS) and Induced Circular Dichroism 
(ICD)
Circular dichroism spectroscopy is a technique that measures the difference in the 
absorption of left handed circularly polarised light (L CPL) and right handed 
circularly polarised light (R CPL) by chiral chromophores or by chromophores in a 
chiral environment. CD spectroscopy is in widespread use to study chiral molecules 
and biological macromolecules such as proteins and DNA.74
CD spectroscopy is usually carried out in the UV-visible wavelength region. 
Molecules that contain chiral chromophores will absorb one form of circularly 
polarised light to a higher extent than the other form. Thus the difference between the 
intensity of R-CPL and L-CPL being transmitted through the sample would be non-
zero and a CD signal will appear at the corresponding wavelength (Figure 1.21).75
CD spectroscopy can be exploited to determine binding parameters of small 
molecules binding to DNA. Duplex DNA usually shows a negative CD band around 
250 nm, which is attributed to a right handed helical form of DNA and a positive band 
around 275 nm resulting from base stacking in B-DNA structures (Figure 1.8). Upon 
binding of small molecules with DNA, a change in ellipticity of DNA bands can 
occur. A plot of changes in DNA ellipticity against added ligand can be analysed
using binding models, such as multiple independent binding sites (MIS) model to
obtain binding parameters.
Figure 1.21 Circular dichroism spectra of d-(CTCGAG)2 interacting with 
mitoxantrone.
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Molecular interactions between chiral and achiral compounds can lead to induced 
circular dichroism (ICD) of the achiral counterpart (Figure 1.22). The induced CD 
spectra that are obtained give information about configuration of the chiral component 
and the direction of the molecules relative to each other in the complex.
Figure 1.22 Induced circular dichroism (ICD) spectra for beneril interacting with
CTDNA.76
Induced CD spectra for DNA binders can be interpreted empirically in terms of the 
binding mode,76 because for molecules interacting with DNA, the interaction between 
the transition dipole moments of the ligand and the DNA bases substantially affects 
the ICD signal of the binder.77 Minor groove binders usually produce a transition 
moment that is orientated along the groove of B-form DNA and is at an angle of 45° 
with the DNA bases, leading to a strong positive ICD signal. On the other hand, the 
ICD signal for an intercalator is significantly dependent on the displacement
experienced with respect to the double helix and the nature of the base-pairs on either 
side of the site of intercalation. For example, for those intercalators which possess 
transition moments oriented along the main axis of the DNA, such as ethidium 
bromide, a negative ICD signal is observed.
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1.10.3 Isothermal Titration Calorimetry (ITC)
Isothermal titration calorimetry is a technique that directly measures the heat 
generated or absorbed as a result of molecular interactions. Modern and sensitive ITC 
has gained wide acceptance in drug discovery in general and in DNA binding studies 
in particular.78, 79 ITC is considered a unique technique because it allows simultaneous 
determination of all binding parameters (Binding constant (K), stoichiometry (N), ΔH
and ΔS) in a single experiment.
An isothermal titration calorimeter (Figure 1.23) consists of two cells, viz. a 
reference and a sample cell. A constant heat flow is applied to the reference cell and
the sample cell is heated in such a way that both cells stay at the same temperature.80
When ligand from the syringe is added to the macromolecule in the sample cell there 
are two possible scenarios. If the interaction is exothermic the temperature in the 
sample cell increases upon addition of the ligand to the macromolecule and this leads 
to the feedback power to the sample cell being decreased. In case of an endothermic 
interaction the sample cell cools down and the feedback power to the sample cell 
would be increased. 
80Schematic representation of the ITC instrument.Figure 1.23
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In a typical experiment, the raw data are plotted as power (heat flow per unit time) 
needed to maintain the sample cell at the same temperature as the reference cell 
against time. Integration of the raw data and dividing by the amount of material 
injected then gives the molar heat effects. These heat effects are then analysed in 
terms of a binding model.
Isothermal Titration Calorimetry data analysis using IC-ITC
In many ITC experiments high concentrations of ligand are required in order to obtain 
detectable heat effects. However, this high ligand concentration can result in self-
aggregation of ligand and leads to measurable heat effects for deaggregation upon 
dilution of the ligand into the cell. Therefore, self-aggregation of ligand should be 
taken into account during the data analysis, in conjunction with the consideration of 
DNA binding processes. When considering ligand self-aggregation in combination 
with binding processes, the mass balance equations become complex and cannot be 
solved analytically. Therefore, we use custom data analysis software, IC-ITC, which 
has been developed in-house.78, 79 Our developed IC-ITC software enables us to 
analyse numerically calorimetric data for combined self-aggregation and DNA 
binding in order to determine thermodynamic parameters for the various equilibria 
involved (Scheme 1.10). This analysis involves equilibrium concentrations 
determined numerically using the Newton-Raphson algorithm and simulated 
annealing for optimization of thermodynamic parameters.81, 82
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The first important step that IC-ITC performs is calculating all relevant total 
concentrations (e.g. biomolecule, ligand) in the sample cell after each injection and 
subsequently solving the mass balance equation (Equation 4.2).
-[L]t + = 0                                                             Equation 4.2
In equation 4.2, [L]t is the total ligand concentration, and [L]x represents the 
concentrations of ligand in all different states X, for example, free, bound to DNA, 
aggregated, etc. The formal relation between the concentrations of ligand taken up in 
the complexes and aggregated forms, [L]x, the free ligand concentration [L]f, total 
macromolecule concentrations [M]t and interaction parameters ax for the 
complexation events (i.e. equilibrium constants and stoichiometries) are illustrated in 
Equation 4.5.
[L]x = f([L]t, [M]t, ax)                                               Equation 4.5
During data analysis, IC-ITC determines the optimal parameter values ax, as 
identified by the lowest sum over square deviations. In addition, IC-ITC calculates the 
error margins and covariances for different variables.
1.10.4 Viscosimetry 
Viscosimetry is a useful technique for the study of the interaction mode of a binder 
with DNA in aqueous solution.83, 84 Intercalation of a species between the base pairs 
of DNA causes the separation of these bases, leading to an overall increase in the 
length of the DNA helix and therefore an increased viscosity of the DNA solution. In 
contrast, a minor groove binder results in negligible perturbation of the DNA length, 
the net result of which is a negligible change or no change in the viscosity of the DNA 
solution.
The relative viscosity (η) of the DNA solution can be determined using a glass 
capillary viscometer, and is calculated through equation 1.5.    
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Where t is the observed flow time of the DNA solution in the viscometer and t0 is the 
flow time of the buffer. As stated by Cohen and Eisenberg,85 the change in the 
viscosity of the free and bound DNA (L / L0) is given by calculating equation 1.6.
The terms in Equation 1.6 are defined as follows;
L is the contour length of rod-like macromolecules; p is the axial ratio of the rods; r is 
ratio of bound complex to DNA; η is the intrinsic viscosity of the DNA solution at 
different binding ratios, r.
1/3)0η/ηThe subscripts zero indicate the absence of the binder. The relative viscosity (
is plotted against the binding ratio r, and an increase or no increase in the viscosity of 
DNA is observed, depending on the modes of interaction (i.e. groove binding or 
intercalation).
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1.10.5 Competition dialysis
Another powerful quantitative tool for finding structure-selective compounds that 
bind with specific nucleic acid structures is competition dialysis.89 The competition 
dialysis experiment is based on the basic thermodynamic principle of equilibrium 
dialysis. This experiment is usually carried out by dialysis of an array of nucleic acid 
structures against a ligand solution. The array containing the nucleic acid structures is
placed above ligand solution and separated through a semi-permeable membrane that 
is characterized by pore sizes which permit ligands to go through but disallow large 
macromolecules (Figure 1.24).90
Figure 1.24 Schematic of the competition dialysis experiment.90
At equilibrium, the amount of free ligand in both of the dialysis parts (i.e. a chamber 
that contains ligand and a chamber that contains nucleic acid) must be same. Any 
increase in total ligand at the nucleic acid side, is the result of the affinity between 
nucleic acid and ligand, and the increase therefore corresponds to bound ligand with 
nucleic acid. Thus, equilibrium dialysis can be manipulated to determine binding
affinities of small molecules for nucleic acids such as duplex DNA.
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)mT(temperatureMelting 61.10.
Melting temperature of nucleic acids can be exploited to study interaction of small-
molecules to nucleic acids, particularly DNA and RNA. A plot of recorded UV 
absorption of DNA as a function of temperature gives a so-called melting curve.91 The 
midpoint of that melting curve is defined as a melting temperature (Tm), where 
absorbance increases most strongly with increasing temperature. Mainly, the melting 
temperature (Tm) is affected by nature of base composition of DNA, length of DNA 
strands, salt concentration and type of counter-ion in the solution. Interaction of small 
molecules to duplex DNA also affects the melting temperature (Tm). Binding of small 
molecules as intercalators to duplex DNA can increase stability of DNA, leading to
increase melting temperature (Tm) considerably around 5-8 °C, whereas, non-
intercalative binding results in smaller or negligible change in melting temperature 
(Tm).92
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1.11 Project Aims
Compounds binding to DNA have interested many scientists and researchers since the 
importance of DNA has been revealed.  Binding of a compound with selectivity for a 
specific DNA sequence is of significant interest in medical and pharmaceutical 
respects. Compounds that are able to bind with a specific DNA sequence can be used 
as anti-cancer agents, blocking interaction of mutated sequences with proteins. 
Alternatively, if DNA binding is accompanied by changes in physical properties of 
the DNA binders (such as absorbance spectra, redox properties), such binders can be 
used as components of genosensors. In addition, binding of ligands with nucleic acids 
can be manipulated for the assembly of functional multicomponent structures 
containing active components.
The main aim of this project is to advance optoelectronically active DNA-binding 
compounds that show sequence selectivity for use as sensitisers in sensors for 
detection of genetic biomarkers. The sensitisers bind to DNA and their spectroscopic 
and electronic properties may change upon interaction with DNA, thus allowing 
different applications including in biosensors. Of particular interest are sensitisers that 
can be used in multimodal genosensors such as the design we have recently 
published.65 
In our project we have introduced three different sets of DNA binders. The first group 
is composed of 1,8-naphthalimide derivatives which are oligoheteroaromatic 
compounds having a flat π-conjugated framework attached to different side-groups. 
Based on their structure, we anticipate the compounds of this group to bind to duplex 
DNA mostly through intercalation and this binding may change spectroscopic and 
electronic properties of these DNA binders. The second group of DNA binders is a 
family of dendrimeric compounds. These compounds consist of a highly fluorescent 
flat moiety that is attached to small poly(amido amine) side-groups to increase 
solubility in aqueous medium. According to their structure, we also expect the 
compounds of dendrimeric family bind to duplex DNA via intercalation and they may 
change their optical and electronic behaviours upon binding. The third group of our 
DNA binders consists of a variety of compounds that have diverse structural 
frameworks.    
Introduction
43
1.12 References  
1) Lippert, B., Cisplatin: chemistry and biochemistry of a leading anticancer drug, 
John Wiley & Sons, 1999.
2) Najari, A.; Ho, H. A.; Gravel, J. F.; Nobert, P.; Boudreau, D.; Leclerc, M., Anal.  
Chem. 2006, 78 (22), 7896-7899.
3) Gottesfeld, J. M.; Neely, L.; Trauger, J. W.; Baird, E. E.; Dervan, P. B., Nature
1997, 387 (6629), 202-205.
4) Voet, D. and Voet, J. G., Biochemistry, 2nd ed., John Wiley & Sons, New York,
1995.
5) McMurry, J., Organic Chemistry, 3rd ed., Brooks/Cole, 1992.
6) Mainwaring, W.I.P.; Parish, J.H.; Pickering, J. D. and Mann N.H., Nucleic acid                              
biochemistry and molecular biology, Blackwell Scientific, Oxford, 1982.
7) Sriram, M.; Vandermarel, G. A.; Roelen, H.; Vanboom, J. H.; Wang, A. H. J., 
Embo Journal 1992, 11 (1), 225-232.
8) Lowe, C. R., Trends in Biotechnology 1984, 2(3), 59–65.
9) Sun, Z.; Liao, T.; Zhang, Y.; Shu, J.; Zhang, H. and Zhang, G. J., Biosensors and 
Bioelectronics 2015, 86, 194-201.
10) Zhang, F.T.; Cai, L.Y.; Zhou, Y. L. and Zhang, X. X., TrAC Trends in Analytical 
Chemistry 2016, 85, 17-32.
11) Chao, J.; Zhu, D.; Zhang, Y.; Wang, L. and Fan, C., Biosensors and 
Bioelectronics 2016, 76, 68-79.
12) Justino, C. I.; Freitas, A. C.; Pereira, R.; Duarte, A. C. and Santos, T. A. R., TrAC 
Trends in Analytical Chemistry 2015, 68, 2-17.
13) Drummond, T.G.; Hill, M.G. and Barton, J.K., Nature biotechnology 2003, 
21(10), 1192-1199.
14) Marazuela, M.; Moreno-Bondi, M., Anal. Bioanal. Chem. 2002, 372- 664.
15) [Anonymous], The Structures of DNA and RNA, p1-33, 2002. Available from: 
http://biology.kenyon.edu/courses/biol63/watson_06.pdf.
Introduction
44
16) Watson, J. D. and Crick, F. H., Nature 1953,171, 737-738.
17) Yakovchuk, P.; Protozanova, E.; Frank-Kamenetskii, M. D., Nucleic Acids 
Research 2006, 34 (2), 564-574.
18) Blackburn, G. M.; Gait M. J.; Loakes, D.; Williams, D. M., Nucleic Acids in 
Chemistry and Biology 3rd Edition Introduction and Overview, Royal Soc 
Chemistry: 2006.
19) Jeremy, M.; Berg, J. L. T.; Lubert Stryer, Biochemistry, WH Freeman and 
Company: New York, 2006.
20) Wing R.; Drew, H.; Takano, T.; Broka, C.; Tanaka, S.; Itakura, K.; Dickerson, R. 
E., Nature 1980, 287 (5784), 755-758.
21) Alberts, B.; Johnson, A.; Walter, P.; Lewis, J.; Raff, M. and Roberts, K., 
Molecular biology of the cell. References edition, 5th ed. Edn., Garland Science, 
New York, N.Y.; Abingdon, 2008.
22) Kastan, M.B. and Bartek, J., Nature, 2004, 432, 316-323.
23) Roat-Malone, R.M.; Wiley, J.; Sons, I., Bioinorganic Chemistry, 2002.
24) Stryer, L., Biochemistry, 4th ed., W.H. Freeman, 1999.
25) Chaires, J. B.; Dattagupta, N.; Crothers, D. M., Biochemistry 1982, 21 (17), 
39333940.
26) Neto, B. A. D.; Lapis, A. A. M., Molecules 2009, 14 (5), 1725-1746.
27) Zimmer, C.; Wahnert U., Progress in Biophysics & Molecular Biology 1986, 47 
(1), 31-112.
28) Shui, X. Q.; Sines C. C.; McFail-Isom, L.; Van Derveer, D.; Williams, L. D., 
Biochemistry 1998, 37 (48), 16877-16887.
29) Boresch, S.; Karplus M., Journal of Molecular Biology 1995, 254 (5), 801-807. 
30) Strekowski, L.; Wilson, B., Mutation Research-Fundamental and Molecular 
Mechanisms of Mutagenesis 2007, 623 (1-2), 3-13.
Introduction
45
31) Nakamoto, K.; Tsuboi, M.; Strahan, G. D., Drug-DNA interactions: structures 
and spectra; John Wiley & Sons, Inc., Hoboken, New Jersey; 2008.
32) Goodsell, D.S.; Kopka, M. L. and Dickerson, R. E., Biochemistry, 1995, 34, 4983-
4993.
33) Wartell, R. M.; Larson, J. E. and Wells, R.D., The Journal of Biological 
Chemistry, 1974, 249, 6719-6731.
34) Pullmanand, A.; Pullman, B., Quarterly Reviews of Biophysics, 1981, 14, 289-
380.
35) Dickinson, L. A.; Burnett, R.; Melander C.; Edelson, B. S.; Arora, P. S.; Dervan, 
P. B.; Gottesfeld, J. M., Chemistry & Biology 2004, 11 (11), 1583-1594. 
36) Dervan, P. B.; Edelson, B. S., Current Opinion in Structural Biology 2003, 13 (3), 
284-299. 38.
37) Kopka, M. L.; Yoon, C.; Goodsell, D.; Pjura, P.; Dickerson, R. E., Proceedings of 
the National Academy of Sciences of the United States of America 1985, 82 (5), 
13761380.
38) Pelton, J. G.; Wemmer, D. E., Proc. Natl. Acad. Sci. U.S.A. 1989, 86 (15), 5723-
5727.
39) Lah, J.; Carl, N.; Drobnak, I.; Sumiga, B.; Vesnaver, G., Acta Chim. Slov. 2006, 
53(3), 284-291.
40) Harshman, K. D.; Dervan, P. B., Nucleic Acids Research 1985, 13 (13), 
48254835.
41) Moon, J. H.; Kim, S. K.; Sehlstedt, U.; Rodger, A.; Norden, B., Biopolymers
1996, 38 (5), 593-606.
42) Dervan, P. B., Bioorg. Med. Chem. 2001, 9 (9), 2215-2235.
43) Kelly, J. J.; Baird, E. E.; Dervan, P. B., Proc. Natl. Acad. Sci. U.S.A. 1996, 93 
(14), 6981-6985.
44) Herman, D. M.; Baird, E. E.; Dervan, P. B., Chem.-Eur. J. 1999, 5 (3), 975-983. 
45) Weyermann, P.; Dervan, P. B., J. Am. Chem. Soc. 2002, 124 (24), 6872-6878.
Introduction
46
46) Painter, P. C. C., Michael M., Fundamentals of Polymer Science: an introductory 
text. Technomic Pub. Co.: Lancaster, 1997.
47) Jaiswal, M.; Menon, R., Polym. Int. 2006, 55, 1371-1384. 
48) Murphy, A. R.; Frechet, J. M. J., Chem. Rev. 2007, 107, 1066-1096.
49) Wilson, W. D.; Tanious, F. A.; Ding, D. Y.; Kumar, A.; Boykin, D. W.; Colson, 
P.; Houssier, C.; Bailly, C., Journal of the American Chemical Society 1998, 120 (40), 
10310-10321.
50) Ho, H. A.; Najari, A.; Leclerc, M., Accounts Chem. Res. 2008, 41 (2), 168-178.
51) Leclerc, M. Optical and Electrochemical Transducers Based on Functionalized 
Conjugated Polymers. Adv. Mater. 1999, 11, 1491–1498.
52) Bakker, E.; Telting-Diaz, M., Anal. Chem. 2002, 74 (12), 2781-2800
53) Alligrant, T.M.; Nettleton, E.G. and Crooks, R.M., Lab on a Chip 2013, 13(3), 
349-354.
54) Cai, Z.; Song, Y.; Wu, Y.; Zhu, Z.; Yang, C.J. and Chen, X., Biosensors and 
Bioelectronics 2013, 41, 783-788.
55) Jing, X.; Cao, X.; Wang, L.; Lan, T.; Li, Y. and Xie, G., Biosensors and 
Bioelectronics 2014, 58, 40-47.
56) Balintová, J.; Špaček, J.; Pohl, R.; Brázdová, M.; Havran, L.; Fojta, M. and 
Hocek, M., Chemical Science 2015, 6(1), 575-587.
57) Korri-Youssou¿, H.; Garnier, F.; Srivastava, P.; Godillot, P.; Yassar, A., J. Am. 
Chem. Soc. 1997, 119, 7388–7389.
58) Li, G. T.; Kossmehl, G.; Welzel, H. P.; Engelmann, G.; Hunnius, W. D.; Plieth, 
W.; Zhu, H. S., Macromol. Chem. Phys. 1998, 199 (4), 525-533.
59) Lee, T. Y.; Shim, Y. B., Anal. Chem. 2001, 73 (22), 5629-5632.
60) Ronkainen, N. J.; Halsall, H. B.; Heineman, W. R., Chem. Soc. Rev. 2010, 39 (5),
1747-1763.
61) Keighley, S. D.; Li, P.; Estrela, P.; Mighorato, P., Biosens. Bioelectron. 2008, 23 
(8), 1291-1297.
Introduction
47
62) Peng, H.; Zhang, L. J.; Soeller, C.; Travas-Sejdic, J., Biomaterials 2009, 30 (11), 
2132-2148. 
63) Keighley, S. D.; Estrela, P.; Li, P.; Mighorato, P., Biosens. Bioelectron. 2008, 24 
(4), 906-911.
64) Li, Z.; Miao, X.; Xing, K.; Zhu, A. and Ling, L., Biosens. Bioelectron. 2015, 74, 
687-690.
65) Regan, E. M.; Hallett, A. J.; Wong, L. C.; Saeed, I. Q.; Jones, E. E.; Buurma, N. 
J.; Pope, S.; Estrela, P., Electrochimica Acta 2014, 128, 10-15.
66) Nielsen, P. E., Current Opinion in Biotechnology 2001, 12(1), 16-20.
67) Cao, M.; Deng, L. and Xu, H., Colloids and Surfaces A: Physicochemical and 
Engineering Aspects 2015, 470, 46-51.
68) Du, D.; Guo, S.; Tang, L.; Ning, Y.; Yao, Q. and Zhang, G. J., Sensors and 
Actuators B: Chemical 2013, 186, 563-570.
69) Liu, X.; Qu, X.; Fan, H.; Ai, S. and Han, R., Electrochimica Acta 2010, 55(22), 
6491-6495.
70) Choi, Y.; Metcalf, G.; Sleiman, M.H.; Vair-Turnbull, D. and Ladame, S. 
Bioorganic & medicinal chemistry 2014, 22(16), 4395-4398.
71) S. L. Upstone, Encyclopedia of Analytical Chemistry, R.A. Meyers (Ed.) John 
Wiley & Sons Ltd, Chichester, 2000, 1699–1714.
72) Moore, J. W. and Pearson, R. G., Kinetics and Mechanism, John Wiley & Sons. 
Inc., New York, USA, 1981.
73) Pavia, D. L.; Lampman, G. M. and Kriz, G. S., Ultraviolet Spectroscopy. 
Introduction to Spectroscopy. Harcourt College Publishers, Edition 3, 2001, 353-358.
74) Corrêa, D. H. A. and C. H. I. Ramos, African Journal of Biochemistry Research, 
2009, 3, 164-173. 
75) SH. M. Kelly and N. C. Price, Current Protein and Peptide Science, 2000, 1, 349-
384.
76) N.C. Garbett, P.A. Ragazzon, and J.B. Chaires, Nature protocols, 2007, 2, 3166-
3172.
Introduction
48
77) Eriksson, M.; Norden, B., Drug-Nucleic Acid Interactions 2001, 340, 68-98.
78) Buurma, N. J.; Haq, I., Methods, 2007, 42, 2, 162-172.
79) Burrma, N. J.; Haq, I., J. Mol. Biol., 2008, 381, 3, 607-621.
80) Freyer, M. W.; Lewis, E.A., Biophysical Tools for Biologists, Volume One: In 
Vitro Techniques, 4, 2008, 79-113.
81) Press, W. H.; Flannery, B. P.; Teukolsky, S. A.; Vetterling, W. T., Numerical 
Recipes in Pascal 2004, 270. 
82) Kirkpatrick, S.; Gelatt, C. D.; Vecchi, M. P., Science 1983, 220 (4598), 671-680.
83) Satyanarayana, S.; Dabrowiak, J. C.; Chaires, J. B., Biochemistry 1993, 32 (10), 
2573-2584. 
84) Suh, D.; Chaires, J. B., Bioorg. Med. Chem. 1995, 3 (6), 723-728.
85) Cohen, G.; Eisenber.H, Biopolymers 1969, 8 (1), 45-55.
86) Hidalgo, M.; Izbicka, E.; Cerna, C.; Gomez, L.; Rowinsky, E.K.; Weitman, S.D. 
and Von Hoff, D.D., Anti-cancer drugs 1999, 10 (3), 295-302.
87) Cai, X.; Gray, P.J. and Von Hoff, D.D., Cancer treatment reviews 2009, 35 (5), 
437-450.
88) Boger, D.L., Pure and applied chemistry 1994, 66 (4), 837-844.
89) Jaumot, J. and Gargallo, R., Current pharmaceutical design 2012, 18 (14), 1900-
1916.
90) Waring, M.J.; Chaires, J.B. and Armitage, B.A., DNA binders and related 
subjects 2005, (Vol. 253). Springer Science & Business Media.
91) Blackburn, G.M., Nucleic acids in chemistry and biology 2006. Royal Society of 
Chemistry.
92) Bi, S.; Zhao, T.; Wang, Y.; Zhou, H.; Pang, B. and Gu, T., Spectrochimica Acta 
Part A: Molecular and Biomolecular Spectroscopy 2015, 150, 921-927.
93) Schöning, M.J. and Poghossian, A., Analyst 2002, 127 (9), 1137-1151.
94) Pejcic, B. and De Marco, R., Electrochimica Acta 2006, 51 (28), 6217-6229.
95) Daniels, J.S. and Pourmand, N., Electroanalysis 2007, 19 (12), 1239-1257.
96) Park, J.Y. and Park, S.M., Sensors 2009, 9 (12), 9513-9532.
Introduction
49
97) Brand, U.; Brandes, L.; Koch, V.; Kullik, T.; Reinhardt, B.; Rüther, F.; Scheper, 
T.; Schügerl, K.; Wang, S.; Wu, X. and Ferretti, R., Applied microbiology and 
biotechnology 1991, 36 (2), 167-172.
98) Maddalena, F.; Kuiper, M.J.; Poolman, B.; Brouwer, F.; Hummelen, J.C.; de 
Leeuw, D.M.; De Boer, B. and Blom, P.W., Journal of Applied Physics 2010, 108 
(12), 124501.
99) Zhang, J.; Song, S.; Wang, L.; Pan, D. and Fan, C., Nature protocols 2007, 2 (11), 
2888-2895.
100) Wei, F.; Lillehoj, P.B. and Ho, C.M., Pediatric research 2010, 67 (5), 458-468.
101) Perumal, V. and Hashim, U., Journal of Applied Biomedicine 2014, 12 (1), 1-15.
102) Daly, C.J. and McGrath, J.C., Pharmacology & therapeutics 2003, 100 (2), 101-
118.
103) Ramanathan, A.; Pape, L. and Schwartz, D.C., Analytical biochemistry 2005, 
337 (1), 1-11.
Chapter 2
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Abstract
In this chapter we describe the results of studies of the interactions of a group of 1,8-
naphthalimide derivatives with double- stranded DNA using variety of techniques viz.
spectroscopy, calorimetry, viscosity and molecular docking studies. Most ligands bind 
to duplex DNA moderately strongly through different binding modes varying from 
minor-groove binding to intercalation to side-by-side binding in the minor groove. 
Sequence selectivity of this group of compounds for specific sequences 
(dAdT)12●(dAdT)12 and (dGdC)12●(dGdC)12 was also studied via UV-visible 
spectroscopy, showing that the 1,8-naphthalimide derivatives have a higher affinity 
for (dAdT)12●(dAdT)12 than for (dGdC)12●(dGdC)12.  
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2.1 Introduction
DNA-binding can be studied using a variety of techniques, including UV-visible
spectroscopy, isothermal titration calorimetry (ITC), circular dichroism spectroscopy 
and viscosimetry. A full description and discussion of these techniques is provided in 
Chapter 1 but a short review of these methods is provided below.
2.1.1 UV-Visible Spectroscopy (UV-Vis)
UV-visible spectroscopy is a technique that measures the interaction of electromagnetic 
radiation with matter. This technique is usually applied to those molecules which are able 
to absorb radiation energy in the UV-visible range. The absorbed energy is used to excite 
electrons from the electronic ground state to an excited state. Most organic molecules with 
highly conjugated systems, and many biological macromolecules such as proteins and 
nucleic acids, can be analysed using UV-visible spectroscopy.10
Absorption spectroscopy is therefore considered a good method to study ligand-DNA 
interactions because data can be deconvoluted to yield concentrations of free and 
bound species. As a result of interactions of molecules with DNA alteration in 
structural conformations of ligands and local medium effects occur and these effects 
can lead to changes in spectroscopic response. The change may correspond to an 
increase (hyperchromicity) or decrease (hypochromicity) in molar absorptivity of 
ligands or possibly a shift of the wavelength of maximum absorption to higher 
wavelength (red shift) or lower wavelength (blue shift).
2.1.2 Circular Dichroism Spectroscopy (CDS)
Circular dichroism spectroscopy is a technique that measures the difference in the 
absorption of left handed circularly polarised light (L CPL) and right handed 
circularly polarised light (R CPL) by chiral chromophores or by chromophores in a 
chiral environment. CD spectroscopy is in widespread use to study chiral molecules 
and biological macromolecules such as proteins and DNA.8
CD spectroscopy is usually carried out in the UV-visible wavelength region. 
Molecules that contain chiral chromophores will absorb one form of circularly 
polarised light to a higher extent than the other form. Thus the difference between the 
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intensity of R-CPL and L-CPL being transmitted through the sample would be non-
zero and a CD signal will appear at the corresponding wavelength.5
Molecular interactions between chiral and achiral compounds can lead to induced 
circular dichroism (ICD) of the achiral counterpart. The induced CD spectra that are 
obtained give information about configuration of the chiral component and the 
direction of the molecules relative to each other in the complex. Induced CD spectra 
for DNA binders can be interpreted empirically in terms of the binding mode.1
2.1.3 Isothermal Titration Calorimetry (ITC)
Isothermal titration calorimetry is a technique that directly measures the heat 
generated or absorbed as a result of molecular interactions. Modern and sensitive ITC 
has gained wide acceptance in drug discovery in general, and in DNA binding studies 
in particular.2,3 ITC is considered a unique technique because it allows simultaneous 
determination of all binding parameters (K, N, ΔH and ΔS) in a single experiment.
An isothermal titration calorimeter consists of two cells, viz. a reference and a sample 
cell. A constant heat flow is applied to both cells and the cells should stay at the same 
temperature. When ligand from the syringe is added to the macromolecule in the 
sample cell there are two possible scenarios. If the interaction is exothermic the 
temperature in the sample cell increases upon addition of the ligand to the 
macromolecule and this leads to the feedback power to the sample cell being 
decreased. In case of an endothermic interaction the sample cell cools down and the 
feedback power to the sample cell would be increased.
In a typical experiment, the raw data are plotted as power (heat flow per unit time) 
needed to maintain the sample cell at the same temperature as the reference cell 
against time. Integration of the raw data and dividing by the amount of material 
injected then gives the molar heat effects. These heat effects are then analysed in 
terms of a binding model.
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2.1.4 Viscosimetry 
Viscosimetry is a useful technique for the study of the mode of interaction of a binder 
with DNA in aqueous solution.7 Intercalation of a species between the base pairs of 
DNA causes the separation of these bases, leading to an overall increase in the length 
of the DNA helix and therefore an increased viscosity of the DNA solution. In 
contrast, binding of a minor groove binder results in negligible perturbation of the 
DNA length, the net result of which is a negligible change or no change in the 
viscosity of the DNA solution.
DNA binding studies for 1,8-naphthalimide derivatives
55
2.1.5 Aims
Our objectives in this chapter are to quantify thermodynamics of binding for a group 
of 1,8-naphthalimide derivatives (Scheme 2.1) to duplex DNA, and establish the 
mode of interactions, using several techniques viz, UV-visible spectroscopy, 
isothermal titration calorimetry, circular dichroism spectroscopy, viscometry and 
molecular docking study.
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Scheme 2.1
All compounds in Scheme 2.1 were provided by our collaborator (Simon Pope group).
These compounds consist of flat aromatic frameworks (1,8-naphthalimide) with a
variety of side-groups attached. According to their structure, we expect that the 
compounds of this family bind to duplex DNA via intercalation and their optical and 
electronic behaviours may change upon binding. For all compounds 2.1-2.9, their 
structural frameworks are fluorescent, which allows use in fluorimetry-based assays. 
Compounds 2.1-2.3 carry significant negative charges, which may make these 
compounds of interest for use as sensitisers in electrochemical impedance 
spectroscopy (EIS) genosensors upon binding with DNA. Compound 2.4 is 
redoxactive and could be used in coulometry. Like 2.1-2.3 compounds 2.8 and 2.9 
carry negative charges, which make these compounds potentially interesting as signal 
enhancer in genosensors based on EIS.
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2.2 Results and Discussion
The results of the interaction studies for compounds 2.1-2.9 with DNA will be shown
and discussed for each individual compound.
2.2.1 UV-visible spectroscopy
2.2.1.a UV-visible spectroscopy studies of 2.1 binding to DNA
The binding of 2.1 to DNA was studied using UV-visible spectroscopy; the changes 
in absorption of 2.1 upon addition of FSDNA were measured in buffer (25 mM 
MOPS, pH 7.0, 50 mM NaCl) at 25 °C (Figure 2.1).
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Figure 2.1 UV-visible spectra for 0.066 mM 2.1 upon addition of 0 – 3.33 mM 
FSDNA in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl) at 25 °C.
Figure 2.1 shows a hypochromic shift in absorbance (at the λmax of 347 nm) and a
hyperchromic shift (at 390 nm) of 2.1 upon addition of FSDNA. This change in UV-
visible absorption may occur as a result of geometrical distortion of 2.1 when it 
interacts with DNA, but it may also be a local medium effect.  
To quantify the affinity of 2.1 for FSDNA, the absorbances at 347 and 390 nm were 
plotted as a function of concentration of FSDNA (Figure 2.2, for data in tabular 
format see appendix, Tables A15.1 & A15.2).
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Figure 2.2 Absorbance at 347 nm (■) and at 390 nm (●) of a solution of 0.066 mM 
2.1 as a function of DNA concentration, absorbance at 347 nm (▲) and at 390 nm (▼) 
of a solution of 0.093 mM 2.1 as a function of DNA concentration, in buffer (25 mM 
MOPS, pH 7.0, 50 mM NaCl) at 25 °C. The solid lines represent a global fit of a 
multiple independent sites model to the data.
The titration curves in Figure 2.2 were analysed globally in terms of a multiple 
independent binding sites model, which also takes ligand dilution into account, giving 
an equilibrium constant (Kbinding) of (5.21 ± 5.76) ×103 M-1 and a binding site size of 
(2.01 ± 1.80) base pairs. The large error margins suggest significant parameter 
covariance. We therefore re-analysed the data for a binding site size n restricted to 3 
base pairs (for these types of DNA binders the average binding site size n is around 3 
base pairs). The fit gave an equilibrium constant (Kbinding) of (8.58 ± 0.85) ×103 M-1.
2.2.1.b UV-visible spectroscopy studies of 2.2 binding to DNA
The binding of 2.2 to DNA was similarly studied using UV-visible spectroscopy; the 
changes in absorption of 2.2 upon addition of FSDNA were measured in buffer (25 
mM MOPS, pH 7.0, 50 mM NaCl) at 25 °C (Figure 2.3).
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Figure 2.3 UV-visible spectra for 0.068 mM 2.2 upon addition of 0 – 2.9 mM 
FSDNA in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl) at 25 °C.
Figure 2.3 shows a hypochromic shift in absorbance (at the λmax of 347 nm) and a
hyperchromic shift (at 390 nm) of 2.2 upon addition of FSDNA. This change in UV-
visible absorption may occur as a result of geometrical distortion of 2.2 when it 
interacts with DNA, but it may also be a local medium effect.  
To quantify the affinity of 2.2 for FSDNA, the absorbances at 347 and 390 nm for 
three titrations were plotted as a function of concentration of FSDNA (Figure 2.4, for 
data in tabular format see appendix, Tables A15.3, A15.4 & A15.5).
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Figure 2.4 Absorbance at 347 nm (■) and at 390 nm (●) of a solution of 0.068 mM 
2.2 as a function of DNA concentration, absorbance at 347 nm (▲) and at 390 nm (▼) 
of a solution of 0.082 mM 2.2 as a function of DNA concentration, absorbance at 347 
nm (♦) and at 390 nm (◄) of a solution of 0.046 mM 2.2 as a function of DNA 
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concentration, in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl) at 25 °C. The solid 
lines represent a global fit of a multiple independent sites model to the data.
The titration curves in Figure 2.4 were analysed globally in terms of a multiple 
independent binding sites model, which also takes ligand dilution into account. This 
fit produces an equilibrium constant (Kbinding) of (0.016 ± 2.28) ×104 M-1 and a binding 
site size of (0.061 ± 8.16) base pairs. The obtained binding parameters from data 
analysis were not reasonable therefore the data were reanalyzed with the 
stoichiometry restricted to binding sites of 3.0 base pairs, giving a binding constant 
(Kbinding) of (10.94 ± 2.82) ×103 M-1.
2.2.1.c UV-visible spectroscopy studies of 2.3 binding to DNA
The binding of 2.3 to DNA was studied using UV-visible spectroscopy; the changes 
in absorption of 2.3 upon addition of FSDNA were measured in buffer (25 mM 
MOPS, pH 7.0, 50 mM NaCl) at 25 °C (Figure 2.5).
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Figure 2.5 UV-visible spectra for 0.052 mM 2.3 upon addition of 0 – 8.6 mM DNA 
in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl) at 25 °C.
Figure 2.5 shows a hypochromic shift in absorbance (at the λmax of 347 nm) and a
hyperchromic shift (at 390 nm) of 2.3 upon addition of DNA. This change in UV-
visible absorption may occur as a result of geometrical distortion of 2.3 when it 
interacts with DNA, but it may also be a local medium effect.  
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To quantify the affinity of 2.3 for FSDNA, the absorbances at 347 and 390 nm for two 
titrations were plotted as a function of concentration of FSDNA (Figure 2.6, for data 
in tabular format see appendix, Tables A15.6 & A15.7).
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Figure 2.6 Absorbance at 347 nm (■) and at 390 nm (●) of a solution of 0.052 mM 
2.3 as a function of DNA concentration, absorbance at 347 nm (▲) and at 390 nm (▼) 
of a solution of 0.031 mM 2.3 as a function of DNA concentration, in buffer (25 mM 
MOPS, pH 7.0, 50 mM NaCl) at 25 °C. The solid lines represent a global fit of a 
multiple independent sites model to the data.
The titration curves in Figure 2.6 were analysed globally by fitting of a multiple 
independent binding sites model, which also takes ligand dilution into account, to the 
data. The fit indicates an equilibrium constant (Kbinding) of (4.20 ± 6.62) ×104 M-1 and 
a binding site size of (41.68 ± 27.37) base pairs. The obtained value of binding site 
size was unreasonable therefore the data of the titration curves were reanalysed,
giving an equilibrium constant (Kbinding) of (1.20 ± 0.35) ×103 M-1 for a binding site 
size restricted to 3 base pairs.
2.2.1.d UV-visible spectroscopy studies of 2.4 binding to DNA
The binding of 2.4 to DNA was studied using UV-visible spectroscopy; the changes 
in absorption of 2.4 upon addition of DNA were recorded in buffer (25 mM MOPS, 
pH 7.0, 50 mM NaCl) at 25 °C (Figure 2.7).
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Figure 2.7 UV-visible spectra for 0.032 mM 2.4 upon addition of 0 – 2.84 mM DNA 
in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl) at 25 °C.
Figure 2.7 shows a hypochromic shift in absorbance (at the λmax of 347 nm) and a
hyperchromic shift (at 390 nm) of 2.4 upon addition of DNA. This change in UV-
visible absorption may occur as a result of geometrical distortion of 2.4 when it 
interacts with DNA, but it may also be a result of a local medium effect.  
To quantify the affinity of 2.4 for FSDNA, the absorbances at 347 and 390 nm for two 
titrations were plotted as a function of concentration of FSDNA (Figure 2.8, for data 
in tabular format see appendix, Tables A15.8 & A15.9).
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Figure 2.8 Absorbance at 347 nm (■) and at 390 nm (●) of a solution of 0.027 mM 
2.4 as a function of DNA concentration, absorbance at 347 nm (▲) and at 390 nm (▼)
of a solution of 0.034 mM 2.4 as a function of DNA concentration, in buffer (25 mM 
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MOPS, pH 7.0, 50 mM NaCl) at 25 °C. The solid lines represent a global fit to a 
multiple independent sites model.
The titration curves in Figure 2.8 were analysed globally in terms of a multiple 
independent binding sites models, which also takes ligand dilution into account, 
giving an equilibrium constant (Kbinding) of (1.65 ± 26.2) ×103 M-1 and a binding site 
size of (0.37 ± 5.69) base pairs. The obtained value of the stoichiometry was small 
therefore the data of the titration curves were reanalysed, with the binding site size 
restricted to 3 base pairs, giving an equilibrium constant (Kbinding) of (1.7 ± 0.4) ×104 
M-1.
2.2.1.e UV-visible spectroscopy studies of 2.5 binding to DNA
The binding of 2.5 to FSDNA was studied using UV-visible spectroscopy; the 
changes in absorption of 2.5 upon addition of FSDNA were measured in buffer (25 
mM MOPS, pH 7.0, 50 mM NaCl) at 25 °C (Figure 2.9).
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Figure 2.9 UV-visible spectra for 0.027 mM 2.5 upon addition of 0 – 2.64 mM DNA 
in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl) at 25 °C.
Figure 2.9 shows a hypochromic shift in absorbance (at the λmax of 347 nm) and a
hyperchromic shift (at 390 nm) of 2.5 upon addition of DNA. This change in UV-
visible absorption may occur as a result of geometrical distortion of 2.5 when it 
interacts with DNA, but it may also be a local medium effect.  
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To quantify the affinity of 2.5 for FSDNA, the absorbances at 347 and 390 nm for two 
titrations were plotted as a function of concentration of FSDNA (Figure 2.10, for data 
in tabular format see appendix, Tables A15.10 & A15.11).
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Figure 2.10 Absorbance at 347 nm (■) and at 390 nm (●) of a solution of 0.027 mM 
2.5 as a function of DNA concentration, absorbance at 347 nm (▲) and at 390 nm (▼)
of a solution of 0.034 mM 2.5 as a function of DNA concentration, in buffer (25 mM 
MOPS, pH 7.0, 50 mM NaCl) at 25 °C. The solid lines represent a global fit of a 
multiple independent sites model to the data.
The titration curves in Figure 2.10 were analysed globally in terms of a multiple 
independent binding sites models, which also takes ligand dilution into account, 
giving an equilibrium constant (Kbinding) of (2.42 ± 3.53) ×104 M-1 and a binding site 
size of (3.97 ± 4.15) base pairs. The large error margins suggest significant parameter 
covariance. We therefore re-analysed the data for a binding site size n restricted to 3 
base pairs (for these types of DNA binders the average binding site size n is around 3 
base pairs). The resulting fit gave an equilibrium constant (Kbinding) of (1.67 ± 0.28) 
×104 M-1.
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2.2.1.f UV-visible spectroscopy studies of 2.6 binding to DNA
The binding of 2.6 to DNA was studied using UV-visible spectroscopy; the changes 
in absorption of 2.6 upon addition of DNA were measured in buffer (25 mM MOPS,
pH 7.0, 50 mM NaCl) at 25 °C (Figure 2.11).
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Figure 2.11 UV-visible spectra for 0.039 mM 2.6 upon addition of 0 – 0.172 mM 
DNA in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl) at 25 °C.
Figure 2.11 shows a hypochromic shift in absorbance (at the λmax of 440 nm) of 2.6
upon addition of DNA. This change in UV-visible absorption may occur as a result of 
geometrical distortion of 2.6 when it interacts with DNA, but it may also be a local 
medium effect.  
To quantify the affinity of 2.6 for FSDNA, the absorbances at 440 nm for two 
titrations were plotted as a function of concentration of FSDNA (Figure 2.12, for data 
in tabular format see appendix, Tables A15.12 & A15.13).
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Figure 2.12 Absorbance at 440 nm of solutions of 0.039 mM 2.6 (■) and 0.017 mM 
2.6 (●), as a function of DNA concentration, in buffer (25 mM MOPS, pH 7.0, 50 
mM NaCl) at 25 °C. The solid lines represent a global fit of a multiple independent 
sites model to the data.
The titration curves in Figure 2.12 were analysed by fitting a multiple independent 
binding sites models, which also takes ligand dilution into account, to the data, giving 
an equilibrium constant (Kbinding) of (0.03 ± 3) M-1 and a binding site size (0.08 ± 8)
×10-5 base pairs. The obtained values of the stoichiometry and binding constant were 
too small and unreasonable. Therefore the data were reanalysed, with a binding site 
size restricted to 3 base pairs, giving an equilibrium constant (Kbinding) of (1.15 ± 3.08) 
×106 M-1 (Figure 2.13).
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Figure 2.13 Absorbance at 440 nm of a solution of 0.039 mM 2.6 (■) and 0.017 mM 
2.6 (●), as a function of DNA concentration, in buffer (25 mM MOPS, pH 7.0, 50 
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mM NaCl) at 25 °C. The solid lines represent a global fit of a multiple independent 
sites model to the data, binding site size restricted to 3 base pairs (a), restricted to 1 
base pair (b).
The solid lines in Figure 2.13-(a) do not reproduce the titration data well. Therefore 
the data were reanalysed at 1.0 base pair per binding site, giving an equilibrium 
constant (Kbinding) of (11.36 ± 2.70) ×104 M-1.
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2.2.1.g UV-visible spectroscopy studies of 2.7 binding to DNA
The binding of 2.7 to DNA was studied using UV-visible spectroscopy; the changes 
in absorption of 2.7 upon addition of DNA were measured in buffer (25 mM MOPS, 
pH 7.0, 50 mM NaCl) at 25 °C (Figure 2.14).
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Figure 2.14 UV-visible spectra for 0.05 mM 2.7 upon addition of 0 – 2.42 mM DNA 
in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl) at 25 °C.
Figure 2.14 shows a hypochromic shift in absorbance (at the λmax of 434 nm) of 2.7
upon addition of DNA. This change in UV-visible absorption may occur as a result of 
geometrical distortion of 2.7 when it interacts with DNA, but it may also be a local 
medium effect.  
To quantify the affinity of 2.7 for FSDNA, the absorbances at 434 nm for two 
titrations were plotted as a function of concentration of FSDNA (Figure 2.15, for data 
in tabular format see appendix, Tables A15.14 & A15.15).
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Figure 2.15 Absorbance at 434 nm of solutions of 0.05 mM 2.7 (■) and 0.07 mM 2.7
(●) as a function of DNA concentration, in buffer (25 mM MOPS, pH 7.0, 50 mM 
NaCl) at 25 °C. The solid lines represent a global fit of a multiple independent sites 
model to the data.
The titration curves in Figure 2.15 were analysed globally in terms of a multiple 
independent binding sites models, which also takes ligand dilution into account, 
giving an equilibrium constant (Kbinding) of (1.93 ± 1.32) ×104 M-1 and a binding site 
size of (1.81 ± 0.79) base pairs.
2.2.1.h UV-visible spectroscopy studies of 2.8 binding to DNA
The binding of 2.8 to DNA was studied using UV-visible spectroscopy; the changes 
in absorption of 2.8 upon addition of DNA were measured in buffer (25 mM MOPS, 
pH 7.0, 50 mM NaCl) at 25 °C (Figure 2.16).
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Figure 2.16 UV-visible spectra for 0.056 mM 2.8 upon addition of 0 – 1.84 mM 
DNA in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl) at 25 °C.
Figure 2.16 shows a small hypochromic shift in absorbance (at the λmax of 400 nm) of 
2.8 upon addition of DNA. This change in UV-visible absorption may occur as a 
result of geometrical distortion of 2.8 when it interacts with DNA, but it may also be a 
local medium effect or simply dilution.  
To quantify the affinity of 2.8 for FSDNA, the absorbances at 400 nm were plotted as 
a function of concentration of FSDNA (Figure 2.17, for data in tabular format see 
appendix, Tables A15.16).
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Figure 2.17 Absorbance at 400 nm of a solution of 0.056 mM 2.8 as a function of 
DNA concentration (■), in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl) at 25 °C. 
The solid line represents a best fit of a multiple independent sites model to the data.
The fits to the data in Figure 2.17 show a straight line, suggesting negligible binding 
and only dilution causing a change in the absorbance of the sample. The titration data
of Figure 2.17 were analysed globally in terms of a multiple independent binding sites 
model, which also takes ligand dilution into account, giving an equilibrium constant 
(Kbinding) of (0.53 ± 489) M-1 for a binding site size restricted to 3 base pairs. Because 
equilibrium constants cannot be negative, we express the error margin as a confidence 
interval so that the equilibrium constant is 0.53 [0 – 489] M-1. The highest reasonable 
value of equilibrium constant is therefore 489 M-1, corresponding to a c-value of 
0.027. This value indicates negligible binding for the concentrations used in this 
experiment.
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2.2.1.i UV-visible spectroscopy studies of 2.9 binding to DNA
The binding of 2.9 to DNA was studied using UV-visible spectroscopy; the changes 
in absorption of 2.9 upon addition of DNA were measured in buffer (25 mM MOPS, 
pH 7.0, 50 mM NaCl) at 25 °C (Figure 2.18).
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Figure 2.18 UV-visible spectra for 0.017 mM 2.9 upon addition of 0 – 1.17 mM 
DNA in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl) at 25 °C.
Figure 2.18 shows a small hypochromic shift in absorbance (at the λmax of 445 nm) of 
2.9 upon addition of DNA. This change in UV-visible absorption may occur as a 
result of geometrical distortion of 2.9 when it interacts with DNA, but it may also be a 
local medium effect or simply dilution. In addition, the change in absorbance in the
range of 350 – 390 nm is due to poor performance of the UV-visible machine in this 
region.
To quantify the affinity of 2.9 for FSDNA, the absorbances at 445 nm were plotted as 
a function of concentration of FSDNA (Figure 2.19, for data in tabular format see 
appendix, Tables A15.17).
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Figure 2.19 Absorbance at 445 nm of a solution of 0.017 mM 2.9 as a function of 
DNA concentration (■), in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl) at 25 °C. 
The solid line represents a best fit of a multiple independent sites model to the data.
Figure 2.19 shows a straight line fit to the data, suggesting only dilution of the ligand 
is occurring. The titration data of Figure 2.19 were analysed in terms of a multiple 
independent binding sites model, which also takes ligand dilution into account to the 
data, giving an equilibrium constant (Kbinding) of (0.33 ± 140) M-1 for a binding site 
size restricted to 3 base pairs. Because equilibrium constants cannot be negative, we 
express the error margin as a confidence interval so that the equilibrium constant is 
0.33 [0 – 140] M-1. The highest reasonable value of the equilibrium constant is 
therefore 140 M-1, corresponding to a c-value of 0.002. This value indicates negligible 
binding for the concentrations used in this experiment.
Summary
The UV-visible titrations for 1,8-naphthalimide derivatives with duplex DNA show 
that ligands 2.1-2.7 bind to FS-DNA. The affinities of these compounds for FS-DNA 
are summarised in Table 2.1.  
Table 2.1 Binding affinities and binding site sizes for binding of 2.1-2.9 to FS-
DNA in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl) at 25 °C.
Ligand Binding constant
K / M-1
Binding site size
n / bp
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2.1 (8.58 ± 0.85) ×103 3*
2.2 (10.94 ± 2.82) ×103 3*
2.3 (1.20 ± 0.35) ×103 3*
2.4 (1.71 ± 0.398) ×104 3*
2.5 (1.67 ± 0.28) ×104 3*
2.6 (11.3 ± 2.7) ×104 1*
2.7 (1.93 ± 1.32) ×104 1.81 ± 0.79
2.8 No binding
2.9 No binding
* restricted.
Table 2.1 shows that the highest affinity is for the rhenium complex 2.6 with a 
binding constant of ~ 105 M-1. We may attribute this high affinity to the presence of
more aromatic rings which leads to an increase in hydrophobic interactions between 
ligand and DNA. The weakest binders are 2.1-2.3 with a binding constant ~ 103. 
These low affinities of 2.1-2.3 to duplex FS-DNA may be attributed to presence a 
negatively charged group (COO-) on the ligand, leading to an increase of repulsion 
force between ligand and DNA. 
Compounds 2.4, 2.5 and 2.7 have moderate affinity (~ 104 M-1) for DNA. The 
differences in affinity between ligand 2.3 and its metal complexes 2.4 and 2.5 are 
clearly observed. A lower negative charge density on the metal complex compared to 
the ligand may cause an increase of affinity of metal complex to DNA. However 
compounds 2.8 and 2.9 do not show any affinity for duplex FS-DNA. We may 
attribute this to the negative charge of the sulphonate group on the ligand, leading to 
an increase in repulsion force between ligand and DNA. The binding site size for 
some ligands is restricted to 3.0 base pairs in order to obtain a good fit to the titration 
curve.     
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2.2.2 Isothermal titration calorimetry (ITC) 
To investigate further the binding of 1,8-naphthalimide derivatives with DNA, we used 
isothermal titration calorimetry (ITC).  In order to obtain thermodynamic parameters for 
binding of these compounds with DNA, the titration data were analysed using our IC ITC 
software.  
2.2.2.a Dilution of 2.1
In order to evaluate self-aggregation of 2.1 in MOPS buffer, the dilution of a 2.23 mM
solution of 2.1 in MOPS buffer (25 mM MOPS, 50 mM NaCl, pH 7.0) was studied 
using isothermal titration calorimetry. The differential heat flow and derived 
integrated heat effects for this dilution were recorded at 25 °C (Figure 2.20).
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Figure 2.20 Enthalpogram for dilution of a 2.23 mM solution of 2.1 (a), fit for the 
integrated heat effects for the same experiment (b) in buffer (25 mM MOPS, 50 mM 
NaCl, pH 7.0), at 25 °C, experimental heat (■), calculated heat (●). 
Figure 2.20 shows heats of dilution of 2.23 mM 2.1 in MOPS buffer. Our IC ITC 
software was used to analyse the data, giving self-aggregation parameters as 
summarised in Table 2.2.
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Table 2.2 Thermodynamic parameters for self aggregation of 2.1 in MOPS 
buffer, pH 7.0, at 25 °C.
K aggregation/ x 103 M-1 ΔH aggregation/ kcal mol-1 
1.06 (0.51 – 2.95)                                -0.837 (-0.83 – -129)
Table 2.2 shows self aggregation parameters for 2.1 in MOPS buffer. The results of 
dilution analysis show that 2.1 self aggregates to a significant extent and that an 
appreciable amount of heat of deaggregation is involved in the dilution process.
2.2.2.b ITC studies of 2.1 binding to DNA
To further explore the binding of 2.1 with DNA, the binding of 2.1 to DNA was studied 
using isothermal titration calorimetry. The differential heat flow and derived integrated
heat effects for titrations of solutions of 2.1 (all 2.23 mM) into fish sperm DNA solutions 
(0.2, 0.3 & 0.4) mM were measured in buffer (25 mM MOPS, 50 mM NaCl, pH 7.0), at 25 
°C (Figure 2.21).
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Figure 2.21 Titration of a 2.23 mM solution of 2.1 into a 0.2 mM solution of DNA (a),
titration of a 2.23 mM solution of 2.1 into a 0.3 mM solution of DNA (b), titration of a 
2.23 mM solution of 2.1 into a 0.4 mM solution of DNA (c), global fit for integrated heat 
effects of titrations (a) and (b) and (c) in terms of a binding model involving one type of 
binding site, aggregation included (d), in buffer (25 mM MOPS, 50 mM NaCl, pH 7), at 
25 °C.
Figure 2.21 shows enthalpograms for the interaction of 2.1 with DNA, which suggest 
weakly exothermic interactions. In order to quantify the binding parameters of 2.1
binding to DNA we used our IC ITC software to analyse the titration data globally. 
The results of global data analysis showed a big binding site size (see appendix, Table 
A1.1). Therefore, the data were reanalyzed with the stoichiometry within error margin 
(see appendix, Figure A1.3), restricted to 3.0 base pairs. The resulting binding 
parameters are summarised in Table 2.3.
Table 2.3 Thermodynamic parameters for binding of 2.1 to FSDNA in 25 mM 
MOPS, 50 mM NaCl, pH 7.0, at 25 °C
KA1
(103M-1)
1/nA1
(bp)
∆HA1
(kcal mol-1)
-T∆SA1
(kcal mol-1)
{Σdev2/dof}½ 
(µcal)
2.1 3.16 (0.46 –
9.43)
3* -4.75 (-4.75 
– -485)
-0.018 2.31
* restricted.
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2.2.2.c Dilution of 2.2
In order to explore self aggregation of 2.2 in MOPS buffer, the dilution of 2.2 in
MOPS buffer was studied using isothermal titration calorimetry. The differential heat 
flow and derived integrated heat effects for dilution of a series of solutions of 2.2 
(1.25 & 2.51) mM into buffer (25 mM MOPS, 50 mM NaCl, pH 7.0), at 25 °C were 
measured (Figure 2.22).
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Figure 2.22 Enthalpograms for dilution of a 1.25 mM solution of 2.2 (a), dilution of a 
2.51 mM solution of 2.2 (b), into buffer (25 mM MOPS, 50 mM NaCl, pH 7.0) at 25 
°C.
Figure 2.22 shows heats of dilution of 1.25 & 2.51 mM 2.2 in MOPS buffer. Because
of the complexity of the heat effects of dilution and non-reproducibility of dilution 
enthalpograms we were unable to analyse the data of dilutions.  
2.2.2.d ITC studies of 2.2 binding to DNA
To investigate further the binding of 2.2 with DNA, the binding of 2.2 to DNA was
studied using isothermal titration calorimetry. The differential heat flow and derived 
integrated heat effects for titrations of solutions of 2.2 (all 2.51 mM) into fish sperm DNA 
solutions (0.2 & 0.5) mM were measured in buffer (25 mM MOPS, 50 mM NaCl, pH 7.0), 
at 25 °C (Figure 2.23).
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Figure 2.23 Titration of a 2.51 mM solution of 2.2 into a 0.5 mM solution of DNA 
(a), titration of a 2.51 mM solution of 2.2 into a 0.2 mM solution of DNA (b), in
buffer (25 mM MOPS, 50 mM NaCl, pH 7.0), at 25 °C.
The enthalpograms for the interaction of 2.2 with DNA in Figure 2.23 suggest 
negligible binding of 2.2 with DNA or weakly exothermic interactions.  
2.2.2.e Dilution of 2.6
To determine the heats of dilution for 2.6 in MOPS buffer, the dilution of 2.6 to 
MOPS buffer was studied using isothermal titration calorimetry. The differential heat 
flow and derived integrated heat effects for dilution of a solution of 0.184 mM 2.6 
into buffer (25 mM MOPS, 50 mM NaCl, pH 7.0), at 25 °C were measured (Figure 
2.24).
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Figure 2.24 Enthalpogram for dilution of a 0.184 mM solution of 2.6 in buffer (25 
mM MOPS, 50 mM NaCl, pH 7.0), at 25 °C.
The enthalpogram in the figure 2.24 shows small heat effects resulting from dilution 
which suggests that self-aggregation is negligible at the concentration used. 
2.2.2.f ITC studies of 2.6 binding to DNA
To further explore the binding of 2.6 with DNA, the binding of 2.6 to DNA was studied 
using isothermal titration calorimetry. The differential heat flow and derived integrated
heat effects for titrations of solutions of 2.6 (all 0.184 mM) into fish sperm DNA solutions 
(both 0.1 mM) were measured in buffer (25 mM MOPS, 50 mM NaCl, pH 7.0), at 25 °C 
(Figure 2.25).
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Figure 2.25 Titration of a 0.184 mM solution of 2.6 into a 0.1 mM solution of DNA 
(a), repeat titration of a 0.184 mM solution of 2.6 into a 0.1 mM solution of DNA (b),
global fit for integrated heat effects of titrations (a) and (b) in terms of a binding 
model involving one type of binding site, aggregation not included (c), in 25 mM 
MOPS, 50 mM NaCl, pH 7.0, at 25 °C.
Figure 2.25 shows two enthalpograms (a) and (b) for the interactions of 2.6 with DNA. 
Both titrations were carried out at the same DNA concentration and conditions. The 
titrations (a) and (b) show exothermic interactions, suggesting one binding event. In order 
to determine binding parameters for the interaction of 2.6 with DNA, the titrations data 
were analysed globally using IC ITC software. The results of global data analysis for 
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titrations (a) and (b) showed a big binding site size (see appendix, Table A6.1). Therefore 
the data were reanalyzed with the stoichiometry restricted to 3.0 base pairs. The resulting 
binding parameters are summarised in Table 2.4.
Table 2.4 Thermodynamic parameters for binding of 2.6 to FSDNA in 25 mM 
MOPS, 50 mM NaCl, pH 7.0, at 25 °C.
KA1
(103 M-1)
1/nA1
(bp)
∆HA1
(kcal mol-1)
-T∆SA1
(kcal mol-1)
{Σdev2/dof}½ 
(µcal)
2.6 12.5 (11.2 –
122)
3.0* -9.94 (-7.9 
– -267)
4.35 1.02
* restricted.
The thermodynamic parameters in Table 2.4 obtained from data analysis where the 
binding site size was not restricted were not reasonable values. When the
stoichiometry was restricted to 3.0 all thermodynamic parameters values become 
reasonable. The negative value of enthalpy change for interaction of 2.6 with FSDNA 
suggests that intercalation is a likely mode of binding. It should be pointed out that 
ligand self-aggregation was not taken in to account in the data analysis because the 
heat effects of aggregation were small and constant.  
2.2.2.g Dilution of 2.7
To quantify aggregation of 2.7 in MOPS buffer, the dilution of a solution of 1.53 mM 
2.7 in MOPS buffer (25 mM MOPS, 50 mM NaCl, pH 7.0) was studied using 
isothermal titration calorimetry. The differential heat flow and derived integrated heat 
effects for this dilution were recorded at 25 °C (Figure 2.26).
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Figure 2.26 Heat effects for dilution of a 1.53 mM solution of 2.7 into a 25m M 
MOPS, 50 mM NaCl, pH 7.0, at 25 °C (a) and, fit for the integrated heat effects for 
the same experiment (b), experimental heat (■), calculated heat (●). 
 
Figure 2.26 shows non-constant heat effects for diluting 2.7 into MOPS buffer, 
indicating ligand self-aggregation. The data were analysed using IC ITC software, 
giving diluting parameters as summarised in Table 2.5.
Table 2.5 Thermodynamic parameters for diluting 2.7 into MOPS buffer, pH 
7.0, at 25 °C.
K aggregation/ M-1 ΔH aggregation/ kcal mol-1 
453 (87 – 1050) -4.68 (-4.68 – -22.2)
Table 2.5 shows aggregation parameters for 2.7 in MOPS buffer. The results of 
dilution analysis show that a considerable amount of heat of aggregation is involved 
in the dilution process but that self aggregation is not too strong.
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2.2.2.h ITC studies of 2.7 binding to DNA
The binding of 2.7 to DNA was studied using isothermal titration calorimetry. The 
differential heat flow and derived integrated heat effects for titrations of solutions of 2.7 
(all 1.53 mM) into fish sperm DNA solutions (both 0.2 mM) were measured in buffer (25 
mM MOPS, 50 mM NaCl, pH 7.0), at 25 °C (Figure 2.27). 
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Figure 2.27 Titration of a 1.53 mM solution of 2.7 into a 0.2 mM solution of DNA (a), 
repeat titration of a 1.53 mM solution of 2.7 into a 0.2 mM solution of DNA (b), global fit 
for integrated heat effects of titrations (a) and (b) in terms of a binding model involving 
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one type of binding site with aggregation included(c), in 25 mM MOPS, 50 mM NaCl, pH
7.0, at 25 °C.
The enthalpograms for interactions of 2.7 with DNA (Figure 2.27) suggest one 
binding event. In order to quantify the binding parameters of 2.7 interacting with 
DNA, the data were analysed using IC ITC software. The obtained binding site size 
from the global fit (see appendix, Table A7.1) was considered unreasonably big. 
Therefore the data were reanalysed with a stoichiometry within error margin (see 
appendix, Figure A7.2), restricted to 4 base pairs. All thermodynamic parameters 
were determined and are summarised in Table 2.6.
Table 2.6 Thermodynamic parameters for binding of 2.7 to FSDNA in MOPS 
buffer, pH 7.0, at 25 °C.
KA1
(103M-1)
1/nA1
(bp)
∆HA1
(kcal mol-1)
-T∆SA1
(kcal mol-1)
{Σdev2/dof}½ 
(µcal)
2.7                    11.8 (8.69 –
15.9)
4* -15.7 (-13.1 
– -19.1)
10.15 1.13
* restricted.
The binding constant and binding site size in the table 2.6 show a good agreement 
with UV-visible results. The exothermic interaction suggests 2.7 binds to FSDNA via 
intercalation. 
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Summary
The interactions of 2.1-2.2 and 2.6-2.7 with DNA were further investigated by 
isothermal titration calorimetry. The thermodynamic parameters for these compounds
interacting with DNA and for their dilution in MOPS buffer were determined and are 
summarised in Tables 2.7 and 2.8.  
Table 2.7 Thermodynamic parameters for self aggregations of 2.1-2.2 and 2.6-2.7 
in MOPS buffer, pH 7.0, at 25 °C.
Ligand K aggregation/ x 103 M-1 ΔH aggregation/ kcal mol-1 
2.1 1.06 (0.51 – 2.95) -0.837 (-0.83 – -129)
2.2 n.d. n.d.
2.6 n.d. n.d.
2.7 0.453 (0.08 – 1.0) -4.68 (-4.68 – -22.2)
n.d. not determined.
Table 2.8 Thermodynamic parameters for binding of 2.1-2.2 and 2.6-2.7 to 
FSDNA in 25 mM MOPS, pH 7.0, 50 mM NaCl at 25 °C.
Ligand KA1
(M-1)
1/nA1
(bp)
∆HA1
(kcal mol-1)
-T∆SA1
(kcal mol-1)
{Σdev2/dof}½ 
(µcal)
2.1 (3.16 × 103) 3.0* -4.75 -0.018 2.31
2.2 No binding - - - -
2.6 (12.5 × 103) 3.0* -9.94 4.35 1.02
2.7 (11.8 × 103) 4.0* -15.7 10.15 1.13
* restricted.
Compound 2.1 shows an exothermic interaction with fish sperm DNA, this interaction 
can be clearly seen from its heat effects. The enthalpograms for the interaction of 2.2
with DNA suggest negligible binding of 2.2 with DNA or very weakly exothermic 
interactions. Compound 2.6 interacts with fish sperm DNA and exothermic interaction 
can be observed. The titration data of 2.6 interacting with FS-DNA were analysed 
using IC-ITC software where the heat of dilution was neglected, giving a binding 
constant of 12.5 × 103 M-1 for a binding site size restricted to 3.0 base pairs. 
Compound 2.7 also binds to FS-DNA and shows an exothermic interaction. The 
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enthalpograms of 2.7 were analysed and the heat of aggregation was also taken into 
account, giving a binding constant of 11.8 × 103 M-1 for a binding size of 4.0 base 
pairs. The binding site sizes for all titrations were restricted to a number with in the 
margin of error in order to obtain reasonable binding parameters. Furthermore, the 
binding constants of these compounds obtained from ITC titrations are smaller 
compared to the binding constants obtained from UV-visible titrations.  
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2.2.3 Induced circular dichroism (ICD)
2.2.3.a Induced circular dichroism for 2.1 interacting with FSDNA
The binding mode of interaction of 2.1 with FSDNA was studied using circular dichroism 
spectroscopy. Circular dichroism spectra for 2.1 were recorded at different FSDNA 
concentrations (0 mM – 1.58 mM) in buffer (25 mM MOPS, pH 7.0 and 50 mM NaCl) at 
25 °C (Figure 2.28).
250 300 350 400 450 500
-60
-50
-40
-30
-20
-10
0
10
20
30
40
50
60
 (
m
de
g)
nm
Figure 2.28 Circular dichroism spectra for 0.065 mM of 2.1 in the presence of 
different concentrations of FSDNA (0  mM – 1.58 mM) in buffer (25 mM MOPS, 50 
mM NaCl, pH 7.0) at 25 °C.
Figure 2.28 does not show any significant induced circular dichroism around the 
wavelength of interest 347 nm where compound 2.1 absorbs.
2.2.3.b Induced circular dichroism for 2.2 interacting with FSDNA
The binding mode of interaction of 2.2 with FSDNA was also studied using circular 
dichroism spectroscopy. Circular dichroism spectra for 2.2 were recorded at different 
FSDNA concentrations (0 mM – 1.83 mM) in buffer (25 mM MOPS, pH 7.0 and 50 mM 
NaCl) at 25 °C (Figure 2.29).
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Figure 2.29 Circular dichroism spectra for 0.065 mM of 2.2 in the presence of 
FSDNA (0 mM – 1.83 mM) in buffer (25 mM MOPS, 50 mM NaCl, pH 7.0) at 25 °C.
The spectra in the figure 2.29 do not show any significant induced circular dichroism 
around the wavelength of interest 347 nm.
2.2.3.c Induced circular dichroism for 2.3 interacting with FSDNA
The binding mode of interaction of 2.3 with FSDNA was studied using circular dichroism 
spectroscopy. Circular dichroism spectra for 2.3 were recorded at different FSDNA 
concentrations (0 mM – 1.8 mM) in buffer (25 mM MOPS, pH 7.0 and 50 mM NaCl) at 
25 °C (Figure 2.30).
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Figure 2.30 Circular dichroism spectra for 0.046 mM of 2.3 in the presence of 
FSDNA (0 mM – 1.8 mM)  in buffer (25 mM MOPS, 50 mM NaCl, pH 7.0) at 25 °C.
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The circular dichroism spectra in Figure 2.30 again do not show any significant 
induced signal around the wavelength of interest 347 nm.
2.2.3.d Induced circular dichroism for 2.4 interacting with FSDNA
The binding mode of interaction of 2.4 with FSDNA was studied using circular dichroism 
spectroscopy. Circular dichroism spectra for a solution of 2.4 were recorded at different 
FSDNA concentrations (0 mM – 1.27 mM) in buffer (25 mM MOPS, pH 7.0 and 50 mM 
NaCl) at 25 °C (Figure 2.31).
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Figure 2.31 Circular dichroism spectra for 0.029 mM 2.4 in the presence of different
concentrations of FSDNA (0 mM – 1.27 mM)  in buffer (25 mM MOPS, 50 mM 
NaCl, pH 7.0) at 25 °C.
As before, circular dichroism spectra in Figure 2.31 do not show any significant 
induced signal around the wavelength of interest 347 nm.
2.2.3.e Induced circular dichroism for 2.5 interacting with FSDNA
The binding mode of interaction of 2.5 with FSDNA was studied using circular dichroism 
spectroscopy. Circular dichroism spectra for 2.5 were measured at different FSDNA 
concentrations (0 mM – 1.24 mM) in buffer (25 mM MOPS, pH 7.0 and 50 mM NaCl) at 
25 °C (Figure 2.32).
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Figure 2.32 Circular dichroism spectra for a solution of 0.031 mM of 2.5 in the 
presence of different concentrations of FSDNA (0 mM – 1.24 mM)  in buffer (25 mM 
MOPS, 50 mM NaCl, pH 7.0) at 25 °C.
The circular dichroism spectra in the figure 2.32 do not show any significant induced 
signal around the wavelength of interest 347 nm.
2.2.3.f Induced circular dichroism for 2.6 interacting with FSDNA
The binding mode of interaction of 2.6 with FSDNA was studied using circular dichroism 
spectroscopy. Circular dichroism spectra for 2.6 were measured at different FSDNA 
concentrations (0 mM – 0.46 mM) in buffer (25 mM MOPS, pH 7.0 and 50 mM NaCl) at 
25 °C (Figure 2.33).
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Figure 2.33 Circular dichroism spectra for 0.012 mM of 2.6 in the presence of 
FSDNA (0 mM – 0.46 mM)  in buffer (25 mM MOPS, 50 mM NaCl, pH 7.0) at 25 
°C.
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The circular dichroism spectra in the figure 2.33 do not show significant induced 
signal around the wavelength of interest 440 nm.
2.2.3.g Induced circular dichroism for 2.7 interacting with FSDNA
The binding mode of interaction of 2.7 with FSDNA was studied using circular dichroism 
spectroscopy. Circular dichroism spectra for 2.7 were recorded at FSDNA concentrations 
between 0 and 1.85 mM in buffer (25 mM MOPS, pH 7.0 and 50 mM NaCl) at 25 °C 
(Figure 2.34).
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Figure 2.34 Circular dichroism spectra for 0.051 mM of 2.7 in the presence of 0 –
1.85 mM FSDNA in buffer (25 mM MOPS, 50 mM NaCl, pH 7.0) at 25 °C.
The circular dichroism spectra in Figure 2.34 do not show induced ellipticity around 
the wavelength of interest 434 nm.
Summary
All compounds in this group do not show any significant induced circular dichroism 
signal upon titration with DNA, therefore no important observation was found to be 
used as an evidence to determine the mode of interactions of this group with DNA. 
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2.2.4 Viscosity
2.2.4.a Binding of 2.1 and 2.2 to calf thymus DNA (CT-DNA)
The mode of binding of 2.1 and 2.2 to double-stranded DNA was further studied using 
viscometry.  In order to find out whether 2.1 and 2.2 are groove binders or intercalators, 
the relative viscosity of DNA upon addition of 2.1 and 2.2 was compared with viscosities 
of equivalent DNA solutions that contained known DNA binders which are either an 
intercalator (ethidium bromide) or a minor groove binder (H33258).7 The relative 
viscosities of CT-DNA solutions were measured upon addition of 2.1 and 2.2 in buffer (25 
mM MOPS, pH 7.0 and 50 mM NaCl) at 25 °C (Figure 2.35).
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Figure 2.35 Relative viscosity of a 0.5 mM CT-DNA solution upon addition of 2.1
(■), 2.2 (▼), H33258 (▲) and ethidium bromide (●) at 25 °C in 25 mM MOPS pH 
7.0, 50 mM NaCl. 
Figure 2.35 shows a small decrease in relative viscosity upon the first addition of 2.1 
and 2.2 and then increases slightly; suggesting groove binding is the dominant 
binding mode for both 2.1 and 2.2.
2.2.4.b Binding of 2.4 and 2.5 to calf thymus DNA 
The modes of binding of 2.4 and 2.5 to double-stranded DNA were similarly studied using 
viscometry.  In order to find out whether these two compounds are groove binders or 
intercalators, the relative viscosity of DNA upon addition 2.4 and 2.5 were compared with 
viscosities of equivalent DNA solutions that contained known DNA binders which act 
either as an intercalator (ethidium bromide) or a minor groove binder (H33258). The 
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relative viscosities of CT-DNA solutions were measured upon addition of 2.4 and 2.5 in 
buffer (25 mM MOPS, pH 7.0 and 50 mM NaCl) at 25 °C (Figure 2.36).
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Figure 2.36 Relative viscosity of a 0.5 mM CT-DNA solution upon addition of 2.4
(▼), 2.5 (■), H33258 (▲) and ethidium bromide (●) at 25 °C in 25 mM MOPS, pH 
7.0, 50 mM NaCl. 
Figure 2.36 shows that the relative viscosity of CT-DNA solution significantly 
increased upon addition of 2.4 or 2.5, with an even bigger increase in viscosity than 
the increase observed upon addition of ethidium bromide. This observation indicates 
both compounds 2.4 and 2.5 bind with CT-DNA via intercalation.  
2.2.4.c Binding of 2.6 to calf thymus DNA 
The mode of binding of 2.6 to double-stranded DNA was studied using viscometry.  In 
order to find out whether 2.6 is a groove binder or an intercalator, the relative viscosity of 
DNA upon addition 2.6 was compared with the viscosities of equivalent DNA solutions 
that contained known DNA binders which act either as an intercalator (ethidium bromide) 
or a minor groove binder (H33258). The relative viscosities of CT-DNA solutions were 
measured upon addition of 2.6 in buffer (25 mM MOPS, pH 7.0 and 50 mM NaCl) at 25 
°C (Figure 2.37).
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Figure 2.37 Relative viscosity of a 0.5 mM CT-DNA solution upon addition of 2.6
(■), H33258 (▲) and ethidium bromide (●) at 25 °C in 25 mM MOPS pH 7.0, 50 mM 
NaCl. 
Figure 2.37 shows that the relative viscosity of CT-DNA solution increased upon 
addition of 2.6 and this increase is bigger than the increase observed upon addition of 
ethidium bromide, indicating that 2.6 interacts with CT-DNA via intercalation, like 
complexes 2.4 and 2.5. 
2.2.4.d Binding of 2.7 to calf thymus DNA 
The mode of binding of 2.7 to double-stranded DNA was also studied using viscometry.  
In order to find out whether 2.7 is a groove binder or an intercalator, the relative viscosity 
of DNA upon addition 2.7 was compared with viscosities of equivalent DNA solutions 
that contained known DNA binders which act either as an intercalator (ethidium bromide) 
or a minor groove binder (H33258). The relative viscosities of CT-DNA solutions were 
measured upon addition of 2.7 in buffer (25 mM MOPS, pH 7.0 and 50 mM NaCl) at 25 
°C (Figure 2.38).
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Figure 2.38 Relative viscosity of a 0.5 mM CT-DNA solution upon addition of 2.7
(■), H33258 (▲) and ethidium bromide (●) at 25 °C in 25 mM MOPS, pH 7.0, 50 
mM NaCl. 
Figure 2.38 shows that the relative viscosity of CT-DNA solution increased upon 
addition of 2.7 although less than ethidium bromide. This increase in viscosity 
suggests that 2.7 interacts with CT-DNA through intercalation; however the minor 
groove binding of 2.7 with DNA is not excluded since the increase in viscosity of 2.7
solution is relatively smaller than the increase in viscosity upon addition of ethidium 
bromide. 
Summary
To further study the mode of the binding for 2.1-2.2 and 2.4-2.7 with duplex DNA, 
viscometry was used. The relative viscosity of CT-DNA solution significantly 
increased upon addition of 2.4-2.6, suggesting intercalation is a mode of binding for 
the interactions of 2.4-2.6 with CT-DNA. Also, adding of 2.7 to CT-DNA solution
caused to increase the relative viscosity of CT-DNA; however this increase in 
viscosity is relatively smaller than the increase in viscosity upon addition of known 
binder ethidium bromide, which suggests that intercalation and groove binding are 
both possible modes. 
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On the other hand, the small decrease in viscosity in the first addition of 2.1 and 2.2 
into CT-DNA solution and then increase slightly, suggesting groove binding is the 
dominant binding mode.
2.2.5 Molecular docking studies
2.2.5.a Docking studies of 2.1 and 2.2 binding to DNA
The binding mode for interactions of 2.1 and 2.2 with duplex DNA was further 
studied through molecular docking using Auto Dock Vina.6 Our previously 
developed9 open-d(ATCGAGACGTCTCGAT)2 was used as a biomacromolecular 
target.
(a) (b)
Figure 2.39 Top 3 docked poses for 2.1 (a), 2.2 (b) interacting with open-
d(ATCGAGACGTCTCGAT)2.
The results of the molecular docking study show that minor groove binding is a 
favourable binding mode for 2.1 and 2.2. From orientation of these compounds along 
the double-stranded DNA structure we observed that non-planarity of the hydrophilic 
parts of 2.1 and 2.2 hinder the intercalation of the hydrophobic parts between the base 
pairs. The complex structure in Figure 2.39 is in a reasonable agreement with the 
results of the binding mode study using viscometry (Section 2.2.4).   
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2.2.5.b Docking studies of 2.3- 2.5 binding to DNA
The binding modes for interactions of 2.3-2.5 with duplex DNA were similarly 
studied through a molecular docking study.
(a) (b) 
Figure 2.40 Top 3 docked poses for 2.3 (a), 2.4 and 2.5 (b) interacting with open-
d(ATCGAGACGTCTCGAT)2.
The results of molecular docking study show that intercalation is a favourable binding 
mode for 2.3-2.5. Docking shows that for these compounds, the hydrophobic parts can 
penetrate between the base pairs. The complex structure in Figure 2.40 is in
agreement with the result of the binding mode study using viscometry.   
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2.2.5.c Docking studies of 2.6 and 2.7 binding to DNA
Finally, the binding modes for interactions of 2.6 and 2.7 with duplex DNA were also 
studied through the analogous molecular docking study.
(a) (b)
Figure 2.41 Top 3 docked poses for 2.6 (a) and 2.7 (b) interacting with open-
d(ATCGAGACGTCTCGAT)2.
The results of the molecular docking study show that minor groove binding and 
intercalation are both possible binding modes for 2.6. The complex structures (a) in 
Figure 2.41 are in agreement with the results of the binding mode study of 
viscometry. On the other hand, according to the results of docking study compound 
2.7 is a groove binder; however, this finding cannot be conclusive since the binding 
mode study by viscometry shows that intercalation and minor groove binding are both 
potential binding modes for 2.7.     
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2.2.6 Sequence selectivity
The affinities for FS-DNA as reported in section 2.2.1 represent averaged affinities 
for the heterogeneous sequence of FS-DNA. In order to study the selectivity of a 
group of 1,8-naphthalimide derivatives for selected specific sequences of DNA, viz. 
(dAdT)12●(dAdT)12 and (dGdC)12●(dGdC)12, additional UV-visible spectroscopy
titrations were carried out.
2.2.6.a Binding of 2.1 to (dAdT)12●(dAdT)12
The binding of 2.1 to (dAdT)12●(dAdT)12 was studied using UV-visible spectroscopy; 
the changes in absorption of 2.1 upon addition of (dAdT)12●(dAdT)12 were measured 
in buffer (25 mM MOPS, pH 7.0 and 50 mM NaCl) at 25 °C (Figure 2.42).
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Figure 2.42 UV-visible spectra for 0.032 mM 2.1 upon addition of 0 – 0.64 mM 
(dAdT)12●(dAdT)12 in 25 mM MOPS, pH 7.0, 50 mM NaCl, at 25 °C.
Figure 2.42 shows a hypochromic shift in absorbance (at the λmax of 347 nm) and 
hyperchromic shift (at 390 nm) of 2.1 upon addition of (dAdT)12●(dAdT)12, this 
change in UV-visible absorption may occur as a result of geometrical distortion of 2.1
when it interacts with DNA, but it may also be a local medium effect.  
To quantify the affinity of 2.1 for (dAdT)12●(dAdT)12, the absorbances at 347 were 
plotted as a function of concentration of (dAdT)12●(dAdT)12 (Figure 2.43). This 
choice of wavelength avoids the data at λ > 350 nm that appears to be affected by a 
poorly performing visible light source. 
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Figure 2.43 Absorbance at 347 nm of a solution of 0.032 mM 2.1 (■) and of a 
solution of 0.020 mM 2.1 (●), as a function of (dAdT)12●(dAdT)12 concentration, in 
25 mM MOPS, pH 7.0, 50 mM NaCl, at 25 °C. The solid lines represent a global fit 
of a multiple independent sites model to the data.
The titration curves of Figure 2.43 were analysed globally by fitting a version of the
multiple independent binding sites models, which also takes ligand dilution into 
account, to the data. This fit gives an equilibrium constant (Kbinding) of (18.35 ± 20.6) 
×103 M-1 and a binding site size of (1.7 ± 1.4) base pairs. The large error margins 
suggest significant parameter covariance. We therefore re-analysed the data for a 
binding site size n restricted to 3 base pairs (for these types of DNA binders the 
average binding site size n is around 3 base pairs). The fit gave an equilibrium 
constant (Kbinding) of (4.10 ± 0.80) ×104 M-1.
2.2.6.b Binding of 2.1 to (dGdC)12●(dGdC)12
The binding of 2.1 to (dGdC)12●(dGdC)12 was studied using UV-visible spectroscopy; 
the changes in absorption of 2.1 upon addition of (dGdC)12●(dGdC)12 were measured 
in buffer (25 mM MOPS, pH 7.0 and 50 mM NaCl) at 25 °C (Figure 2.44).
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Figure 2.44 UV-visible spectra for 0.020 mM 2.1 upon addition of 0 – 0.26 mM 
(dGdC)12●(dGdC)12 in 25 mM MOPS, pH 7.0, 50 mM NaCl, at 25 °C.
Figure 2.44 shows a hypochromic shift in absorbance (at the λmax of 347 nm) and 
hyperchromic shift (at 390 nm) of 2.1 upon addition of (dGdC)12●(dGdC)12. This
change in UV-visible absorption may occur as a result of geometrical distortion of 2.1
when it interacts with (dGdC)12●(dGdC)12, but it may also be a local medium effect.  
To quantify the affinity of 2.1 for (dGdC)12●(dGdC)12, the absorbances at 347 were 
plotted as a function of concentration of (dGdC)12●(dGdC)12 (Figure 2.45).
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Figure 2.45 Absorbance at 347 nm of a solution of 0.020 mM 2.1 (■) and of a 
solution of 0.029 mM 2.1 (●), as a function of (dGdC)12●(dGdC)12 concentration in 
25 mM MOPS, pH 7.0, 50 mM NaCl, at 25 °C. The solid lines represent a global fit in 
term of a multiple independent sites model.
The titration curves of Figure 2.45 were analysed globally in terms of a multiple 
independent binding sites models, which also takes ligand dilution into account. The 
analysis gave an equilibrium constant (Kbinding) of (1.05 ± 1.7) ×104 M-1 and a binding 
site size of (0.45 ± 0.62) base pairs. The obtained binding site size was small therefore 
the data were reanalysed at stoichiometry (n) restricted to 2.0 base pairs, giving a
binding constant of (9.64 ± 1.81) ×104 M-1. 
The sequence selectivity study of compounds 2.2 and 2.4-2.7 for selected specific 
sequences of DNA, (dAdT)12●(dAdT)12 and (dGdC)12●(dGdC)12 were similarly 
carried out using UV-visible spectroscopy (see appendix, A14). The binding 
parameters for these compounds interacting with specific sequences of DNA were 
determined and are summarised in Table 2.9.
Table 2.9 Binding parameters from UV-visible spectroscopy for 2.1-2.2 and 2.4-
2.7 binding to (dAdT)12●(dAdT)12 and (dGdC)12●(dGdC)12, in 25 mM MOPS, pH 
7.0, 50 mM NaCl, at 25 °C.
(dAdT)12●(dAdT)12 (dGdC)12●(dGdC)12
Compound Binding constant
K / M-1
Binding site size
n / bp
Binding constant
K / M-1
Binding site size
n / bp
2.1 (4.10 ± 0.80) 
×104
3.0* (9.64 ± 1.81) 
×104
2.0*
2.2 (92.49 ± 19.97) 
×103
1.0* (25.45 ± 5.85) 
×103
1.0*
2.4 (14.41 ± 3.12) 
×103
3.0* (8.05 ± 2.03) 
×103
3.0*
2.5 (25.61 ± 13.02) 
×103
3.42 ± 1.07 (9.30 ± 2.70) 
×103
3.0*
2.6 74×104[0 –
76×104]
1.0* (13.67 ± 1.93) 
×104
3.0*
2.7 (10.28 ± 2.56) 
×104
2.53 ± 0.28 (18.18 ± 3.07)
×104
4.23 ± 0.17
* restricted.
Table 2.9 shows that all compounds studied for sequence selectivity show different 
affinities toward specific sequences of DNA, (dAdT)12●(dAdT)12 and 
(dGdC)12●(dGdC)12. All compounds 2.1-2.2 and 2.4-2.7 bind to (dAdT)12●(dAdT)12
with binding affinities between 104 to 105 M-1. The binding site size for ligands 2.1-
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2.2 and 2.4-2.7 is between 1 to 3 base pairs. Also, all compounds bind to 
(dGdC)12●(dGdC)12 with binding affinities between 104 to 105 M-1. The binding site 
size for compounds 2.1-2.2 and 2.4-2.7 interacting with (dGdC)12●(dGdC)12 is 
between 1 to 4 base pairs. In general, most compounds of this family have preferences
for the (dAdT)12●(dAdT)12 sequence over (dGdC)12●(dGdC)12.
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2.3 Conclusion 
Most compounds of the group of 1,8-naphthalimide derivatives bind to double-
stranded DNA moderately and the binding is accompanied by change in 
optoelectronic properties of the compound with a hypochromic shift in absorbance at 
maximum absorption and a hypochromic shift mostly observed. The binding 
constants for 2.1-2.7 are in the range of 103 to 105 M-1 with the binding site size 
between 1.0 to 3.0 base pairs. The binding site size of 1.0 base pair for some bindings 
seems to be small, suggesting a side by side interaction is a mode of binding. The 
affinity of the metal complexes (Eu, Gd) of ligand 2.3 are greater than the ligand 2.3
itself, this might be due to the net negative charges of metal complex is smaller than 
the ligand, leading to decrease in repulsion force between negative charges of DNA 
and the metal complex. Both compounds 2.8 and 2.9 do not show any affinity for 
duplex DNA. The reason for not interacting with duplex DNA may be the presence of 
a sulphonate group, which places negative charges on the compounds, leading to 
increased repulsion between duplex DNA and ligands.
Isothermal titration calorimetry shows one binding event for 2.1 and 2.6-2.7 binding 
to FS-DNA. Although, the result of UV-visible spectroscopy of 2.2 interacting with 
DNA shows that compound 2.2 has affinity toward FS-DNA; the enthalpograms for 
the interaction of 2.2 with DNA from ITC suggest negligible binding of 2.2 with 
DNA or very weakly exothermic interactions. 
We used induced circular dichroism spectroscopy (ICD) as a first technique to study 
and investigate the mode of binding between 2.1-2.7 and duplex DNA, unfortunately 
none of compounds 2.1-2.7 showed any significant ICD signal to provide support for 
either binding mode. 
The binding mode was further studied using viscometry. The small decrease in 
relative viscosity of calf thymus DNA solution followed by a small increase upon 
addition of 2.1, indicating the minor groove is the dominant binding site. On the other 
hand, the relative viscosities of CT-DNA solutions significantly increased upon 
addition of 2.4-2.6, suggesting intercalation is a mode of interaction. The relative 
viscosity of CT-DNA solution also increased upon addition of ligand 2.7, however, 
this increase is relatively smaller compared to the known intercalator ethidium 
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bromide, and therefore two modes of interactions are suggested viz. intercalation as a 
dominant mode and a minor groove. 
Molecular docking studies were also used to support the results of viscometry. The 
results of molecular docking study for 2.1 showed that this ligand interacts with 
duplex DNA in the minor groove which is also suggested by viscometry. On the other 
hand, the docking results of 2.4 and 2.5 confirm that intercalation is a mode of 
binding, in agreement with viscometry results. We attribute this difference in the 
binding mode to a presence of a benzene ring in between hydrophobic and 
hydrophilic parts of 2.4 and 2.5 which helps the hydrophobic parts of these molecules 
to intercalate easily between base pairs. The docking studies for 2.6 and 2.7 suggest 
that intercalation is a dominant mode of binding for 2.6, and 2.7 interacting with 
duplex DNA through groove binding, although the intercalation is not excluded as a 
second mode of interaction for 2.7. This observation is also supported by viscometry. 
Compounds 2.1-2.2 and 2.4-2.7 bind to a specific DNA sequence (dAdT)12●(dAdT)12
with binding affinities between 104 to 105 M-1. The binding site size for ligands 2.1-
2.2 and 2.4-2.7 is between 1 to 3 base pairs. Also, all the compounds bind to 
(dGdC)12●(dGdC)12 with binding affinities between 104 to 105 M-1. The binding site 
size for compounds 2.1-2.2 and 2.4-2.7 interacting with (dGdC)12●(dGdC)12 is 
between 1 to 4 base pairs. In general, both compounds 2.1 and 2.7 show greater 
affinities for (dGdC)12●(dGdC)12 over (dAdT)12●(dAdT)12. In contrast, compounds 
2.2 and 2.4–2.6 have more affinty toward (dAdT)12●(dAdT)12.
The driving forces for the compounds of this family binding to DNA could be 
provided by hydrophobic interactions between the conjugated aromatic frameworks of 
binders and hydrophobic parts of the base pairs, in addition to electrostatic interaction 
between cationic charge on (NH3+) and the negative charges on the DNA.
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2.4 Materials and Methods
2.4.1 DNA preparation
All compounds studied in this chapter were provided by our collaborators. All 
experiments were carried out in buffer (25 mM MOPS, 50 mM NaCl, pH 7.0, at 
25 °C). The pH of the buffer was determined using a Hanna Instruments pH 210 pH 
meter equipped with a VWR 662-1759 glass electrode. The buffer components were 
purchased from Acros and Sigma-Aldrich. Fish sperm DNA and Calf thymus DNA 
were also purchased from Acros and Sigma-Aldrich. The stock solution of calf 
thymus DNA was prepared by sonicating a solution of CT-DNA for about 30 minutes
whereas the stock solution of fish sperm DNA was prepared by sonicating a solution 
of FS-DNA for about 10 minutes. The sonicator was used in DNA preparation in 
order to quicken the solvation of DNA in buffer. Fish sperm DNA needs less 
sonicating because FS-DNA dissolves more quickly in MOPS buffer.
The DNA solution was dialysed against 2.0 litre of buffer using a 3.5 kDa MWCO 
dialysis membrane for 24 hours. The concentration of DNA was determined by UV-
visible spectroscopy using an extension coefficient of 12800 M-1 cm-1 at 260 nm.4
2.4.2 Spectroscopic studies
UV-visible spectra were measured using a Jasco V-630Bio spectrophotometer 
equipped with a peltier temperature controller at 25 °C. Circular dichroism spectra 
were recorded on a Chirascan CD Spectrophotometer. Stock solutions of 2.1-2.9 in 
buffer were freshly prepared and volumes of these stock solutions were added into 
2000-2500 µl of buffer as required in a 1.0 cm path length cuvette. All UV-visible 
titrations were carried out by adding aliquots of the DNA stock solution into 1 cm 
path length cuvette which contains ligand solution, measuring the absorption in the 
range of 200-600 after each addition. The absorption in the range of 0.1-0.6 a.u. was 
measured in a cuvette to avoid self-aggregation and precipitation of the ligand. The 
absorptions at selected wavelength were plotted against DNA concentrations and a 
multiple independent binding sites model (see section 1.10.1 in Chapter 1) was used 
to analyse the UV-visible spectra by Origin 9.0. The baseline absorbance in a titration, 
and hence in the data analysis, corresponds to the absorbance of a cuvette containing
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buffer only because the spectrophotometer was calibrated without cuvettes in the 
sample or reference position (“air versus air”). For CD titrations the same steps were 
followed except the ICD signals were used instead of absorptions in UV-visible 
titrations.
2.4.3 Isothermal titration calorimetry
All ITC experiments were carried out using a Microcal VP ITC microcalorimeter. The 
ligand solutions were prepared in buffer (25 mM MOPS, 50 mM NaCl, pH 7.0) and 
concentrations were determined using UV-visible spectroscopy based on extinction
coefficients. All calorimetric binding experiments were carried out at 25 °C. The 
sample cell and syringe were always cleaned with ethanol followed by distilled water 
before starting any experiment. The sample cell was filled with FS-DNA solution 
(approximately 1.9 ml). The syringe was filled with ligand solution (approximately 
300 µl) with a concentration usually12-fold higher than DNA solution (exact ratios 
depends on individual experiments). The ligand solution was added in 1 injection of 5 
µl for the first addition and 19 injections of 15 µl each to the sample cell, injecting 
every 300 second automatically. During the titration the solutions in the sample cell 
was mixed with a stirring speed of 307 rpm. The heat effects per injection (dh) were 
calculated using Origin (Microcal, Inc). The integrated heat effects were analysed 
using IC ITC.2
2.4.4 Viscometry 
All viscosimetry experiments were carried out in buffer (25 mM MOPS, 50 mM 
NaCl, pH 7.0). A Cannon-Flenske routine viscometer was placed in a temperature-
controlled circulated water bath at 25 °C. The viscometer was filled with fixed 
amount of Calf thymus DNA (3.0 ml of 0.5 mM) and adding  ligand solutions with
concentrations calculated from the ratio of ligand/ DNA (0.03, 0.06, 0.09, 0.12 and 
0.15). The flow time was measured three times for each ligand addition and the results 
were averaged. The relative viscosity was calculated and plotted as a function of the 
ratio [ligand]bound/[DNA] where [ligand]bound was calculated using binding parameters 
from UV-visible spectroscopy.
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2.4.5 Docking studies
Molecular docking studies were performed using Auto Dock Vina.6 The ligand 
structures were generated using chemdraw and then optimised using Avogadro, using 
force fields MMFF94 for ligands and GAFF for metal complexes. The rotable bonds 
in the ligand were assigned using Auto Dock Tools 1.5.6 and the output files were 
saved in PDBQT format. Our previously developed9 open-
d(ATCGAGACGTCTCGAT)2 was used as a biomacromolecular target. An 
exhaustiveness of 200 and number modes of 10 were selected. The results of Auto 
Dock Vina were rendered using Chimera 1.10.2.
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Abstract
We studied the interactions of a family of dendrimeric compounds and the 
corresponding fluorescent core with double- stranded DNA using a variety of 
techniques viz. spectroscopy, calorimetry, viscosity and molecular docking studies. 
The cationic ligands bind to duplex DNA strongly through different binding modes 
predominately intercalation and side-by-side binding in the minor groove. An anionic 
compound was found to interact weakly with duplex DNA. The sequence selectivity of 
this group for (dAdT)12●(dAdT)12 and (dGdC)12●(dGdC)12 was also studied via UV-
visible spectroscopy. A preference for the (dAdT)12●(dAdT)12 sequence over 
(dGdC)12●(dGdC)12 was observed.
DNA binding studies of a family of dendrimeric compounds
111
3.1 Introduction
Our objectives in this chapter are to quantify the thermodynamics of binding for a 
family of dendrimeric compounds and the corresponding fluorescent core to duplex 
DNA, and the mode of interactions. We aim to achieve these objectives by using 
several techniques viz. UV-visible and circular dichroism spectroscopy, isothermal 
titration calorimetry, and viscosity. The structures investigated are summarised in 
Scheme 3.1.
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All compounds in Scheme 3.1 were provided by our collaborator (Alla M.M. El-
Betany).9 These compounds consist of a highly fluorescent flat core (7H-
benz[de]benzimidazo[2,1-a]isoquinoline-7-one) which is attached to different small 
poly(amidoamine) side-groups to increase solubility in aqueous medium. According 
to their structure, we expect the compounds of dendrimeric family bind to duplex 
DNA via intercalation and their optical and electronic behaviours may change upon 
binding.
These compounds are highly fluorescent and they could therefore be used as 
components in genosensors based on fluorimetric detection. Additionally, we expect 
these compounds to bind with duplex DNA as intercalators, enabling these 
compounds to be used as signal enhancers in electrochemical impedance spectroscopy
(EIS) based biosensors. Furthermore, anionic compound 3.2 carries significant 
negative charges and, provided it binds to DNA, could therefore be an excellent
element for use as sensitiser in EIS-based biosensors where surface charge on the 
electrode palys an important role.
3.2 Results and Discussion
The results of the interaction studies for compounds 3.1-3.4 with DNA will be shown
and discussed for each individual compound.
3.2.1 UV-visible spectroscopy
The binding of 3.1, 3.3 and 3.4 to duplex DNA were studied through UV-visible 
spectroscopy. The binding study of 3.2 by UV-visible was not carried out because this 
compound had already been studied by our collaborator and showed low affinity to 
duplex DNA.    
3.2.1.a Binding of 3.1 to DNA
The binding of 3.1 to DNA was studied using UV-visible spectroscopy; the changes 
in absorption of 3.1 upon addition of FSDNA were measured in buffer (25 mM 
MOPS, pH 7.0 and 50 mM NaCl) at 25 °C (Figure 3.1).
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Figure 3.1 UV-visible spectra for 0.03 mM 3.1 upon addition of 0 – 1.72 mM FS-
DNA in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl) at 25 °C.
Figure 3.1 shows a hypochromic shift in absorbance (at the λmax of 444 nm) followed 
by hyperchromic shift (at the λmax of 444 nm) of 3.1 upon addition of FSDNA. In 
addition, a peak at 475 nm grows considerably. This change in UV-visible absorption 
may occur as a result of geometrical distortion of 3.1 when it interacts with DNA, but 
it may also be a local medium effect. On the other hand, absorbance in the range of 
550-600 nm increases upon the first additions of DNA but subsequently decreases 
again. This observation suggests precipitation and subsequent dissolution of a DNA-
ligand complex. Precipitation was also observed by naked-eye.
To quantify the affinity of 3.1 for FSDNA, the absorbances at 444 nm were plotted as 
a function of concentration of FSDNA (Figure 3.2, for data in tabular format see 
appendix, Table A16.1).
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Figure 3.2 Absorbance at 444 nm of a solution of 0.03 mM 3.1 as a function of DNA 
concentration of 0 – 0.015 mM (●) and of 0.023 – 1.7 mM (■), average absorbance of 
580-600 nm as a function of DNA concentration (inset), in buffer (25 mM MOPS, pH 
7.0, 50 mM NaCl) at 25 °C. The solid line represents a fit of a multiple independent 
sites model to the data in the 0.023 – 1.7 mM range.
Figure 3.2 shows two binding events. In the first binding event a rapid decrease in 
absorbance was observed. We attribute this rapid decrease in absorption to strong 
binding of 3.1 to the sugar-phosphate backbone of DNA at low DNA/ligand ratios, 
leading to charge neutralization of 3.1-DNA complexes and eventually precipitation.    
The titration data in Figure 3.2 (with the first event not included) were analysed in 
terms of a multiple independent binding sites models, which also takes ligand dilution 
into account, giving an apparent equilibrium constant (Kbinding) of (0.002 ± 0.126) M-1 
and a binding site size of (0.05 ± 3.3) ×10-5 base pairs. The obtained binding 
parameters were unreasonably small with an ill-defined stoichiometry. Therefore the 
data were reanalyzed with the stoichiometry restricted to 3.0 base pairs, giving an 
apparent binding constant of (1.36 ± 0.15) ×104 M-1. 
3.2.1.b Binding of 3.3 to DNA
The binding of 3.3 to DNA was studied using UV-visible spectroscopy; the changes 
in absorption of 3.3 upon addition of FSDNA were measured in buffer (25 mM 
MOPS, pH 7.0 and 50 mM NaCl) at 25 °C (Figure 3.3).
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Figure 3.3 UV-visible spectra for 0.029 mM 3.3 upon addition of 0 – 0.69 mM 
FSDNA in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl) at 25 °C.
Figure 3.3 shows a hypochromic shift in absorbance (at the λmax of 452 nm) followed 
by hyperchromic shift (at the λmax of 452 nm) of 3.3 upon addition of FSDNA.This 
change in UV-visible absorption may occur as a result of geometrical distortion of 3.3
when it interacts with DNA, but it may also be a local medium effect. In addition, this 
compound shows an increase in absorbance in the range of 550 – 600 nm upon the 
first additions of DNA. This observation suggests precipitation and subsequent 
dissolution of a DNA-ligand complex. Precipitation was also observed by naked-eye.
To quantify the affinity of 3.3 for FSDNA, the absorbances at 452 nm were plotted as 
a function of concentration of FSDNA (Figure 3.4, for data in tabular format see 
appendix, Table A16.2).
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Figure 3.4 Absorbance at 452 nm of a solution of 0.029 mM 3.3 as a function of 
DNA concentration of 0 – 0.062 mM (●) and of 0.083 – 0.69 mM (■), average 
absorbance of 580-600 nm as a function of DNA concentration (inset), in buffer (25 
mM MOPS, pH 7.0, 50 mM NaCl) at 25 °C. The solid line represents a fit of a 
multiple independent sites model to the data in the 0.083 – 0.69 mM range.
Figure 3.4 also shows two binding events. In the first binding event a steep decrease 
in absorbance was observed. We attribute this steep decrease in absorption to strong 
binding of 3.3 to the sugar-phosphate backbone of DNA at low DNA/ligand ratios, 
leading to charge neutralization of 3.3-DNA complexes and eventually precipitation.    
The titration data in Figure 3.4 (with the first event not included) were analysed in 
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terms of a multiple independent binding sites model, which also takes ligand dilution 
into account, to the data. The fit gave an apparent equilibrium constant (Kbinding) of 
(9.83 ± 17.7) ×104 M-1 and a binding site size of (3.85 ± 3.67) base pairs. The large 
error margins suggest significant parameter covariance. We therefore re-analysed the 
data for a binding site size n restricted to 3 base pairs (for these types of DNA binders 
the average binding site size n is around 3 base pairs). The fit gave an equilibrium 
constant (Kbinding) of (6.43 ± 1.61) ×104 M-1.
3.2.1.c Binding of 3.4 to DNA
The binding of 3.4 to DNA was studied using UV-visible spectroscopy; the changes 
in absorption of 3.4 upon addition of FSDNA were measured in buffer (25 mM 
MOPS pH, 7.0 and 50 mM NaCl) at 25 °C (Figure 3.5).
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Figure 3.5 UV-visible spectra for 0.04 mM 3.4 upon addition of 0 – 0.18 mM 
FSDNA in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl) at 25 °C.
Figure 3.5 shows a hypochromic shift in absorbance (at the λmax of 454 nm) of 3.4
upon addition of FSDNA. This change in UV-visible absorption may occur as a result 
of geometrical distortion of 3.4 when it interacts with DNA, but it may also be a local 
medium effect. In addition, this compound shows a significant increase in absorbance 
in the range of 550 – 600 nm upon the first additions of DNA, indicative of 
precipitation followed by dissolution of a DNA-ligand complex. Precipitation was
also clearly observed by naked-eye during the titration.
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To quantify the affinity of 3.4 for FSDNA, the absorbances at 454 nm were plotted as 
a function of concentration of FSDNA (Figure 3.6, for data in tabular format see 
appendix, Table A16.3).
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Figure 3.6 Absorbance at 454 nm of a solution of 0.04 mM 3.4 as a function of DNA 
concentration of 0 – 0.04 mM (●) and of 0.058 – 0.18 mM (■), average absorbance of 
580-600 nm as a function of DNA concentration (inset), in buffer (25 mM MOPS, pH 
7.0, 50 mM NaCl) at 25 °C. The solid line represents a fit of a multiple independent 
sites model to the data in the 0.058 – 0.18 mM range.
Figure 3.6 shows changes in absorbance of 3.4 upon addition of DNA. We may 
attribute these changes in absorption to strong binding of 3.4 to DNA, leading to 
precipitation of ligand-DNA complexes. However, when we tried to analyse the data 
in terms of a multiple independent binding sites model, we were unable to analyse the 
titration curve satisfactorily due to the complexity of the data. Therefore, we tried to 
analyse titration data in another way. We believe that the increase in absorbance at 
530 nm is solely due to scattering and that the increase as a result of scattering at the 
λmax of 454 nm is almost the same. Thus, we subtracted the absorbances at 530 nm 
from the absorbances at 454 nm in order to remove the amount of absorbance 
resulting from scattering.
To quantify the affinity of 3.4 for FSDNA, the absorbances at 454 nm – 530 nm were 
plotted as a function of concentration of FSDNA (Figure 3.7, for data in tabular 
format see appendix, Table A16.4).
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Figure 3.7 Absorbance at 454 nm – 530 nm of a solution of 0.04 mM 3.4 as a 
function of DNA concentration of 0 – 0.058 mM (●) and of 0.076 – 0.18 mM (■), in 
buffer (25 mM MOPS, pH 7.0, 50 mM NaCl) at 25 °C. The solid line represents a fit 
of a multiple independent sites model to the data in the 0.076 – 0.18 mM range.
Figure 3.7 shows two binding events. In the first binding event a sharp decrease in 
absorbance was observed. We attribute this sharp decrease in absorption to strong 
binding of 3.4 to the sugar-phosphate backbone of DNA at low DNA/ligand ratios, 
leading to charge neutralization of 3.4-DNA complexes and eventually precipitation.    
The titration data in Figure 3.7 (with the first event not included) were analysed in 
terms of a multiple independent binding sites models, which also takes ligand dilution 
into account, giving an apparent equilibrium constant (Kbinding) of (5.07± 4.41) ×106
M-1 and a binding site size of (4.69 ± 0.09) base pairs.
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Summary
The results of UV-visible titrations for compounds of 3.1 and 3.3-3.4 with duplex 
DNA show that these ligands 3.1 and 3.3-3.4 bind to FSDNA. The apparent affinities 
of these compounds to FS-DNA are summarised in Table 3.1.  
Table 3.1 Apparent binding affinities and binding site sizes for binding of 3.1 and
3.3-3.4 to FSDNA, in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl) at 25 °C.
Ligand Binding constant
K / M-1
Binding site size
n / bp
3.1 (1.30 ± 0.21) ×104 3*
3.3 (6.43 ± 1.61) ×104 3*
3.4 (5.07± 4.41) ×106 4.69 ± 0.09
* restricted.
Table 3.1 shows that all ligands bind to duplex DNA with different affinities. Ligand 
3.4 binds more strongly with DNA compares to 3.3 and 3.1. We may attribute these 
differences in affinities to structural variation of these ligands. Compound 3.4 has 
bigger poly(amideamido) PAMAM side-group compared to 3.1 and 3.3, therefore, 
compound 3.4 possesses more sites of interactions and can bind more strongly with 
DNA. All ligands 3.1, 3.3-3.4 bind to fish sperm DNA in two separate events. The 
first event occurs at low DNA/ligand ratio where the ligand binds to both the highest 
affinity binding sites but also to the sugar-phosphate backbone of DNA, leading to
precipitation of charge-neutralised ligand-DNA complexes. At high DNA/ligand ratio 
the second event occurs where ligand binds to main binding sites viz. minor groove or 
intercalation of DNA. The binding site sizes of 3.1 and 3.3 were restricted to 3.0 base 
pairs in order to obtain reasonable binding parameters. Compound 3.4 also shows 
affinity to FSDNA and causes a hypochromic shift in absorbance at maximum 
absorption 454 nm.  However, this interaction cannot be analysed directly due to
forming a lot of precipitation of ligand-DNA complexes which makes the titration 
curve difficult to analyse by our present model. Therefore, we decided to analyse the 
titration data of compound 3.4 in another way, as we discussed before (Section 
3.2.1.c).  
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3.2.2 Isothermal titration calorimetry (ITC)
To investigate further the binding of compounds 3.1-3.3 with duplex DNA, we used 
isothermal titration calorimetry (ITC).  In order to obtain thermodynamic parameters for 
binding of compounds 3.1-3.3 with DNA, the titrations data were analysed using our IC 
ITC software. We started these investigations by studying the interactions of the anionic 
compound 3.2 with DNA.
3.2.2.a dilution of anionic 3.2 
In order to determine the heats of dilution for 3.2 in MOPS buffer, the dilutions of a 
series of solutions of 3.12, 2.34 and 2.34 mM of 3.2 in MOPS buffer (25 mM MOPS, 
50 mM NaCl, pH 7.0) were studied using isothermal titration calorimetry. The 
differential heat flow and derived integrated heat effects for these dilutions were 
recorded at 25 °C (Figure 3.8).
DNA binding studies of a family of dendrimeric compounds
121
-0.2 0.0 0.2 0.4 0.6
0
2
-10 0 10 20 30 40 50 60 70 80 90 100 110
0.0
0.5
1.0
1.5
2.0
2.5
Time (min)
µc
al/
se
c
[L]
tot 
/ mmol dm
-3
kc
al/
mo
le 
of 
inj
ec
tan
t
(a)
0.0 1.0x10
-4
2.0x10
-4
3.0x10
-4
4.0x10
-4
5.0x10
-4
6.0x10
-4
1.0x10
-5
2.0x10
-5
3.0x10
-5
4.0x10
-5
5.0x10
-5
6.0x10
-5
7.0x10
-5
8.0x10
-5
9.0x10
-5
He
at(
Q)
[L]tot
(d)
-0.2 0.0 0.2 0.4 0.6
0
1
2
3
-10 0 10 20 30 40 50 60 70 80 90 100 110
0.0
0.5
1.0
1.5
2.0
2.5
Time (min)
µc
al/
se
c
[L]
tot 
/ mmol dm
-3
kc
al/
mo
le 
of 
inj
ec
tan
t
(b)
0.0 1.0x10
-4
2.0x10
-4
3.0x10
-4
4.0x10
-4
1.0x10
-5
2.0x10
-5
3.0x10
-5
4.0x10
-5
5.0x10
-5
6.0x10
-5
7.0x10
-5
8.0x10
-5
9.0x10
-5
He
at(
Q)
[L]tot
(e)
DNA binding studies of a family of dendrimeric compounds
122
-0.2 0.0 0.2 0.4 0.6
0
1
2
3
-10 0 10 20 30 40 50 60 70 80 90 100 110
0.0
0.5
1.0
1.5
2.0
2.5
Time (min)
µc
al/
se
c
[L]
tot 
/ mmol dm
-3
kc
al/
mo
le 
of 
inj
ec
tan
t
(c)
0.0 1.0x10
-4
2.0x10
-4
3.0x10
-4
4.0x10
-4
1.0x10
-5
2.0x10
-5
3.0x10
-5
4.0x10
-5
5.0x10
-5
6.0x10
-5
7.0x10
-5
8.0x10
-5
9.0x10
-5
HE
AT
(Q
)
[L]tot
(f)
Figure 3.8 Enthalpograms for dilution of a 3.12 mM solution of 3.2 (a), of a 2.34 mM 
solution of 3.2 (b), and of a 2.34 mM solution of 3.2 (c), into a 25 mM MOPS, 50 mM 
NaCl, pH 7.0, at 25 °C, fit in terms of dilution (d), (e) and (f), experimental heat (■), 
calculated heat (●).
Figure 3.8 shows the heats of dilution of 3.12, 2.34 and 2.34 mM of 3.2 in MOPS
buffer. Our IC ITC software was used to analyse the data, giving self-aggregation
parameters as summarised in Table 3.2.
Table 3.2 Thermodynamic parameters for self-aggregation of 3.2 in a 25 mM 
MOPS, 50 mM NaCl, pH 7.0, at 25 °C
Experiment Kagg /104 M-1 ΔHagg / kcal mol-1 
(a) 2.39 ± (1.47-7.61) -3.95 ±(-6.03- -3.29)
(b) 3.19 ± (2.07- 7.14) -5.27 ± (-6.99- -4.53)
(c) 1.93 ± (1.28- 3.64) -4.4 3± (-5.30- -3.97)
Average 2.50 -4.55
The obtained dilution parameters in Table 3.2 show that a significant amount of heat 
is absorbed as a result of diluting 3.2 into MOPS buffer. The results of all three 
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experiments also show good reproducibility which can be seen clearly from the 
margin of errors of their dilution parameters (Figure 3.10).
3.2.2.b ITC studies of anionic 3.2 binding to DNA
To explore the interaction of anionic 3.2 with DNA, the binding of 3.2 to DNA was
studied using isothermal titration calorimetry. The differential heat flow and derived 
integrated heat effects for titration of a 3.12 mM solution of 3.2 into a 0.5 mM 
FSDNA solution were measured in 25 mM MOPS, 50 mM NaCl, pH 7.0, at 25 °C 
(Figure 3.9).
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Figure 3.9 Titration of a 3.12 mM solution of 3.2 into a 0.5 mM solution of FSDNA
(a-top), integrated heat effects of titrations (a-bottom), fit in terms dilution (b),
experimental heat (■), calculated heat (●), in 25 mM MOPS, 50 mM NaCl, pH 7, at 
25 °C.
The enthalpogram for interaction of 3.2 with DNA in Figure 3.9 does not show big 
differences compared to the enthalpogram for dilution of 3.2 in MOPS buffer. We 
attribute this to a weak to negligible interaction between 3.2 and DNA, leading to 
small additional heat effects. Therefore, in order to find whether the binding is fully
absent or only weak, we decided to analyse the titration data in terms of a model 
accounting only for dilution. The resulting thermodynamic parameters are 
summarized in Table 3.3.
Table 3.3 Thermodynamic parameters for interaction of 3.2 to FSDNA in 25 mM 
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MOPS, 50 mM NaCl, pH 7.0, at 25 °C, analysed in terms of a self-aggregation 
model only.
K aggregation/ x103 M-1 ΔH aggregation/ kcal mol-1 
9.18 (7.57 – 11.4)                 -2.55 (-2.46 – -2.67)
The dilution parameters obtained from analyzing the titration data in terms of self 
aggregation only (Table 3.3) can be compared with the parameters obtained from 
previous dilution experiments of 3.2. The comparison shows that analyzing the
titration data of 3.2 in the presence of DNA in the sample cell in terms of diluting 
model involving self-aggregation only yields parameters (Kagg and ∆Hagg ) which are 
not in the ranges of the margin of error of (Kagg and ∆Hagg ) obtained from the dilution 
experiments (Figure 3.10). Therefore, we decided to reanalyse the titration data in 
terms of self-aggregation in combination with binding (Figure 3.11).
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Figure 3.10 Normalised Σdev2/dof for dilution parameters of dilutions of 3.12 mM 
solution of 3.2 (■), of 2.34 mM solution of 3.2 (●), and of 2.34 mM solution of 3.2
(▲), into 25 mM MOPS, 50 mM NaCl, pH 7, at 25 °C.
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Figure 3.11 Fit for integrated heat effects of a titration of a 3.12 mM solution of 3.2
into a 0.5 mM solution of DNA in 25 mM MOPS, 50 mM NaCl, pH 7, at 25 °C, in 
terms of a binding model involving one type of binding site, aggregation included,
experimental heat (■), calculated heat (●).
The titration data were reanalysed by our IC ITC software. Ligand aggregation was
included with the values of Kagg and ∆Hagg restricted to numbers which were obtained 
from the dilution experiments. All binding parameters were determined are 
summarized in Table 3.4.
Table 3.4 Thermodynamic parameters for binding of 3.2 to FSDNA in 25 mM 
MOPS, 50 mM NaCl, pH 7.0, at 25 °C.
KA1
(M-1)
1/nA1
(bp)
∆HA1
(kcal mol-1)
-T∆SA1
(kcal mol-1)
{Σdev2/dof}½ 
(µcal)
3.2 8.62n.d. 0.73 (0.08 –
9)
-357 (-18.3 
– -492)
355.7 0.42
n.d. the margin of error not determined.
The obtained binding constant in Table 3.4 is small and the enthalpy of interaction is 
too big. Therefore the data were reanalyzed where 1/nA1 was restricted to 3 base pairs
(Figure 3.12)
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Figure 3.12 Fit for integrated heat effects of a titration of a 3.12 mM solution of 3.2
into a 0.5 mM solution of DNA in 25 mM MOPS, 50 mM NaCl, pH 7, at 25 °C, in 
terms of a binding model involving one type of binding site, aggregation included,
experimental heat (■), calculated heat (●).
The titration data were reanalysed using IC ITC software. As before, the ligand 
aggregation was included and the values of Kagg and ∆Hagg were restricted to numbers 
which were obtained from dilution experiments. All resulting binding parameters are 
summarized in Table 3.5.
Table 3.5 Thermodynamic parameters for binding of 3.2 to FSDNA in 25 mM 
MOPS, 50 mM NaCl, pH 7.0, at 25 °C.
KA1
(M-1)
1/nA1
(bp)
∆HA1
(kcal mol-1)
-T∆SA1
(kcal mol-1)
{Σdev2/dof}½ 
(µcal)
3.2 25.2n.d. 3* -500 (-500 
– -19.3)
498 0.40
* restricted; n.d. the margin of error not determined.
The obtained enthalpy of interaction in Table 3.5 is still too big and unreasonable. 
Therefore the data were reanalyzed where ∆HA1 is restricted to -10 kcal. mol-1 (Figure 
1.5). The reason for restricting ∆HA1 to this value is that the average enthalpy of 
binding for this group of binders is around -10 kcal. mol-1 (vide infra).
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Figure 3.13 Fit for integrated heat effects of a titration of a 3.12 mM solution of 3.2
into a 0.5 mM solution of DNA in 25 mM MOPS, 50 mM NaCl, pH 7, at 25 °C, in 
terms of a binding model involving one type of binding site, aggregation included,
experimental heat (■), calculated heat (●).
The titration data were reanalysed using IC ITC software. As before, ligand 
aggregation was also included and the values of Kagg and ∆Hagg were restricted to 
numbers which were obtained from dilution experiments. Binding parameters were 
determined as summarized in Table 3.6.
Table 3.6 Thermodynamic parameters for binding of 3.2 to FSDNA in 25 mM 
MOPS, 50 mM NaCl, pH 7.0, at 25 °C.
KA1
(M-1)
1/nA1
(x10-3 bp)
∆HA1
(kcal mol-1)
-T∆SA1
(kcal mol-1)
{Σdev2/dof}½ 
(µcal)
3.2 1.61n.d. 2.6 (1.4 –
30)
-10* 9.7 0.81
* restricted; n.d. the margin of error not determined.
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The obtained binding site size in Table 3.6 is unreasonably small. Therefore, we 
decided to reanalyze the data one more time with a stoichiometry restricted to 3 base 
pairs (Figure 3.14). As before, the ligand aggregation was also included and the 
values of Kagg and ∆Hagg were restricted to the numbers which were obtained from 
dilution experiments. The resulting binding parameters are summarized in Table 3.7.
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Figure 3.14 Fit for integrated heat effects of a titration of a 3.12 mM solution of 3.2
into a 0.5 mM solution of DNA in 25 mM MOPS, 50 mM NaCl, pH 7, at 25 °C, in 
terms of a binding model involving one type of binding site, aggregation included,
experimental heat (■), calculated heat (●).
Table 3.7 Thermodynamic parameters for binding of 3.2 to FSDNA in 25 mM 
MOPS, 50 mM NaCl, pH 7.0, at 25 °C.
KA1
(M-1)
1/nA1
(bp)
∆HA1
(kcal mol-1)
-T∆SA1
(kcal mol-1)
{Σdev2/dof}½ 
(µcal)
3.2 1930n.d. 3* -10* 5.52 0.86
* restricted; n.d. the margin of error not determined.
The obtained binding constant in Table 3.7 suggests that compound 3.2 has low 
affinity to duplex DNA, but does indeed bind to duplex DNA despite its negative 
charge.  
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3.2.2.c dilution of 3.1
In order to determine the heats of dilution for 3.1 in MOPS buffer, the dilutions of a 
series of solutions of 3.1 in MOPS buffer (25 mM MOPS, 50 mM NaCl, pH 7.0) were
studied using isothermal titration calorimetry. The dilution experiments were repeated 
five times but the results were non-reproducible. We attribute this surprising non-
reproducibility of the dilution experiments to self-aggregation of the ligand in 
unknown aggregate types in the sample cell. Therefore we were unable to determine 
the dilution parameters for compound 3.1.
3.2.2.d ITC studies of 3.1 binding to DNA
To investigate further the binding of 3.1 with DNA, the binding of 3.1 to DNA was
studied using isothermal titration calorimetry. The differential heat flow and derived 
integrated heat effects for titrations of solutions of 3.1 (1.06 & 1.29) mM into fish sperm
DNA solutions (both 0.12 mM) were measured in 25 mM MOPS, 50 mM NaCl, pH 7.0, at 
25 °C (Figure 3.15).
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Figure 3.15 Titration of a 1.06 mM solution of 3.1 into a 0.12 mM solution of 
FSDNA (a), of a 1.29 mM solution of 3.1 into a 0.12 mM solution of FSDNA (b), fit 
for integrated heat effects of titrations (a) and (b) in terms of a binding model 
involving two types of binding site, aggregation included (c) and (d), in 25 mM 
MOPS, 50 mM NaCl, pH 7, at 25 °C, experimental heat (▀), calculated heat (●). 
The enthalpograms for binding of 3.1 to FSDNA suggest more than one binding 
event, which was also observed by UV-visible titration. The first event occurs at high 
DNA/ligand ratio where ligand binds to the main binding sites of DNA viz. minor 
groove or intercalation. At low DNA/ligand ratio the second event occurs where the 
ligand binds to the sugar-phosphate backbone of DNA which leads to forming a 
precipitate of ligand-DNA complexes.2, 3 According to Figure 3.11 the interaction 
between 3.1 and DNA is exothermic. The titration data were analysed using our ITC 
data analysis IC ITC software. Ligand aggregation was included and the values of 
Kagg and ∆Hagg were non-restricted because these parameters could not be obtained 
from the independent dilution experiments (vide supra). The resulting thermodynamic 
parameters are summarized in Table 3.8.
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Table 3.8 Thermodynamic parameters for binding of 3.1 to FSDNA in 25 mM 
MOPS, 50 mM NaCl, pH 7.0, at 25 °C.
Binding parameters Experiment (a) Experiment (b)
KA1 (109 M-1) 1.24 (0.1 ˗ 1.24) 0.91 (0.12 ˗ 0.91)
1/nA1 (bp) 4 (2.27 ˗ 17) 4.76 (3.4 ˗ 10)
∆HA1 (kcal mol-1) -7.15 (-15 ˗ -0.83) -7.08 (-22.4 ˗ -4.84)
-T∆SA1 (kcal mol-1) -5.24 -5.2
KB1 (106 M-1) 6.92n.d. 3.78n.d.
1/nB1 (bp) 0.38 (0.15 ˗ 0.4) 0.4 (0.41 ˗ 0.36)
∆HB1 (kcal mol-1) -2.93 (-5.9 ˗ 1.52) -2.75 (-3.73 ˗ -1.7)
-T∆SB1 (kcal mol-1) -6.39 -6.21
{Σdev2/dof}½ (µcal) 3.46 3.43
n.d. not determined.
Table 3.8 shows that 3.1 binds to FS-DNA in two separate events, the first event 
occurs at low ligand/DNA ratio with an affinity of ~ 109M-1and a binding site size of 
~ 4 base pairs. At high ligand/DNA ratio the second event happens with an affinity of 
~ 106 M-1 and a binding site size of ~ 0.4 base pair. The results of data analysis for 
both titrations in Table 3.8 show good reproducibility of the experimental data. The 
negative molar enthalpy change and favorable standard molar entropy change for the 
first binding event suggest that 3.1 binds to FS-DNA as a groove binder, however it is 
difficult to decide based on ITC result to confirm the mode of binding of 3.1 with 
DNA because the ratio ∆H/∆G of 3.1 is close to the range for typical intercalators 
(0.83 - 1.97).5
3.2.2.e Dilution of 3.3
In order to determine whether compound 3.3 aggregates in MOPS buffer, the dilution 
of 0.99 mM solution of 3.3 in MOPS buffer (25 mM MOPS, 50 mM NaCl, pH 7.0)
was studied using isothermal titration calorimetry. The differential heat flow and 
derived integrated heat effects for this dilution were recorded at 25 °C (Figures 3.16)
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Figure 3.16 Enthalpogram for dilution of a 0.99 mM solution of 3.3 (a), into a 25 
mM MOPS, 50 mM NaCl, pH 7.0, at 25 °C, fit for integrated heat effects of the 
dilution (b), experimental heat (■), calculated heat (●).
Figure 3.16 shows non-constant heats of dilution of 0.99 mM of 3.3 in MOPS buffer, 
indicating self aggregation. Our IC ITC software was used to analyse the data. The 
obtained self aggregation parameters were determined and are summarised in Table 
3.9.
Table 3.9 Thermodynamic parameters for diluting of 3.3 into a 25 mM MOPS, 
50 mM NaCl, pH 7.0, at 25 °C
K aggregation/ M-1 ΔH aggregation/ kcal mol-1 
1100n.d. -5.87n.d.
n.d. the margin of error not determined.
The obtained dilution parameters for diluting of 3.3 into MOPS in Table 3.9 suggest 
that a considerable amount of heat is absorbed in the sample cell as a result of ligand 
disaggregation. 
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3.2.2.f ITC studies of 3.3 binding to DNA
In order to further explore the binding of 3.3 with DNA, the interactions of 3.3 with DNA 
were studied using isothermal titration calorimetry. The differential heat flow and derived 
integrated heat effects for titrations of solutions (both 0.99 mM) of 3.3 into fish sperm
DNA solutions (0.20 & 0.25) mM were measured in 25 mM MOPS, 50 mM NaCl, pH 7.0, 
at 25 °C (Figure 3.17, a & b).
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Figure 3.17 Titration of a 0.99 mM solution of 3.3 into a 0.20 mM solution of 
FSDNA (a), and of a 0.99 mM solution of 3.3 into a 0.25 mM solution of FSDNA (b), 
fit for integrated heat effects of titrations (a) and (b) in terms of a binding model 
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involving two types of binding site, aggregation included (c) and (d), in 25 mM 
MOPS, 50 mM NaCl, pH 7, at 25 °C, experimental heat (■), calculated heat (●).
The enthalpograms for binding of 3.3 to FSDNA again suggest more than one binding 
event, as was the case for 3.1, which also confirms the results from the UV-visible 
titrations. The first event occurs at high DNA/ligand ratio where ligand binds to main 
binding sites of DNA viz. minor groove or intercalation. At low DNA/ligand ratio the 
second event occurs where the ligand binds to the sugar-phosphate backbone of DNA, 
leading to formation of a precipitate of ligand-DNA complexes.2, 3 According to 
Figure 3.17 the interaction between 3.3 and DNA is exothermic. The titration data 
were analysed using our IC ITC software. All thermodynamic parameters are 
summarized in Table 3.10.
Table 3.10 Thermodynamic parameters for binding of 3.3 to FSDNA in 25 mM 
MOPS, 50 mM NaCl, pH 7.0, at 25 °C.
Binding parameters Experiment (a) Experiment (b)
KA1 (107 M-1) 1.55 (0.56 ˗ 9.0) 2.22 (1.6 - 4.1)
1/nA1 (bp) 6.6 (5.2 - 25) 6.6 (5.5 - 11.1)
∆HA1 (kcal mol-1) -14.6 (-48.8 - -11.6) -15.3 (-33.7 - -15.3)
-T∆SA1 (kcal mol-1) 4.8 5.3
KB1 (105 M-1) 4.10 (1.8 - 16.2) 5.67 (5.1 - 31)
1/nB1 (bp) 1.1 (0.93 - 1.2) 1.35 (1.2 - 1.47)
∆HB1 (kcal mol-1) -4.2 (-4.95 - -3.3) -4.45 (-3.6 - -5.2)
-T∆SB1 (kcal mol-1) -3.5 -3.4
{Σdev2/dof}½ (µcal) 4.83 5.5
Table 3.10 shows that compound 3.3 binds to FSDNA in two different events. The 
first event occurs at low ligand/DNA ratio with an affinity of ~ 107M-1and a binding 
site size of ~ 6 base pairs. At high ligand/DNA ratio the second event happens with an 
affinity of ~ 105 M-1 and a binding site size of ~ 1.0 base pair. The results of data 
analysis for both titrations in Table 3.10 show good reproducibility of the
experimental data. The negative values of enthalpy and entropy change in the first 
binding event suggest that 3.3 binds to FSDNA between base pairs as an intercalator.5
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Summary
The interactions of 3.1-3.3 with DNA were investigated by isothermal titration 
calorimetry. The thermodynamic parameters for these compounds interacting with 
FSDNA were determined and are summarised in Table 3.11.
Table 3.11 Thermodynamic parameters for binding of 3.1-3.3 to FSDNA in 25 
mM MOPS, 50 mM NaCl, pH 7.0, at 25 °C.
3.1 Binding parameters Experiment (a) Experiment (b)
KA1 (109 M-1) 1.24 (0.1 ˗ 1.24) 0.91 (0.12 ˗ 0.91)
1/nA1 (bp) 4 (2.27 ˗ 17) 4.76 (3.4 ˗ 10)
∆HA1 (kcal mol-1) -7.15 (-15 ˗ -0.83) -7.08 (-22.4 ˗ -4.84)
-T∆SA1 (kcal mol-1) -5.24 -5.2
KB1 (106 M-1) 6.92n.d. 3.7n.d.
1/nB1 (bp) 0.38 (0.15 ˗ 0.4) 0.4 (0.41 ˗ 0.36)
∆HB1 (kcal mol-1) -2.93 (-5.9 ˗ 1.52) -2.75 (-3.73 ˗ -1.7)
-T∆SB1 (kcal mol-1) -6.39 -6.21
{Σdev2/dof}½ (µcal) 3.46 3.43
3.3
KA1 (107 M-1) 1.55 (0.56 ˗ 9.0) 2.22 (1.6 - 4.1)
1/nA1 (bp) 6.6 (5.2 - 25) 6.6 (5.5 - 11.1)
∆HA1 (kcal mol-1) -14.6 (-48.8 - -11.6) -15.3(-33.7 - -15.3)
-T∆SA1 (kcal mol-1) 4.8 5.29
KB1 (105 M-1) 4.10 (1.8 - 16.2) 5.67 (5.1 - 31)
1/nB1 (bp) 1.1 (0.93 - 1.2) 1.35 (1.2 - 1.47)
∆HB1 (kcal mol-1) -4.2 (-4.95 - -3.3) -4.45 (-3.6 - -5.2)
-T∆SB1 (kcal mol-1) -3.49 -3.39
{Σdev2/dof}½ (µcal) 4.83 5.5
3.2
KA1 (103 M-1) 1.93n.d.
1/nA1 (bp) 3*
∆HA1 (kcal mol-1) -10*
-T∆SA1 (kcal mol-1) 5.52
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{Σdev2/dof}½ (µcal) 0.86
* restricted; n.d. the margin of error not determined.
Both compound 3.1 and 3.3 show strong exothermic interactions with FSDNA in two 
separate events. The titration data of 3.1 and 3.3 interacting with FS-DNA were 
analysed using our IC-ITC software where the effects of aggregation were included, 
giving thermodynamic binding parameters (see Table 3.11). The results of data 
analysis for both ligands in Table 3.11 show good reproducibility of experimental 
data. The negative values of enthalpy and entropy change in the first binding event 
suggest that 3.3 binds to FSDNA via intercalation. In addition, the obtained binding 
constant in Table 3.7 suggests that compound 3.2 has low, but non-zero affinity to 
duplex DNA.
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3.2.3 Induced circular dichroism (ICD)
3.2.3.a Induced circular dichroism for 3.1 interacting with FSDNA
The binding mode of interaction of 3.1 with FSDNA was further studied using circular 
dichroism spectroscopy. Circular dichroism spectra for 3.1 were recorded at different 
FSDNA concentrations (0 mM – 0.11 mM) in buffer (25 mM MOPS, pH 7.0 and 50 mM 
NaCl) at 25 °C (Figure 3.18).
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Figure 3.18 Circular dichroism spectra for 0.015 mM of 3.1 in the presence of 
different concentrations of FSDNA (0 mM – 0.11 mM) (a), recorded UV-visible 
spectra for the same titration (b), in buffer (25 mM MOPS, 50 mM NaCl, pH 7.0) at 
25 °C.
Figure 3.18 does not show any significant induced circular dichroism around the 
wavelength of interest 347 nm where compound 3.1 absorbs.
3.2.3.b Induced circular dichroism for 3.3 interacting with FSDNA
The binding mode of interaction of 3.3 with FSDNA was further studied using circular 
dichroism spectroscopy. Circular dichroism spectra for 3.3 were recorded at different 
FSDNA concentrations (0 mM – 0.11 mM) in buffer (25 mM MOPS, pH 7.0 and 50 mM 
NaCl) at 25 °C (Figure 3.19).
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Figure 3.19 Circular dichroism spectra for 0.02 mM of 3.3 in the presence of 
different concentrations of FSDNA (0 mM – 0.11 mM) (a), recorded UV-visible 
spectra for the same titration (b), in buffer (25 mM MOPS, 50 mM NaCl, pH 7.0) at 
25 °C.
Figure 3.19 shows a significant induced circular dichroism spectrum around the 
wavelength of interest 452 nm where compound 3.3 absorbs. To quantify the affinity 
of 3.3 for FSDNA, the ellipticities at 452 nm were plotted as a function of 
concentration of FSDNA (Figure 3.20).
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Figure 3.20 Ellipticity at 452 nm plotted against FSDNA concentrations for 0.02 mM 
of 3.3, in buffer (25 mM MOPS, 50 mM NaCl, pH 7.0) at 25 °C. The solid line 
represents the best fit to a multiple independent sites model.
DNA binding studies of a family of dendrimeric compounds
139
The titration curve in Figure 3.20 was analysed by fitting a multiple independent 
binding sites model, which also takes ligand dilution into account, to the data. The fit 
gives an equilibrium constant (Kbinding) of (2.10 ± 3.3) ×107 M-1 and a binding site size 
of (1.97 ± 0.07) base pairs. A negative ICD signal suggests that 3.3 intercalates 
between the base pairs.1
Summary   
The titration of 3.1 against FSDNA did not show any noticeable ICD signal therefore 
no evidence was found to determine the mode of binding. In contrast, the titration of 
3.3 against FSDNA showed a significant negative ICD signal which suggests that 3.3
binds with FSDNA through intercalation. The titration data of 3.3 with FSDNA were 
analysed in terms of a multiple independent binding sites model, giving an apparent
equilibrium constant (Kbinding) of (2.10 ± 3.3) ×107 M-1 and an apparent binding site 
size of (1.97 ± 0.07) base pairs. The large error margins suggest significant parameter 
covariance. We therefore re-analysed the data for a binding site size n restricted to 2 
base pairs (the reason for not restricting n to 3 base pairs is that for n = 3 the fit 
doesnot reproduce the experimental data well). The fit gave an equilibrium constant 
(Kbinding) of (2.8 ± 3.8) ×107 M-1. Because equilibrium constants cannot be negative, 
we express the error margin as a confidence interval so that the equilibrium constant 
is 2.8 ×107 [0 – 6.6×107] M-1.
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3.2.4 Viscosity
3.2.4.a Binding of 3.1 and 3.3 to calf thymus DNA (CT-DNA)
In order to find out whether compound 3.1 and 3.3 are groove binders or intercalators, the 
relative viscosity of CT-DNA upon addition of 3.1 or 3.3 was compared with viscosities of 
equivalent CT-DNA solutions that contained known DNA binders which are either an 
intercalator (ethidium bromide) or a minor groove binder (H33258).7 The relative 
viscosities of CT-DNA solutions were measured upon addition of 3.1 and 3.3 in buffer (25 
mM MOPS, pH 7.0 and 50 mM NaCl) at 25 °C (Figure 3.21).
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Figure 3.21 Relative viscosity of a 0.5 mM CT-DNA solution upon addition of 3.1
(■), 3.3 (▼), H33258 (▲) and ethidium bromide (●) at 25 °C in 25 mM MOPS, pH 
7.0, 50 mM NaCl. 
Figure 3.21 shows a significant increase in relative viscosity of CT-DNA solution 
upon the addition of 3.1 and 3.3. The increase in viscosity is similar to the increase 
observed upon addition of ethidium bromide, suggesting intercalation as the binding 
mode.
Summary
The addition of 3.1 and 3.3 to CT-DNA solution cause a significant increase in 
relative viscosity of CT-DNA solution, similar to the increase in the viscosity of CT-
DNA solution that is observed upon addition of known intercalator ethidium bromide 
which suggests that both compound 3.1 and 3.3 bind to CT-DNA via intercalation.    
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3.2.5 Molecular docking studies
3.2.5.a Docking studies of 3.1 and 3.3 binding to DNA
The binding mode for interaction of 3.1 and 3.3 with ds-DNA was further studied 
through a molecular docking study using Auto Dock Vina.6 Our previously 
developed8 open-d(ATCGAGACGTCTCGAT)2 was used as the biomacromolecular 
target.
(a) (b)
Figure 3.22 Top 3 docked poses for 3.1 (a) and 3.3 (b) interacting with open-
d(ATCGAGACGTCTCGAT)2.
The results of the molecular docking study (Table 3.12) show that intercalation is a 
favourable binding mode for 3.1 and 3.3 where the planar hydrophobic parts of 
molecule intercalate between base pairs. The complex structures in Figure 3.22 are in 
agreement with the results of the binding mode study by viscometry.
Table 3.12 Mode and enthalpy of binding for top 3 docked poses of 3.1 and 3.3.
Compound 3.1 Mode of binding Energy / kcal. mole-1 
Pose 1 intercalated -9.6
Pose 2 intercalated -8.9
Pose 3 intercalated -8.9
Compound 3.3
Pose 1 minor groove -8.8
Pose 2 intercalated -8.7
Pose 3 intercalated -8.7
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3.2.6 Sequence selectivity
The selectivity of a family of dendrimeric compounds 3.1 and 3.3 for selected specific 
sequences of DNA, viz. (dAdT)12●(dAdT)12 and (dGdC)12●(dGdC)12 was studied 
using UV-visible spectroscopy.
3.2.6.a Binding of 3.1 to (dAdT)12●(dAdT)12
The binding of 3.1 to (dAdT)12●(dAdT)12 was studied using UV-visible spectroscopy; 
the changes in absorption of 3.1 upon addition of (dAdT)12●(dAdT)12 were measured 
in buffer (25 mM MOPS, pH 7.0 and 50 mM NaCl) at 25 °C (Figure 3.23).
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Figure 3.23 UV-visible spectra for 0.008 mM 3.1 upon addition of 0 – 2.2 mM 
(dAdT)12●(dAdT)12 in 25 mM MOPS, pH 7.0, 50 mM NaCl, at 25 °C.
Figure 3.23 shows a hypochromic shift in absorbance (at the λmax of 444 nm) followed 
by hyperchromic shift (at the λmax of 444 nm) of 3.1 upon addition of 
(dAdT)12●(dAdT)12. In addition, a peak at 475 nm grows considerably. This change in 
UV-visible absorption may occur as a result of geometrical distortion of 3.1 when it 
interacts with DNA, but it may also be a local medium effect. On the other hand, 
absorbance in the range of 550-600 nm increases slightly at the first additions of 
DNA, suggesting some precipitation. Precipitation was also observed by naked-eye.
To quantify the affinity of 3.1 for (dAdT)12●(dAdT)12, the absorbances at 444 nm 
were plotted as a function of concentration of (dAdT)12●(dAdT)12 (Figure 3.24).
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Figure 3.24 Absorbance at 444 nm of a solution of 0.008 mM 3.1 as a function of 
(dAdT)12●(dAdT)12 concentration of 0 – 0.018 mM (●) and of 0.022 – 2.2 mM (■), in 
25 mM MOPS, pH 7.0, 50 mM NaCl, at 25 °C. The solid line represents a fit of a 
multiple independent sites model to the data in the range of 0.022 – 2.2 mM.
Figure 3.24 shows two binding events. In the first binding event a sudden decrease in 
absorbance was observed. We attribute this sudden decrease in absorption to strong 
binding of 3.1 to the sugar-phosphate backbone of DNA at low DNA/ligand ratio, 
leading to charge neutralization of 3.1-DNA complexes and eventually precipitation.    
The titration data of Figure 3.20 (with the first event excluded) were analysed in terms 
of a multiple independent binding sites models, which also takes ligand dilution into 
account, giving an apparent equilibrium constant (Kbinding) of (0.15 ± 49) M-1 and a 
binding site size of (2.1 ± 0.06) ×10-6 base pairs. The obtained binding parameters 
were unreasonably small with an ill-defined stoichiometry therefore the data were 
reanalyzed at fixed stoichiometry n=3. The fit gave an apparent binding constant of 
(17.35 ± 3.3) ×104 M-1. 
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3.2.6.b Binding of 3.1 to (dGdC)12●(dGdC)12
The binding of 3.1 to (dGdC)12●(dGdC)12 was studied using UV-visible spectroscopy; 
the changes in absorption of 3.1 upon addition of (dGdC)12●(dGdC)12 were measured 
in buffer (25 mM MOPS, pH 7.0 and 50 mM NaCl) at 25 °C (Figure 3.25).
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Figure 3.25 UV-visible spectra for 0.0085 mM 3.1 upon addition of 0 – 2.26 mM 
(dGdC)12●(dGdC)12 in 25 mM MOPS, pH 7.0, 50 mM NaCl, at 25°C.
Figure 3.25 shows a hypochromic shift in absorbance (at the λmax of 444 nm) followed 
by hyperchromic shift (at the λmax of 444 nm) of 3.1 upon addition of 
(dGdC)12●(dGdC)12. In addition, a peak at 475 nm grows considerably. This change 
in UV-visible absorption may occur as a result of geometrical distortion of 3.1 when it 
interacts with DNA, but it may also be a local medium effect. On the other hand, 
absorbance in the range of 550-600 nm increases at the first additions of DNA, again 
suggesting some precipitation. Precipitation was also observed by naked-eye.
To quantify the affinity of 3.1 for (dGdC)12●(dGdC)12, the absorbances at 444 nm 
were plotted as a function of concentration of (dGdC)12●(dGdC)12 (Figure 3.26).
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Figure 3.26 Absorbance at 444 nm of a solution of 0.0085 mM 3.1 as a function of 
(dGdC)12●(dGdC)12 concentration of 0 – 0.029 mM (●) and of 0.041 – 2.26 mM (■), 
in 25 mM MOPS, pH 7.0, 50 mM NaCl, at 25 °C. The solid line represents a fit of a 
multiple independent sites model to the data in the range of 0.041 – 2.2 mM.
Figure 3.26 shows two binding events. For the first binding event a sudden decrease 
in absorbance was observed. We attribute this sudden decrease in absorption to strong
non-specific binding of 3.1 to the sugar-phosphate backbone of (dGdC)12●(dGdC)12 at 
low DNA/ligand ratio, leading to charge neutralization of 3.1-DNA complexes and 
eventually precipitation. The titration data of Figure 3.26 (with the first event not 
included) were analysed by fitting a multiple independent binding sites model, which 
also takes ligand dilution into account, to the data, giving an apparent equilibrium 
constant (Kbinding) of (5.7 ± 0.7) ×104 M-1 for a binding site size restricted to 3.0 base 
pairs.
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3.2.6.c Binding of 3.3 to (dAdT)12●(dAdT)12
The binding of 3.3 to (dAdT)12●(dAdT)12 was studied using UV-visible spectroscopy; 
the changes in absorption of 3.3 upon addition of (dAdT)12●(dAdT)12 were measured 
in buffer (25 mM MOPS, pH 7.0 and 50 mM NaCl) at 25 °C (Figure 3.27).
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Figure 3.27 UV-visible spectra for 0.011 mM 3.3 upon addition of 0 – 1.8 mM 
(dAdT)12●(dAdT)12 in 25 mM MOPS, pH 7.0, 50 mM NaCl, at 25°C.
Figure 3.27 shows a hypochromic shift in absorbance (at the λmax of 452 nm) followed 
by hyperchromic shift (at the λmax of 452 nm) of 3.3 upon addition of 
(dAdT)12●(dAdT)12. In addition, peak at 475 nm grows considerably. This change in 
UV-visible absorption may occur as a result of geometrical distortion of 3.3 when it 
interacts with DNA, but it may also be a local medium effect. As before, the 
absorbance in the range of 550-600 nm increases at the first additions of DNA, 
suggesting some precipitation. Precipitation was also observed by naked-eye.
To quantify the affinity of 3.3 for (dAdT)12●(dAdT)12, the absorbances at 452 nm 
were plotted as a function of concentration of (dAdT)12●(dAdT)12 (Figure 3.28).
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Figure 3.28 Absorbance at 452 nm of a solution of 0.011 mM 3.3 as a function of 
(dAdT)12●(dAdT)12 concentration of 0 – 0.021 mM (●) and of 0.024 – 1.8 mM (■), in 
25 mM MOPS, pH 7.0, 50 mM NaCl, at 25 °C. The solid line represents a fit in terms 
of a multiple independent sites model to the data in the range of 0.024 – 1.8 mM.
Figure 3.28 shows two binding events. In the first binding event a sudden decrease in 
absorbance was observed. We attribute this sudden decrease in absorption to strong 
binding of 3.3 to the sugar-phosphate backbone of (dAdT)12●(dAdT)12 at low 
DNA/ligand ratio, leading to charge neutralization of 3.3-DNA complexes and 
eventually precipitation. The titration data of Figure 3.28 (with the first event not 
included) were analysed in terms of a multiple independent binding sites model, 
which also takes ligand dilution into account, to the data. The fit gave an apparent 
equilibrium constant (Kbinding) of (30.9 ± 5.57) ×103 M-1for a binding site size 
restricted to 3.0 base pairs.
3.2.6.d Binding of 3.3 to (dGdC)12●(dGdC)12
The binding of 3.3 to (dGdC)12●(dGdC)12 was studied using UV-visible spectroscopy; 
the changes in absorption of 3.3 upon addition of (dGdC)12●(dGdC)12 were measured 
in buffer (25 mM MOPS, pH 7.0 and 50 mM NaCl) at 25 °C (Figure 3.29).
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Figure 3.29 UV-visible spectra for 0.011 mM 3.3 upon addition of 0 – 2.2 mM 
(dGdC)12●(dGdC)12 in 25 mM MOPS, pH 7.0, 50 mM NaCl, at 25°C.
Figure 3.29 shows a hypochromic shift in absorbance (at the λmax of 452 nm) followed 
by hyperchromic shift (at the λmax of 452 nm) of 3.3 upon addition of 
(dGdC)12●(dGdC)12. This change in UV-visible absorption may occur as a result of 
geometrical distortion of 3.3 when it interacts with DNA, but it may also be a local 
medium effect. The absorbance in the range of 550-600 nm increases at the first 
additions of DNA, as before, suggesting some precipitation. Precipitation was also 
visible by naked-eye.
To quantify the affinity of 3.3 for (dGdC)12●(dGdC)12, the absorbances at 452 nm 
were plotted as a function of concentration of (dGdC)12●(dGdC)12 (Figure 3.30).
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Figure 3.30 Absorbance at 452 nm of a solution of 0.011 mM 3.3 as a function of 
(dGdC)12●(dGdC)12 concentration of 0 – 0.07 mM (●) and of 0.11 – 2.2 mM (■), in 
25 mM MOPS, pH 7.0, 50 mM NaCl, at 25 °C. The solid line represents a fit in terms 
of a multiple independent sites model to the data in the range of 0.11 – 2.2 mM.
Figure 3.30 shows two binding events. For the first binding event a rapid decrease in 
absorbance was observed. We attribute this sudden decrease in absorption to strong 
binding of 3.3 to the sugar-phosphate backbone of (dGdC)12●(dGdC)12 at low 
DNA/ligand ratio, leading to charge neutralization of 3.3-DNA complexes and 
eventually precipitation. The titration data of Figure 3.30 (with the first event 
excluded) were analysed in terms of a multiple independent binding sites model, 
which also takes ligand dilution into account, giving an apparent equilibrium constant
(Kbinding) of (7.19 ± 2.64) ×103 M-1 for a binding site size restricted to 3.0 base pairs.
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Summary
The results of UV-visible titrations for compounds of 3.1 and 3.3 with specific 
sequences of DNA, (dAdT)12●(dAdT)12 and (dGdC)12●(dGdC)12 show that these 
ligands 3.1 and 3.3 have different affinities toward (dAdT)12●(dAdT)12 and 
(dGdC)12●(dGdC)12. The obtained affinities of these compounds are summarised in 
Table 3.13.
Table 3.13 Apparent binding constants Kbind and binding site sizes n from UV-
visible spectroscopy for 3.1 and 3.3 binding to (dAdT)12●(dAdT)12, 
(dGdC)12●(dGdC)12, and FS-DNA in 25 mM MOPS, pH 7.0, 50 mM NaCl, at 25 °C.
Compound (dAdT)12●(dAdT)12 (dGdC)12●(dGdC)12 FS-DNA
Kbind / ×104
M-1 
n / bp Kbind / ×104
M-1 
n / bp Kbind / ×104
M-1 
n / bp
3.1 17.35 ± 3.3 3* 5.7 ± 0.7 3* 1.30 ± 0.21 3*
3.3 2.95 ± 0.54 3* 0.65 ± 0.23 3* 6.43 ± 1.61 3*
* restricted.
Compounds 3.1 and 3.3 bind to specific sequences of DNA, viz. (dAdT)12●(dAdT)12 
and (dGdC)12●(dGdC)12 with different affinities. Compound 3.1 binds to 
(dAdT)12●(dAdT)12 with a binding constant of (17.35 ± 3.3) ×104 M-1 for a binding 
site size restricted to 3.0 base pairs, whereas 3.1 has a weaker affinity to 
(dGdC)12●(dGdC)12 with a binding constant of (5.7 ± 0.7) ×104 M-1 for a binding site 
size restricted to 3.0 base pairs. Similarly, compound 3.3 shows a bigger affinity to 
(dAdT)12●(dAdT)12 with a binding constant of (29.57 ± 5.4) ×103 M-1 for a binding 
site size restricted to 3.0 base pairs, whereas, compound 3.3 binds more weakly to 
(dGdC)12●(dGdC)12 with a binding constant of (6.5 ± 2.3) ×103 M-1 for a binding site 
size restricted to 3.0 base pairs. In addition, the binding parameters that were 
determined here are apparent binding constants and binding site sizes since the 
ligands have non-specific binding to the sugar-phosphate backbone of DNA. The 
binding site size was restricted to 3.0 base pairs for most titrations in order to obtain 
reasonable binding parameters.
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3.3 Conclusions
All compounds of the dendrimeric family bind to duplex DNA to a different extent 
and binding is typically accompanied by change in optoelectronic properties of the 
compound with consecutive hypochromic and hyperchromic shifts in absorbances at
maximum absorption. The binding constants for 3.1 and 3.3 are in the range of (104 to 
105) M-1 with the binding site size restricted to 3.0 base pairs. 3.1 and 3.3 bind 
strongly to duplex FSDNA in two separate binding events. In the UV-visible titration 
the first event occurs at high ligand/DNA ratio, leading to a sudden decrease in the 
maximum absorption. We attribute this change in absorption to strong binding of 3.1 
and 3.3 to both high affinity binding sites and to the sugar-phosphate backbone of 
duplex FSDNA, leading to charge neutralization of ligand-DNA complexes and 
eventually precipitation. The second event occurs at low ligand/DNA ratio where 
ligand binds to main binding sites of DNA viz. minor groove or intercalation. 
Compound 3.2 binds more weakly with FSDNA compared to 3.1 and 3.3. We 
attribute this difference to the presence of a negatively charged caboxylate group 
(COO-) in 3.2 which leads to increase net charges on the ligand and results in a 
repulsive force between the negative charges of the DNA backbone and the ligand. 
The interaction between 3.4 and duplex FSDNA leads to significant precipitation and 
changes in UV-visible absorption that makes a titration curve difficult to analyse.
Therefore, we decided to analyse the titration data of compound 3.4 in another way, 
as we described in Section 3.2.1.c.
Isothermal titration calorimetry also suggests two binding events for 3.1 and 3.3 to 
FSDNA, confirming results from UV-visible titrations. The negative enthalpy and 
entropy change of the first binding event for 3.3 suggests that this ligand intercalates
between base pairs. In addition, the results of ITC show that compound 3.2 has low 
affinity to duplex DNA.
Circular dichroism spectroscopy was used to study the mode of binding. Only 3.3
showed a significant negative ICD signal upon the addition of FSDNA, suggesting
intercalation as a binding mode. The binding mode was further studied using 
viscometry. The relative viscosity of CTDNA solution increased rapidly upon the 
addition of 3.1 and 3.3. This rapid increase in the viscosity is similar to the change in 
relative viscosity of CTDNA upon the addition of known intercalator ethidium 
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bromide, again suggesting intercalation as a binding mode. To further support the 
results of binding mode studies by ICD and viscometry, a molecular docking study 
was carried out. The results of molecular docking study for 3.1 and 3.3 showed that 
both ligands interact with duplex DNA via intercalation. Finally, the sequence 
selectivity of 3.1 and 3.3 were explored using UV-visible spectroscopy and the results 
showed that these compounds have higher affinity for (dAdT)12●(dAdT)12 than for 
(dGdC)12●(dGdC)12.
The driving forces for the compounds of dendrimeric family binding to DNA could be 
provided by hydrophobic interactions between the conjugated aromatic frameworks 
and hydrophobic parts of the base pairs, in addition to electrostatic interaction 
between cationic charge on NH3+ and the negative charges on the DNA. 
3.4 Materials and Methods
3.4.1 DNA preparation
All compounds studied in this chapter were provided by our collaborators. All 
experiments were carried out in buffer (25 mM MOPS, 50 mM NaCl, pH 7.0, at 
25 °C). The pH of the buffer was determined using a Hanna Instruments pH 210 pH 
meter equipped with a VWR 662-1759 glass electrode. The buffer components were 
purchased from Acros or Sigma-Aldrich. Fish sperm DNA and Calf thymus DNA 
were also purchased from Acros or Sigma-Aldrich. The stock solution of calf thymus 
DNA was prepared by sonicating a solution of CT-DNA for about 30 minutes
whereas the stock solution of fish sperm DNA was prepared by sonicating a solution 
of FS-DNA for about 10 minutes. The sonicator was used in DNA preparation in 
order to quicken the solvation of DNA in buffer. Fish sperm DNA needs less 
sonicating because FS-DNA dissolves more quickly in MOPS buffer. 
The DNA solution was dialysed against 2.0 litres of buffer using a 3.5 kDa MWCO 
dialysis membrane for 24 hours. The concentration of DNA was determined using
UV-visible spectroscopy using an extinction coefficient of 12800 M-1 cm-1 at 260 
nm.4
DNA binding studies of a family of dendrimeric compounds
153
3.4.2 Spectroscopic studies
UV-visible spectra were recorded using a Jasco V-630 Bio spectrophotometer 
equipped with a peltier temperature controller at 25 °C. Circular dichroism spectra 
were recorded on a Chirascan CD spectrophotometer. Stock solutions of 3.1-3.4 in 
buffer were freshly prepared and volumes of these stock solutions were added into 
2000-2500 µl of buffer as required in a 1.0 cm path length cuvette. All UV-visible 
titrations were carried out by adding aliquots of the DNA stock solution into a 1 cm 
path length cuvette which contains ligand solution, measuring the absorption in the 
range of 200-600 after each addition. The absorption in the range of 0.1-0.6 a.u. was 
measured in a cuvette to avoid self-aggregation and precipitation of the ligand. The 
absorptions at selected wavelength were plotted against DNA concentrations and a 
multiple independent binding sites model (see section 1.10.1 in Chapter 1) was used 
to analyse the UV-visible spectra by Origin 9.0. The baseline absorbance in a titration, 
and hence in the data analysis, corresponds to the absorbance of a cuvette containing 
buffer only because the spectrophotometer was calibrated without cuvettes in the 
sample or reference position (“air versus air”). For CD titrations the same steps were 
followed except the ICD signals were used instead of absorptions in UV-visible 
titrations.
3.4.3 Isothermal titration calorimetry
All ITC experiments were carried out using a Microcal VP ITC microcalorimeter. The 
ligand solutions were prepared in buffer (25 mM MOPS, 50 mM NaCl, pH 7.0) and 
concentrations were determined using UV-visible spectroscopy based on extinction
coefficients. All calorimetric binding experiments were carried out at 25 °C. The 
sample cell and syringe were always cleaned with ethanol followed by distilled water 
before starting any experiment. The sample cell was filled with FS-DNA solution 
(approximately 1.9 ml). The syringe was filled with ligand solution (approximately 
300 µl) with a concentration usually 12-fold higher than DNA solution (exact ratios 
depend on individual experiments). The ligand solution was added in 1 injection of 5 
µl for the first addition and 19 injections of 15 µl each to the sample cell, injecting 
every 300 second automatically. During the titration the solutions in the contents of 
the sample cell were mixed with a stirring speed of 307 rpm. The heat effects per 
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injection (dh) were calculated using Origin (Microcal, Inc). The integrated heat 
effects were analysed using IC ITC.2
3.4.4 Viscometry 
All viscosimetry experiments were carried out in buffer (25 mM MOPS, 50 mM 
NaCl, pH 7.0). A Cannon-Flenske routine viscometer was placed in a temperature-
controlled circulated water bath at 25 °C. The viscometer was filled with fixed 
volume of a Calf thymus DNA solution (3.0 ml of 0.5 mM) and adding  ligand 
solutions with concentrations calculated from the ratio of ligand/ DNA (0.03, 0.06, 
0.09, 0.12 and 0.15). The flow time was measured three times for each ligand addition 
and the results were averaged. The relative viscosity was calculated and plotted as a 
function of the ratio [ligand]bound/[DNA] where [ligand]bound was calculated using 
binding parameters from UV-visible spectroscopy.
2.4.5 Docking studies
Molecular docking studies were performed using Auto Dock Vina.6 The ligand 
structures were generated using chemdraw and then optimised using Avogadro, using 
force fields MMFF94 for ligands and GAFF for metal complexes. The rotable bonds 
in the ligand were assigned using Auto Dock Tools 1.5.6 and the output files were 
saved in PDBQT format. Our previously developed9 open-
d(ATCGAGACGTCTCGAT)2 was used as a biomacromolecular target. An 
exhaustiveness of 200 and number modes of 10 were selected. The results of Auto 
Dock Vina were rendered using Chimera 1.10.2.
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Chapter 4
DNA BINDING STUDIES FOR MISCELLANEOUS COMPOUNDS
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Abstract
In this chapter we describe the results of studies of the interactions of miscellaneous
compounds with double-stranded DNA using a variety of techniques viz. 
spectroscopy, calorimetry, viscosity and molecular docking studies. Most ligands bind 
to duplex DNA moderately strongly with a range of affinities from 104 to 105 M-1. 
Binding modes vary from minor-groove binding to intercalation to side-by-side 
binding in the minor groove. Compound 4.1 binds to duplex DNA via intercalation 
whereas compound 4.2 binds to duplex DNA and the dominant binding site for 4.2 is 
in the minor groove. Compound 4.3 also shows affinity to duplex DNA. Sequence 
selectivity of 4.2 for specific sequences (dAdT)12●(dAdT)12 and (dGdC)12●(dGdC)12
was also explored via UV-visible spectroscopy, showing that (dAdT)12●(dAdT)12 was 
selected over (dGdC)12●(dGdC)12.The results presented in part A of this Chapter have 
been published.7
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Part A
4.1 Introduction
Our aims in the first part of Chapter 4 are to quantify the thermodynamics of binding 
for compound 4.1 (Scheme 4.1) to duplex DNA, using UV-visible spectroscopy. 
Binding modes will be explored through a molecular docking study. 
Scheme 4.1
Compound 4.1 in Scheme 4.1 was provided by our collaborator. Compound 4.1 is 
somewhat water-soluble, redox active, absorbs light with a λmax at 394 nm and has a 
flat aromatic framework. Based on its structure, we anticipate compound 4.1 binds to 
double-stranded DNA through intercalation. This compound could be used as a signal 
enhancer in EIS-based biosensors upon binding with duplex DNA. In addition, 
compound 4.1 is redox active and could therefore be useful in biosensors based on-
coulometry. 
4.2 Results and discussion
The results of the interaction studies for compound 4.1 with DNA will be presented
and discussed for each individual technique.
UV-visible spectroscopy
4.2.1 UV-visible spectroscopy studies of 4.1 binding to DNA
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Binding of 4.1 to duplex DNA was studied using UV-visible spectroscopy; the 
changes in absorption of 4.1 upon addition of FSDNA were recorded in deionised 
water at 25 °C (Figure 4.1). These experiments were carried out in deionised water 
because of poor solubility of compound 4.1 in MOPS buffer. 
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Figure 4.1 UV-visible spectra for 0.041 mM 4.1 upon addition of 0 – 0.25 mM 
FSDNA in deionised water at 25 °C.
Figure 4.1 shows a hypochromic shift in absorbance followed by a hyperchromic shift 
(at the λmax of 394 nm) of 4.1 upon addition of FSDNA. This change in UV-visible 
absorption may occur as a result of geometrical distortion of 4.1 when it interacts with 
DNA, but in light of the rigidity of 4.1, it is likely to be a local medium effect.  
To quantify the affinity of 4.1 for FSDNA, the absorbances at 394 nm for two 
titrations were plotted as a function of concentration of FSDNA (Figure 4.2, for data 
in tabular format see appendix, Tables A17.1 & A17.2).
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Figure 4.2 Absorbance at 394 nm of solutions of 0.041 mM 4.1 as a function of DNA 
concentration (0 – 0.007 mM (▼) and of 0.007 – 0.25 mM (■)), and of 0.084 mM 4.1
as a function of DNA concentration (0 – 0.01 mM (▲) and of 0.014 – 0.28 mM (●)), 
in deionised water at 25 °C. The solid lines represent a global fit of a multiple 
independent sites model to the second part of both data sets.
Figure 4.2 shows two binding events. In the ''first'' binding event a rapid decrease in 
absorbance was observed. We attribute this rapid decrease in absorption to strong
non-selective binding of 4.1 to the sugar-phosphate backbone of DNA at low 
DNA/ligand ratios, leading to charge neutralization of 4.1-DNA complexes and 
eventually precipitation. In the ''second'' phase of titration a hypechromic shifit in 
absorbance was observed as a result of binding of 4.1 to its preferred binding sites of 
DNA. The titration data of Figure 4.2 (with the first event not included) were analysed 
in terms of a multiple independent binding sites models, which also takes ligand 
dilution into account, giving an apparent equilibrium constant (Kbinding) of (5.54 ± 
10.9) ×104 M-1 and a binding site size of (1.34 ± 0.83) base pairs. The large error 
margins suggest significant parameter covariance. We therefore re-analysed the data 
for a binding site size n restricted to 1 base pair (when n is restricted to a value higher 
than one it gives large error margins). The fit gave an equilibrium constant (Kbinding) of 
(3.0 ± 1.87) ×104 M-1.
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Molecular docking studies
4.2.2 Docking study of 4.1 binding to DNA
The binding mode for interaction of 4.1 with duplex DNA was studied through 
molecular docking using Auto Dock Vina.4 Open-d(ATCGAGACGTCTCGAT)2, a 
duplex structure, with a pre-formed intercalation gap, was used as a 
biomacromolecular target.6
Figure 4.3 Top 3 docked poses for 4.1 interacting with open-
d(ATCGAGACGTCTCGAT)2.
The result of the molecular docking study (Table 4.1) shows that intercalation is a 
favourable binding mode for 4.1 binding with DNA as anticipated based on its 
structure.7
Table 4.1 Mode and enthalpy of binding for top 3 docked poses of 4.1.
Compound 4.1 Mode of binding Energy / kcal. mole-1 
Pose 1 intercalated -10.3
Pose 2 intercalated -10.3
Pose 3 intercalated -10.3
Summary
The UV-visible titrations for compound 4.1 with duplex DNA show that ligand 4.1 
binds to FS-DNA. The binding parameters for this compound interacting with FS-
DNA are summarised in Table 4.2.  
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Table 4.2 Binding constant and binding site size for binding of 4.1 to FS-DNA, in 
deionised water, at 25 °C.
Ligand Binding constant
K / ×104 M-1
Binding site size
n / bp
4.1 3.0 ± 1.87 1*
*restricted.
Compound 4.1 has a moderate affinity ~ 104 M-1 to FS-DNA with a small binding site 
size. The low apparent affinity reflects competition between specific and non-specific 
binding sites, rather than full binding of the ligand to its preferred binding sites. We 
attribute this small binding site size to binding of the ligand with DNA backbone in 
the minor groove in “side-by-side” fashion at low DNA concentration, leading to 
precipitation of ligand-DNA complex at the beginning of titration. The result of the 
molecular docking study suggests that intercalation is a favourable binding mode for 
4.1 binding with duplex DNA.
4.3 Conclusion 
Compound 4.1 binds to duplex DNA and binding is accompanied by a change in the 
optoelectronic properties of the compound. Compound 4.1 shows two binding events, 
at low DNA/ligand ratio the ligands bind in the preferred binding sites and to DNA 
backbone, leading to precipitation of ligand-DNA complexes. At high DNA/ligand 
ratio, ligands bind to main binding sites (minor groove or intercalation). The binding 
constant is in the range of 104 M-1 with a binding site size restricted to 1 base pair. 
The binding site size 1 for 4.1 is small which suggests a side by side interaction is also 
present as a mode of binding.
A docking study was exploited to investigate the mode of binding for 4.1 using Auto 
Dock Vina. The results of the molecular docking study show that intercalation is a 
favourable binding mode for 4.1 binding with DNA as expected based on its structure. 
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Part B
4.4 Introduction
Our aims in the second part of Chapter 4 are to quantify the thermodynamics of 
binding for compound 4.2 (Scheme 4.2) to duplex DNA, using several techniques viz.
UV-visible spectroscopy, isothermal titration calorimetry and circular dichroism
spectroscopy. Binding modes will be explored through viscometry and a molecular 
docking study.
Compound 4.2 in Scheme 4.2 was provided by our collaborator (Richard 
Wheelhouse).8 Compound 4.2 is water-soluble, absorbs light with a λmax at 320 and 
has a hydrophobic framework linked by bonds with torsional freedom which 
potentially enables this molecule to bind with DNA, forming a curved shape along the 
minor groove of duplex DNA. Compound 4.2 is known to bind to DNA●RNA hybrid 
duplexes, offering further flexibility in targeting nucleic acid biomarkers such as 
mRNA. 
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4.5 Results and discussion
The results of the interaction studies for compound 4.2 with DNA will be presented
and discussed for each individual technique.
UV-visible spectroscopy
4.5.1 UV-visible spectroscopy studies of 4.2 binding to DNA
The binding of 4.2 to DNA was studied using UV-visible spectroscopy; the changes 
in absorption of 4.2 upon addition of FSDNA were recorded in buffer (25 mM MOPS, 
pH 7.0, 50 mM NaCl) at 25 °C (Figure 4.3).
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Figure 4.3 UV-visible spectra for 0.010 mM 4.2 upon addition of 0 – 0.44 mM DNA 
in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl) at 25 °C.
Figure 4.3 shows a hypochromic shift in absorbance (at the λmax of 320 nm) and a 
hyperchromic shift (at 338 nm) of 4.2 upon addition of DNA. This change in UV-
visible absorption may occur because of geometrical distortion of 4.2 when it interacts 
with DNA, but it may also be a local medium effect. For this relatively flexible 
molecule, we propose that geometrical distortion is likey the dominant effect.
To quantify the affinity of 4.2 for FSDNA, the absorbances at 320 and 338 nm for two 
titrations were plotted as a function of concentration of FSDNA (Figure 4.4, for data 
in tabular format see appendix, Tables A17.3 & A17.4).
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Figure 4.4 Absorbance at 320 nm (●) and at 338 nm (■) of a solution of 0.010 mM 
4.2 as a function of DNA concentration, absorbance at 320 nm (▼) and at 338 nm (▲) 
of a solution of 0.014 mM 4.2 as a function of DNA concentration, in buffer (25 mM 
MOPS, pH 7.0, 50 mM NaCl), at 25 °C. The solid lines represent a global fit of a 
multiple independent sites model to the data.
The titration curves in Figure 4.4 were analysed globally by fitting a multiple 
independent binding sites model, which also takes ligand dilution into account, to the 
data. The fit indicates an equilibrium constant (Kbinding) of (0.86 ± 50.09) ×102 M-1 and 
a binding site size of (0.005 ± 0.3) base pair. The obtained values of binding site size 
and binding constant were unreasonable therefore the data of the titration curves were 
reanalysed, giving an equilibrium constant (Kbinding) of (7.51 ± 1.22) ×104 M-1 for a 
binding site size restricted to 3 base pairs.
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Isothermal titration calorimetry (ITC) 
4.5.2 Dilution of 4.2
In order to determine whether 4.2 aggregates in MOPS buffer, the dilution of 4.2 into 
MOPS buffer was studied using isothermal titration calorimetry. The differential heat 
flow and derived integrated heat effects for dilution of a solution of 0.91 mM of 4.2 
into 25 mM MOPS. pH 7.0, 50 mM NaCl at 25 °C were measured (Figure 4.5).
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Figure 4.5 Enthalpograms for dilution of a 0.91 mM solution of 4.2 (a), fit of the 
isosdesmic self-aggregation model to the integrated heat effects for the same dilution 
experiment (b), experimental heat (■), calculated heat (●), in buffer (25 mM MOPS, 
50 mM NaCl, pH 7.0) at 25 °C.
Figure 4.5 shows the heats of dilution of 0.91 mM 4.2 into MOPS buffer. IC ITC 
software was used to analyse the titration data. The thermodynamic parameters for 
dilution of 4.2 in MOPS buffer were determined and are summarised in Table 4.3.    
Table 4.3 Thermodynamic parameters for self aggregation of 4.2 in 25 mM 
MOPS, pH 7.0, 50 mM NaCl, at 25 °C.
K aggregation/ ×104 M-1 ΔH aggregation/ kcal mol-1 
3.54 (3.54 – 18.1)                                     1.9 (1.75 – 2.9)
The obtained values for thermodynamic parameters for diluting 4.2 into MOPS buffer 
in Table 4.3 show that 4.2 self aggregates relatively strongly in aqueous solutions.
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4.5.3 ITC studies of 4.2 binding to DNA
The binding of 4.2 to DNA was further studied using isothermal titration calorimetry. The 
differential heat flow and derived integrated heat effects for titration of a solution of 0.91 
mM 4.2 into a 0.2 mM fish sperm DNA solution were measured in buffer (25 mM MOPS, 
50 mM NaCl, pH 7.0), at 25 °C (Figure 4.6).
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Figure 4.6 Titration of a 0.91 mM solution of 4.2 into a 0.2 mM solution of DNA (a), 
fit for integrated heat effects of the titration in terms of a binding model involving one 
type of binding site which ligand aggregation included (b), experimental heat (▀), 
calculated heat (●), in 25 mM MOPS. pH 7.0, 50 mM NaCl, at 25 °C. The titration 
was carried out in two consecutive sets of additions.
Figure 4.6 shows the enthalpogram for interaction of 4.2 with DNA, which suggests 
an exothermic interaction and one type of binding event. In order to find the binding 
parameters for 4.2 binding to DNA, IC ITC software was used. The aggregation 
constant and standard molar enthalpy change for aggregation were included and 
restricted to the values that were obtained from the dilution experiment. All 
thermodynamic parameters were determined and are summarized in Table 4.4.
Table 4.4 Thermodynamic parameters for binding of 4.2 to FSDNA in 25 mM 
MOPS. pH 7.0, 50 mM NaCl, at 25 °C.
KA1
(104 M-1)
1/nA1
(bp)
∆HA1
(kcal mol-1)
-T∆SA1
(kcal mol-1)
{Σdev2/dof}½ 
(µcal)
4.2 10.0 (8.6 –
16.6)
3* -2.9 (-1.5 –
-5.6)
-3.96 2.9
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* restricted.
The resulting binding parameters in Table 4.4 are in agreement with the results from 
UV-visible titrations. The binding site size was restricted to 3 base pairs in order to 
obtain reasonable binding parameters. The weakly exothermic interaction suggests 
that 4.2 binds to FSDNA in the minor groove.
Induced circular dichroism (ICD)
4.5.4 Induced circular dichroism for 4.2 interacting with FSDNA
The binding mode of 4.2 interacting with FSDNA was explored using circular 
dichroism spectroscopy. Circular dichroism spectra for 4.2 were recorded at different 
FSDNA concentrations (0 mM – 1.3 mM), in buffer (25 mM MOPS, pH 7.0, 50 mM 
NaCl) at 25 °C (Figure 4.7).
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Figure 4.7 a) Circular dichroism spectra for 0.018 mM of 4.2 in the presence of 
different concentrations of FSDNA (0 mM – 1.3 mM), and b) recorded UV-visible 
spectra for the same titration, in buffer (25 mM MOPS, 50 mM NaCl, pH 7.0), at 25 
°C.
Figure 4.7 shows a small negative induced circular dichroism signal around the 
wavelength of interest 320 nm where compound 4.2 absorbs, suggesting intercalation 
as a mode of binding.1
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Viscosity
4.5.5 Viscometry study of 4.2 binding to calf thymus DNA (CT-DNA)
The mode of binding of 4.2 to double-stranded DNA was further studied using 
viscometry.  In order to find out whether 4.2 is a groove binder or an intercalator, the 
relative viscosity of DNA upon addition of 4.2 was compared with viscosities of 
equivalent DNA solutions that contained known DNA binders which act either as an 
intercalator (ethidium bromide) or a minor groove binder (H33258).5 The relative 
viscosities of CT-DNA solutions were measured upon addition of 4.2 in buffer (25 mM 
MOPS, pH 7.0, 50 mM NaCl), at 25 °C (Figure 4.8).
0.00 0.03 0.06 0.09 0.12 0.15 0.18
0.98
1.00
1.02
1.04
1.06
1.08
1.10
(
 
)1/
3
[Complex]/[DNA]
Figure 4.8 Relative viscosity of a 0.91 mM CT-DNA solution upon addition of 4.2
(■), H33258 (▲) and ethidium bromide (●), in buffer (25 mM MOPS, pH7.0, 50 mM 
NaCl) at 25 °C. 
Figure 4.8 shows a small increase in relative viscosity of CTDNA upon the addition 
of 4.2. However, the increase is negligible compared with the significant increase 
observed for ethidium bromide, suggesting minor groove binding as the dominant 
binding mode.
DNA binding studies for miscellaneous compounds
170
Molecular docking studies
4.5.6 Docking study of 4.2 binding to DNA
The binding mode for interaction of 4.2 with duplex DNA was also studied through 
molecular docking using Auto Dock Vina.4 As before, open-
d(ATCGAGACGTCTCGAT)2 was used as a biomacromolecular target.6
Figure 4.10 Top 3 docked poses for 4.2 interacting with open-
d(ATCGAGACGTCTCGAT)2.
The result of the molecular docking study shows that minor groove binding is a 
favourable binding mode for 4.2, as expected based on its structure. The complex 
structure in Figure 6.2 is in a reasonable agreement with the result of the binding 
mode study by viscometry.
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Summary of results from binding experiments with FSDNA
The UV-visible and ITC titrations for compound 4.2 with duplex DNA show that 
ligand 4.2 binds to FS-DNA. The binding parameters for this compound interacting 
with FS-DNA are summarised in Table 4.5.
Table 4.5 Thermodynamic parameters for binding of 4.2 to FSDNA, in 25 mM 
MOPS, pH 7.0, 50 mM NaCl at 25 °C.
KA1
(104M-1)
1/nA1
(bp)
∆HA1
(kcal mol-1)
-T∆SA1
(kcal mol-1)
{Σdev2/dof}½ 
(µcal)
UV-vis. 7.51 ± 1.22 3* - - -
ITC 10.0 (8.6 –
16.6)
3* -2.88 (-1.5 
– -5.6)
-3.96 2.9
* restricted.
Compound 4.2 binds moderately to FS-DNA ~ 104 M-1 with a binding site size 
restricted to 3.0 base pairs. 
The interaction of 4.2 with DNA was further investigated using isothermal titration 
calorimetry. The thermodynamic parameters determined for 4.2 interacting with DNA 
are summarised in Table 4.5.   
The enthalpogram for 4.2 interacting with FSDNA indicates only one binding event. 
The ligand binds to DNA with an affinity of ~105 M–1 for a binding site size restricted 
to 3 base pairs. The binding is characterised by a negative enthalpy and a favourable 
entropy change, which suggests minor groove binding.
The mode of interactions of 4.2 with DNA was investigated using induced circular 
dichroism spectroscopy. After plotting CD spectra against DNA concentration, a 
small negative ICD signal was observed around the wavelength of interest 320 nm, 
suggesting intercalation as a mode of binding. However, this small negative ICD 
cannot be conclusive to determine the mode of interaction since other binding mode 
studies such as viscometery and docking study do not confirm this conclusion.
The mode of interaction of 4.2 with CT-DNA was further investigated using 
viscometry to confirm the conclusion from CD spectroscopy that this binder is an 
intercalator. In contrast, the result of viscometry of 4.2 binding to CT-DNA shows a 
small increase in relative viscosity upon the addition of 4.2. The increase in relative
viscosity was found to be negligible compared with the significant increase for 
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ethidium bromide which suggests minor groove binding as the dominant binding 
mode.
The mode of binding for 4.2 with duplex DNA was further explored through 
molecular docking study using Auto Dock Vina. The result of docking study shows 
that a favourable mode of binding for compound 4.2 is minor groove binding, as 
expected based on its structure. The result of docking for 4.2 is also in an agreement 
with the result of binding mode study by viscometry. On balance, we suggest that 4.2
interacts with duplex DNA through minor groove binding. 
4.5.7 Sequence selectivity
The selectivity of 4.2 for selected specific sequences of DNA, viz. 
(dAdT)12●(dAdT)12 and (dGdC)12●(dGdC)12 was studied using UV-visible 
spectroscopy.
The binding of 4.2 to (dAdT)12●(dAdT)12 was studied using UV-visible spectroscopy; 
the changes in absorption of 4.2 upon addition of (dAdT)12●(dAdT)12 were measured 
in buffer (25 mM MOPS, pH 7.0 and 50 mM NaCl) at 25 °C (Figure 4.11).
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Figure 4.11 UV-visible spectra for 0.009 mM 4.2 upon addition of 0 – 0.12 mM 
(dAdT)12●(dAdT)12 in 25 mM MOPS, pH 7.0, 50 mM NaCl, at 25 °C.
Figure 4.11 shows a hypochromic shift in absorbance (at the λmax of 320 nm) and 
hyperchromic shift (at 338 nm) of 4.2 upon addition of (dAdT)12●(dAdT)12. As 
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before, this change in UV-visible absorption is likely the result of geometrical 
distortion of 4.2 when it interacts with DNA.
To quantify the affinity of 4.2 for (dAdT)12●(dAdT)12, the absorbances at 320 and 338 
nm were plotted as a function of concentration of (dAdT)12●(dAdT)12 (Figure 4.12). 
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Figure 4.12 Absorbance at 320 nm (●) and at 338 nm (■) of a solution of 0.009 mM 
4.2, absorbance at 320 nm (▼) and at 338 nm (▲) of a solution of 0.013 mM 4.2, as a 
function of (dAdT)12●(dAdT)12 concentration, in buffer (25 mM MOPS, pH 7.0, 50 
mM NaCl), at 25 °C. The solid lines represent a global fit of a multiple independent 
sites model to the data.
The titration curves of Figure 4.12 were analysed globally in terms of a multiple 
independent binding sites model, which also takes ligand dilution into account, giving 
an equilibrium constant (Kbinding) of (6.1 ± 0.86) ×104 M-1 for a binding site size 
restricted to 3.0 base pairs.
The binding of 4.2 to (dGdC)12●(dGdC)12 was similarly studied using UV-visible 
spectroscopy; the changes in absorption of 4.2 upon addition of (dGdC)12●(dGdC)12
were measured in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl) at 25 °C (Figure
4.13).
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Figure 4.13 UV-visible spectra for 0.009 mM 4.2 upon addition of 0 – 0.36 mM 
(dGdC)12●(dGdC)12 in 25 mM MOPS, pH 7.0, 50 mM NaCl, at 25 °C.
Figure 4.13 shows a hypochromic shift in absorbance (at the λmax of 320 nm) and a 
hyperchromic shift (at 338 nm) of 4.2 upon addition of (dGdC)12●(dGdC)12. The 
changes in the absorption spectra are similar to those observed during the titration 
with (dAdT)12●(dAdT)12.   
To quantify the affinity of 4.2 for (dGdC)12●(dGdC)12, the absorbances at 320 and 
338 nm were plotted as a function of concentration of (dGdC)12●(dGdC)12 (Figure 
4.14).
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Figure 4.14 Absorbance at 320 nm (●) and at 338 nm (■) of a solution of 0.009 mM 
4.2, absorbance at 320 nm(▼) and at 338 nm (▲) of a solution of 0.009 mM 4.2, as a 
function of (dGdC)12●(dGdC)12 concentration, in buffer (25 mM MOPS, pH 7.0, 50 
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mM NaCl), at 25 °C. The solid lines represent a global fit of a multiple independent 
sites model to the data.
The titration curves of Figure 4.14 were also analysed globally in terms of a multiple 
independent binding sites model, which also takes ligand dilution into account. The fit 
gave an equilibrium constant (Kbinding) of (1.7 ± 0.3) ×104 M-1 for a binding site size 
restricted to 3.0 base pairs.
The results from the titrations are summarised in Table 4.6. 
Table 4.6 Binding affinities and binding site sizes for binding of 4.2 to 
(dAdT)12●(dAdT)12 and (dGdC)12●(dGdC)12, in buffer (25 mM MOPS, pH 7.0, 
50 mM NaCl), at 25 °C.
(dAdT)12●(dAdT)12 (dGdC)12●(dGdC)12
Ligand Binding constant
K / ×104M-1
Binding site size
n / bp
Binding constant
K / ×104M-1
Binding site size
n / bp
4.2 (6.1 ± 0.86) 3* (1.7 ± 0.3) 3*
* restricted in order to obtain reasonable binding parameters.
Table 4.6 shows that (dAdT)12●(dAdT)12 was mostly selected over 
(dGdC)12●(dGdC)12.
4.6 Conclusion 
Compound 4.2 binds to duplex DNA and the binding is accompanied by changes in 
optoelectronic properties of the compound which a hypochromic shift in absorbance
at maximum absorption and a hyperchromic shift were mostly observed. The binding 
constant is in the range 105 M-1 with a binding site size restricted to 3.0 base pairs. 
Isothermal titration calorimetry indicates one binding event for 4.2 binding to FSDNA 
with the thermodynamic parameters, viz. negative enthalpy and favourable entropy, 
suggesting minor groove binding.
Circular dichroism spectroscopy showed that compound 4.2 exhibits a small negative 
ICD signal, which may be explained by intercalation as the binding mode. The mode 
of interaction of 4.2 with CT-DNA was further investigated using viscometry to 
confirm the conclusion from the ICD spectroscopy that this binder is an intercalator. 
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In contrast to the results from CD spectroscopy, the viscometry experiments for 4.2
binding to CT-DNA show a small increase in relative viscosity upon the addition of 
4.2 which nevertheless seems negligible compared with the significant increase in 
relative viscosity for addition of ethidium bromide. The data thus suggest minor 
groove as the dominant binding site for 4.2. 
A docking study was exploited to further investigate the mode of binding for 4.2
using Auto Dock Vina. The results of the molecular docking study show that 4.2
binds to duplex DNA via minor groove binding, as expected based on its structure.
The selectivity of 4.2 for selected specific sequences of DNA, viz. 
(dAdT)12●(dAdT)12 and (dGdC)12●(dGdC)12 was studied using UV-visible 
spectroscopy. The results show that the affinity of 4.2 is higher for 
(dAdT)12●(dAdT)12 than for (dGdC)12●(dGdC)12.
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Part C
4.7 Introduction
Our aims in the third part of Chapter 4 are to quantify the thermodynamics of binding 
for compound 4.3 (Scheme 4.3) to duplex DNA, using UV-visible spectroscopy.
Compound 4.3 was provided by our collaborator (Simon Pope). Compound 4.3 is a 
sparingly water-soluble, absorbs light with a λmax at 362 and has a flat aromatic 
framework attached to a platinum center. Based on its structural properties we expect 
this compound binds to duplex DNA through intercalation. Compound 4.3 resembles
cis-platin, and may therefore interact covalently with DNA, like cis-platin does.
4.8 Results and discussion
The results of the interaction study for compound 4.3 with DNA by UV-visible 
spectroscopy will be presented and discussed.
4.8.1 UV-visible spectroscopy studies of 4.3 binding to DNA
The binding of 4.3 to DNA was studied using UV-visible spectroscopy; the changes 
in absorption of 4.3 upon addition of FSDNA were measured in 50 vol-% DMSO-
MOPS buffer (25 mM MOPS, pH 7.0, 50 mM NaCl), at 25 °C (Figure 4.15). These 
experiments were carried out in 50 vol-% DMSO because of the poor solubility of 
compound 4.3 in the aqueous medium.
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Figure 4.15 UV-visible spectra for 0.020 mM 4.3 upon addition of 0 – 0.9 mM DNA 
in 50 vol-% DMSO-MOPS buffer (25 mM MOPS, pH 7.0, 50 mM NaCl) at 25 °C.
Figure 4.15 shows a hypochromic shift in absorbance (at the λmax of 362 nm) of 4.3 
and three isosbestic points upon addition of DNA. This change in UV-visible 
absorption may occur as a result of geometrical distortion of 4.3 when it interacts with 
DNA, but it may also be a local medium effect.
To quantify the affinity of 4.3 for FSDNA, the absorbances at 362 and 390 nm for two 
titrations were plotted as a function of concentration of FSDNA (Figure 4.16, for data 
in tabular format see appendix, Tables A17.5 & A17.6)
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Figure 4.16 Absorbance at 362 nm (■) and at 390 nm (●) of a solution of 0.020 mM 
4.3, absorbance at 362 nm (▲) and at 390 nm (▼) of a solution of 0.020 mM 4.3, as a 
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function of FSDNA concentration, in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl), 
at 25 °C. The solid lines represent a global fit of a multiple independent sites model to 
the data.
The titration curves of Figure 4.16 were analysed globally by fitting a multiple 
independent binding sites model, which also takes ligand dilution into account, to the 
data. The fit gives an equilibrium constant (Kbinding) of (0.47 ± 1064) ×103 M-1 and a 
binding site size of (0.03 ± 77) base pair. The obtained binding parameters were small 
and unreasonable. Therefore the data were reanalysed, giving an equilibrium constant
(Kbinding) of (7.4 ± 3.1) ×104 M-1 for a binding site size restricted to 3 base pairs. 
4.9 Conclusion 
Compound 4.3 binds to duplex DNA with an affinity of about 105 M-1 for a binding 
site size restricted to 3 base pairs and binding is accompanied by change in 
optoelectronic properties of the compound. The hypochromic shift in absorbance at 
maximum absorption 362 nm and three isosbestic points for compound 4.3 were 
observed upon the addition of DNA. The binding site size was restricted to 3 base 
pairs in order to obtain reasonable binding parameters.
Part D
4.10 Introduction
Our aims in the last part of Chapter 4 are to quantify the thermodynamics of binding 
for compounds 4.4 and 4.5 (Scheme 4.4) to duplex DNA, using isothermal titration 
calorimetry.
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Compounds 4.4 and 4.5 in Scheme 4.4 were provided by our collaborator (Nicholas 
C. Fletcher). Both compounds 4.4 and 4.5 are sparingly water-soluble and possess flat 
aromatic frameworks that are coordinated to a central metal ruthenium (Ru2+). Based 
on their structural properties we expect that these compounds bind to duplex DNA 
through intercalation. Binding of similar compounds to DNA was studied by N. 
Fletcher and co-workers using UV-visible absorption, emission and CD spectroscopy. 
The results of these studies showed strong affinities of these compounds to DNA.9
These compounds are fluorescent and could therefore be used in fluorimetry-based 
biosensors. Additionally, we anticipate these compounds bind to DNA via 
intercalation and they could therefore be used as signal enhancers in EIS-based 
biosensors.
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4.11 Results and discussion
The results of the interaction studies for compounds 4.4 and 4.5 with DNA will be 
presented and discussed for each individual compound.
4.11.1 ITC studies of 4.4 and 4.5 binding to DNA
In order to study the binding of 4.4 and 4.5 with duplex DNA, we used isothermal 
titration calorimetry (ITC). To analyse the titration data, the heats of dilution for these 
compounds need to be determined. Therefore, a series of dilution experiments were 
carried out in different buffers. These dilution experiments also allow the 
quantification of self-aggregations of these compounds in solution, if any.      
4.11.1.a Dilution of 4.4
In order to investigate self-aggregation and quantify the heats of dilution for 4.4 in 
Tris buffer, the dilution of 0.84 and 0.74 mM solutions of 4.4 in Tris buffer (5 mM 
Tris + methanol (1:1), pH 7.2) was studied using isothermal titration calorimetry. The 
differential heat flow and derived integrated molar heat effects for these dilutions 
were recorded at 25 °C (Figures 4.17). These experiments were carried out in Tris 
buffer with methanol due to low solubility of 4.4 and 4.5 in MOPS buffer. 
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Figure 4.17 Enthalpograms for dilution of a 0.84 mM solution of 4.4 (a) and of a 0.74 
mM solution of 4.4 (b), into 5 mM Tris + methanol (1:1), pH 7.2, at 25 °C.
The enthalpograms for diluting 4.4 in Tris buffer in the figure 4.17 show a lack in 
reproducibility of experimental data for dilution (a) and (b), therefore we were unable 
to analyse the dilution data.
4.11.1.b Dilution of 4.5
In order to investigate self-aggregation and quantify the heats of dilution for 4.5 in 
Tris buffer, the dilution of 1.05 and of 0.8 mM solutions of 4.5 in Tris buffer (5 mM 
Tris + DMSO (1:1), pH 7.2) were studied using isothermal titration calorimetry. The 
differential heat flow and derived integrated molar heat effects for these dilutions 
were recorded at 25 °C (Figures 4.18).
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Figure 4.18 Enthalpograms for dilution of a 1.05 mM solution of 4.5 (a) and of a 0.8 
mM solution of 4.5 (b), into 5 mM Tris + DMSO (1:1), pH 7.2, at 25 °C.
The enthalpograms for diluting 4.5 in Tris buffer in Figure 4.18 also show a lack in 
reproducibility of experimental data for dilution. Therefore we were unable to analyse 
the dilution data.
4.12 Conclusion 
In order to study binding of 4.4 and 4.5 to duplex DNA, we planned to use isothermal 
titration calorimetry. Unfortunately, the enthalpograms for diluting 4.4 and 4.5 in Tris 
buffer showed non-reproducibility of the experimental data. Therefore we were 
unable to analyse the dilution data, quantify the heats of dilution and further 
investigate binding of 4.4 and 4.5 to DNA.
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4.13 Materials and Methods
4.13.1 DNA preparation
All compounds studied in this chapter were provided by our collaborators. The pH of 
the buffer was determined using a Hanna Instruments pH 210 pH meter equipped with 
a VWR 662-1759 glass electrode. The buffer components were purchased from Acros 
or Sigma-Aldrich. Fish sperm DNA and Calf thymus DNA were also purchased from 
Acros or Sigma-Aldrich. The stock solution of calf thymus DNA was prepared by 
sonicating a solution of CT-DNA for about 30 minutes whereas the stock solution of 
fish sperm DNA was prepared by sonicating a solution of FS-DNA for about 10 
minutes. The sonicator was used in the DNA preparation in order to quicken the 
solvation of DNA in buffer. Fish sperm DNA needs less sonicating because FS-DNA 
dissolves more quickly in MOPS buffer. 
The DNA solution was dialysed against 2.0 litres of buffer using a 3.5 kDa MWCO 
dialysis membrane for 24 hours. The concentration of DNA was determined using 
UV-visible spectroscopy using an extinction coefficient of 12800 M-1 cm-1 at 260 
nm.3
4.13.2 Spectroscopic studies
UV-visible spectra were recorded using a Jasco V-630 Bio spectrophotometer 
equipped with a peltier temperature controller at 25 °C. Circular dichroism spectra 
were recorded on a Chirascan CD spectrophotometer. A stock solution of each ligand
in buffer was freshly prepared and a volume of this stock solution was added into 
2000-2500 µl of buffer, as required, in a 1.0 cm path length cuvette. UV-visible 
titrations of 4.1 with DNA were carried out in deionised water. Titrations of 4.2 with 
DNA were carried out in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl). Titrations of
4.3 with DNA were carried out in 50 vol-% DMSO-MOPS buffer (25 mM MOPS, pH 
7.0, 50 mM NaCl), at 25 °C. All UV-visible titrations were carried out by adding 
aliquots of the DNA stock solution into a 1 cm path length cuvette which contains 
ligand solution, measuring the absorption in the range of 200-600 nm after each 
addition. The absorption in the range of 0.1-0.6 a.u. was measured in a cuvette to 
avoid self-aggregation and precipitation of the ligand. The absorptions at selected 
wavelengths were plotted as a function of DNA concentrations and a multiple 
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independent binding sites model (see section 1.10.1 in Chapter 1) was used to analyse 
the UV-visible spectra using Origin 9.0. The baseline absorbance in a titration, and 
hence in the data analysis, corresponds to the absorbance of a cuvette containing 
buffer only because the spectrophotometer was calibrated without cuvettes in the 
sample or reference position (“air versus air”). For CD titrations, the same steps were 
followed except the ICD signals were used instead of absorptions in UV-visible 
titrations.
4.13.3 Isothermal titration calorimetry
All ITC experiments were carried out using a Microcal VP ITC microcalorimeter. 
Compound 4.2 was prepared in 25 mM MOPS, 50 mM NaCl, pH 7.0, compound 4.4 
in 5 mM Tris + methanol (1:1), pH 7.2 and compound 4.5 in 5 mM Tris + DMSO 
(1:1), pH 7.2. All calorimetric binding experiments were carried out at 25 °C. The 
sample cell and syringe were always cleaned with ethanol followed by distilled water 
before starting any experiment. The sample cell was filled with FS-DNA solution 
(approximately 1.9 ml). The syringe was filled with ligand solution (approximately 
300 µl) with a concentration usually 12-fold higher than DNA solution (exact ratios 
depend on individual experiments). The ligand solution was added in 1 injection of 5 
µl for the first addition and 19 injections of 15 µl each to the sample cell, injecting 
every 300 seconds automatically. During the titration the solutions in the sample cell 
were mixed at a stirring speed of 307 rpm. The heat effects per injection (dh) were 
calculated using Origin (Microcal, Inc). The integrated heat effects were analysed 
using IC ITC.2
4.13.4 Viscometry 
The viscosimetry experiment for 4.2 was carried out in buffer (25 mM MOPS, 50 mM 
NaCl, pH 7.0). A Cannon-Flenske routine viscometer was placed in a temperature-
controlled circulated water bath at 25 °C. The viscometer was filled with a fixed 
amount of calf thymus DNA (3.0 ml of 0.5 mM) and adding ligand solutions with 
concentrations, as required, to obtain ratios of ligand / DNA 0.03, 0.06, 0.09, 0.12 and 
0.15. The flow time was measured three times for each ligand addition and the results 
were averaged. The relative viscosity was calculated and plotted as a function of the 
ratio [ligand]bound/[DNA] where [ligand]bound as calculated using binding parameters 
from UV-visible spectroscopy.
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2.4.5 Docking studies
Molecular docking studies were performed using Auto Dock Vina.6 The ligand 
structures were generated using chemdraw and then optimised using Avogadro, using 
force fields MMFF94 for ligands and GAFF for metal complexes. The rotable bonds 
in the ligand were assigned using Auto Dock Tools 1.5.6 and the output files were 
saved in PDBQT format. Our previously developed9 open-
d(ATCGAGACGTCTCGAT)2 was used as a biomacromolecular target. An 
exhaustiveness of 200 and number modes of 10 were selected. The results of Auto 
Dock Vina were rendered using Chimera 1.10.2.
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Abstract
This Chapter gives an overview and general conclusions about the DNA binding 
studies presented in the previous Chapters (2, 3 & 4) and finishes with suggestions for 
future work. 
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5.1 General conclusions
The main objective of this project was to explore and advance optoelectronically 
active DNA-binding compounds for use as sensitisers in sensors for selective 
detection of genetic biomarkers. The sensitisers bind to DNA and their spectroscopic 
and electronic properties may change upon interaction with DNA, thus allowing 
different applications including in biosensors. Additionally, binding of ligands with 
nucleic acids can be manipulated for the assembly of functional multicomponent 
structures containing active components. 
In this thesis we have described the DNA binding studies for three different groups of 
compounds using various techniques such as UV-visible and CD spectroscopy, 
isothermal titration calorimetry, viscometry and molecular docking study. The first 
group is 1,8-naphthalimide derivatives, which are oligoheteroaromatic compounds 
having a flat π-conjugated framework attached to different side-groups. In general, 
based on our results, most compounds of this group show moderate affinity to duplex 
DNA, however, the anionic compounds of 1,8-naphthalimide derivatives compounds 
2.8 and 2.9 do not show any affinity for duplex DNA. This may due to the repulsion 
arising from the ligand negative charge with negative charge of DNA backbone. 
Therefore, anionic 1,8-naphthalimide derivatives are not a good element for DNA 
binding studies. Regarding the sequence selectivity for ds-DNA, most binders of this 
group show preference to A.T-rich DNA sequences over G.C-rich sequences.
Nevertheless, these binders still show considerable affinity toward G.C-rich DNA 
sequences i.e. they are not completely selective to A.T-rich DNA sequences.
The second group of DNA binders is a family of dendrimeric compounds. These 
compounds consist of a highly fluorescent flat framework that is attached to small 
poly(amido amine) side-groups to increase solubility in aqueous medium. The results 
of our studies show that these compounds bind strongly to duplex DNA in two 
separate events and the binding is accompanied by change in the optical behaviours of 
the chromophore. The results of sequence selectivity studies show that these binders 
also prefer to bind A.T-rich DNA sequences over G.C-rich DNA sequences. The 
favourable binding mode of this family is intercalation as expected based on their 
structures. Compounds of this family are promising components for use as sensitisers 
in genosensors because they carry highly negative charges and still interact with 
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duplex DNA. In addition, the binding of this group of compounds with DNA usually 
accompanied by forming precipitation at low DNA concentration, which makes 
titration data difficult to be analysed, therefore, this problem need to be solved.
The third group of our DNA binders consists of a variety of compounds that have 
diverse structural frameworks. Most ligands of this group bind to duplex DNA 
moderately strongly through different binding modes varying from minor-groove
binding to intercalation to side-by-side binding in the minor groove. Binding of 4.1 to 
duplex DNA leads to a change in its optoelectronic properties. Thus, this compound 
can be used as sensitiser to enhance signals of DNA detection. The binding studies for 
both ruthenium complexes 4.4 and 4.5 to duplex DNA were carried out using 
isothermal titration calorimetry. The resulting enthalpograms for diluting 4.4 and 4.5
in Tris buffer (5 mM Tris + DMSO or MeOH (1:1) showed non-reproducibility of the 
experimental data, we may attribute this non-reproducibility of the experimental data 
to using high amount of organic solvent as a co-solvent. Therefore, we were unable to 
analyse the data of dilutions, quantify the heats of dilution and further investigate 
binding of 4.4 and 4.5 to DNA.
5.2 Suggestions for future work 
To confirm and enrich the results of binding studies obtained for our DNA binders, 
further biophysical studies should be performed such as DNA binding studies using 
NMR spectroscopy. With regard to the self-aggregation of our ligands in aqueous 
medium, the aggregation number and the thermodynamic parameters of self-
aggregation should be determined. Additionally, some of the our binders are sparingly 
water soluble, therefore, adding more solubilising groups to their structural 
frameworks facilitate the solubility and reducing self-aggregation. Furthermore, in 
order to obtain highly sequence selective DNA-binders, more ligands should be 
synthesised with new designs and structural properties. DNA binders based (7H-
benz[de]benzimidazo[2,1-a]isoquinoline-7-one) frameworks are promising 
components for use as sensitisers in genosensors when detecting DNA hybridization 
using electrochemical methods, particularly anionic 3.2. Because they carry highly 
negative charges and they may act as a signal enhancer by increasing charge transfer 
resistance when bound to duplex DNA. Furthermore, the family of dendrimeric 
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compounds are fluorescent, they could be used as fluorochromes in fluorimetry-based 
biosensors. The 1,8-naphthalimide derivatives are also promising DNA binders, 
especially compounds 2.1-2.3, they carry significant negative charges. Upon binding 
of compounds 2.1-2.3 with duplex DNA, the negative charges on the duplex DNA 
increase, thus, these binders can be exploited as signal enhancers in EIS-based 
biosensors and Field-Effect Transistor (Bio-FET) detections. Additionally, the 1,8-
naphthalimide derivatives are fluorescent and they could be useful components in 
biosensing based on fluorimetry. Compound 4.2 is known to bind to DNA●RNA 
hybrid duplexes, therefore, compound 4.2 is considered an interesting element to 
study the interaction of small molecules with other nucleic acid biomarkers such as 
mRNA. Some of our metal complexes DNA binders, such as compounds 4.1 and 2.4
are redox-active, they could be used as components in biosensors based on 
coulometry detection. Therefore, we should try these binders in a biosensor with our 
collaborators.     
Finally, in order to determine the affinities of our binders to different nucleic acid 
structures, competition dialysis is a good technique to achieve this objective and it 
would be of interest to explore this technique as well.
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A1 Compound 2.1
1.1 Extinction coefficient 
A stock solution of 2.1 (1.38 mM) in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl)
was prepared. A series of solutions of 0.02, 0.04, 0.05 and 0.07 mM was prepared 
from the stock solution and UV-visible spectra were recorded for these solutions in a 
1.0 cm pathlength cuvette. Ligand absorbances at the λmax of 347 nm were plotted 
against ligand concentrations and a linear fit (red line) was applied to obtain the 
extinction coefficient of (7.45 ± 0.36) × 103 dm3 mol-1 cm-1 (Figure A1.1).
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Figure A1.1 Absorbance for 2.1 as a function of concentration.
1.2 Results and error margins for isothermal titration calorimetry of 
2.1interacting with DNA.
Table A1.1 Thermodynamic parameters for binding of 2.1 to FSDNA in 25 mM 
MOPS, 50 mM NaCl, pH 7.0, at 25 °C.
variable Initial change? avoid 0? Fit value att. changes
Kagg 1.06E+03 0 n 1.06E+03 0
DHagg -8.37E+02 0 n -8.37E+02 0
KA1 5.00E+04 1 y 3.30E+03 98120
DHA1 -5.00E+03 1 y -3.22E+04 98576
nA1 3.30E-01 1 y 4.08E-02 98296
Hdil1 1.40E+02 1 n.d. -7.30E+01 98626
Hdil2 1.40E+02 1 n.d. -1.29E+02 97928
Hdil3 1.40E+02 1 n.d. -8.38E+01 98454
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Figure A1.2 Normalised Σdev2/dof for dilution parameters.
0.0 0.5 1.0 1.5 2.0 2.5 3.0
1.0
1.5
2.0
2.5
3.0
no
rm
ali
se
d  
d
ev
2  /
 do
f
nA1 
0.0 3.0x10
3
6.0x10
3
9.0x10
3
1.2x10
4
1.0
1.5
2.0
2.5
3.0
No
rm
ali
se
d  
d
ev
2  /
 do
f
K
A1 
/ M
-1
-5x10
5
-4x10
5
-3x10
5
-2x10
5
-1x10
5 0
1.0
1.2
1.4
1.6
1.8
No
rm
ali
se
d  
d
ev
2  /
 do
f
H
A1
 / cal mol
-1
Figure A1.3 Normalised Σdev2/dof for binding parameters.
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A2 Compound 2.2
1.1 Extinction coefficient 
A stock solution of 2.2 (3.0 mM) in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl) was 
prepared. A series of solutions of 0.02, 0.04, 0.06 and 0.08 mM was prepared from the 
stock solution and UV-visible spectra were recorded for these solutions in a 1.0 cm 
pathlength cuvette. Ligand absorbances at the λmax of 347 nm were plotted against 
ligand concentrations and a linear fit (red line) was applied to obtain the extinction 
coefficient of (6.0 ± 0.1) × 103 dm3 mol-1 cm-1 (Figure A2.1).
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Figure A2.1 Absorbance for 2.2 as a function of concentration.
A3 Compound 2.3
1.1 Extinction coefficient 
A stock solution of 2.3 (4.2 mM) in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl) was 
prepared. A series of solutions of 0.03, 0.05 and 0.07 mM was prepared from the 
stock solution and UV-visible spectra were recorded for these solutions in a 1.0 cm 
pathlength cuvette. Ligand absorbances at the λmax of 347 nm were plotted against 
ligand concentrations and a linear fit (red line) was applied to obtain the extinction 
coefficient of (11.7 ± 0.02) × 103 dm3 mol-1 cm-1 (Figure A3.1).
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Figure A3.1 Absorbance for 2.3 as a function of concentration.
A4 Compound 2.4
1.1 Extinction coefficient 
A stock solution of 2.4 (0.19 mM) in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl)
was prepared. A series of solutions of 0.04, 0.049 and 0.062 mM was prepared from 
the stock solution and UV-visible spectra were recorded for these solutions in a 1.0 
cm pathlength cuvette. Ligand absorbances at the λmax of 347 nm were plotted against 
ligand concentrations and a linear fit (red line) was applied to obtain the extinction 
coefficient of (9.55 ± 0.04) × 103 dm3 mol-1 cm-1 (Figure A4.1).
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Figure A4.1 Absorbance for 2.4 as a function of concentration.
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A5 Compound 2.5
1.1 Extinction coefficient 
A stock solution of 2.5 (0.20 mM) in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl)
was prepared. A series of solutions of 0.02, 0.04 and 0.06 mM was prepared from the 
stock solution and UV-visible spectra were recorded for these solutions in a 1.0 cm 
pathlength cuvette. Ligand absorbances at the λmax of 347 nm were plotted against 
ligand concentrations and a linear fit (red line) was applied to obtain the extinction 
coefficient of (10.13 ± 0.06) × 103 dm3 mol-1 cm-1 (Figure A5.1).
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Figure A5.1 Absorbance for 2.5 as a function of concentration.
A6 Compound 2.6
1.1 Extinction coefficient 
A stock solution of 2.6 (0.45 mM) in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl)
was prepared. Two series of solutions of 0.01, 0.02, 0.04 and 0.05 mM were prepared 
from the stock solution and UV-visible spectra were recorded for these solutions in a 
1.0 cm pathlength cuvette. Ligand absorbances at the λmax of 440 nm were plotted 
against ligand concentrations and a linear fit (red line) was applied to obtain the 
extinction coefficient of (16.5 ± 0.22) × 103 dm3 mol-1 cm-1 (Figure A6.1).
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Figure A6.1 Absorbance for 2.6 as a function of concentration.
1.2 Results and error margins for isothermal titration calorimetry of 2.6 
interacting with DNA
Table A6.1 Thermodynamic parameters for binding of 2.6 to FSDNA in 25 mM 
MOPS, 50 mM NaCl, pH 7.0, at 25 °C.
variable initial change? avoid 0? fit value att. changes
KA1 5.00E+04 1 y 8.34E+03 235848
DHA1 -5.00E+03 1 y -1.74E+05 235880
nA1 3.33E-01 1 y 2.11E-02 235468
Hdil1 1.00E+02 1 n.d. -8.57E+01 236523
Hdil2 1.00E+02 1 n.d. 3.25E+02 236281
Table A6.1 Thermodynamic parameters for binding of 2.6 to FSDNA in 25 mM 
MOPS, 50 mM NaCl, pH 7.0, at 25 °C.
variable initial change? avoid 0? fit value att. changes
KA1 5.00E+04 1 y 1.25E+04 294829
DHA1 -5.00E+03 1 y -9.94E+03 294540
nA1 3.33E-01 0 n 3.33E-01 0
Hdil1 1.00E+02 1 n.d. 3.15E+00 295348
Hdil2 1.00E+02 1 n.d. 3.97E+02 295283
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Figure A6.2 Normalised Σdev2/dof for binding parameters.
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A7 Compound 2.7
1.1 Extinction coefficient 
A stock solution of 2.7 (1.0 mM) in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl) was 
prepared. Two series of solutions of 0.02, 0.04, 0.05 and 0.07 mM were prepared 
from the stock solution and UV-visible spectra were recorded for these solutions in a 
1.0 cm pathlength cuvette. Ligand absorbances at the λmax of 434 nm were plotted 
against ligand concentrations and a linear fit (red line) was applied to obtain the 
extinction coefficient of (10.68 ± 0.20) × 103 dm3 mol-1 cm-1 (Figure A7.1).
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Figure A7.1 Absorbance for 2.7 as a function of concentration.
1.2 Results and error margins for isothermal titration calorimetry of 2.7 
interacting with DNA.
Table A7.1 Thermodynamic parameters for binding of 2.7 to FSDNA in 25 mM 
MOPS, 50 mM NaCl, pH 7.0, at 25 °C.
variable initial change? avoid 0? fit value att. changes
Kagg 4.53E+02 0 n 4.53E+02 0
DHagg -4.68E+03 0 n -4.68E+03 0
KA1 5.00E+04 1 y 7.99E+03 117794
DHA1 -2.00E+03 1 y -4.52E+04 118189
nA1 1.66E-01 1 y 1.01E-01 117981
Hdil1 -6.00E+01 1 n.d. -9.63E+01 117842
Hdil2 -6.00E+01 1 n.d. -7.53E+01 118194
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Figure A7.2 Normalised Σdev2/dof for binding parameters.
A8 Compound 3.2
1.1 Extinction coefficient 
A stock solution of 3.2 (0.97 mM) in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl)
was prepared. A series of solutions of 0.01, 0.02, 0.03 and 0.04 mM was prepared 
from the stock solution and UV-visible spectra were recorded for these solutions in a 
1.0 cm pathlength cuvette. Ligand absorbances at the λmax of 442 nm were plotted 
against ligand concentrations and a linear fit (red line) was applied to obtain the 
extinction coefficient of (12.77 ± 0.35) × 103 dm3 mol-1 cm-1 (Figure A8.1).
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Figure A8.1 Absorbance for 3.2 as a function of concentration.
1.2 Error margins for isothermal titration calorimetry of 3.2.
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Figure A8.2 Normalised Σdev2/dof for thermodynamic parameter of interaction of 3.2
to FSDNA. The titration data were analysed in terms of a model accounting only for 
dilution.
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A9 Compound 3.1
1.1 Extinction coefficient 
A stock solution of 3.1 (0.24 mM) in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl)
was prepared. A series of solutions of 0.02, 0.03, 0.04 and 0.05 mM was prepared 
from the stock solution and UV-visible spectra were recorded for these solutions in a 
1.0 cm pathlength cuvette. Ligand absorbances at the λmax of 444 nm were plotted 
against ligand concentrations and a linear fit (red line) was applied to obtain the 
extinction coefficient of (16.09 ± 0.30) × 103 dm3 mol-1 cm-1 (Figure A9.1).
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Figure A9.1 Absorbance for 3.1 as a function of concentration.
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1.2 Error margins for isothermal titration calorimetry of 3.1.
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Figure A9.2 Normalised Σdev2/dof for binding parameters of experiment (a).
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Figure A9.3 Normalised Σdev2/dof for binding parameters of experiment (b).
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A10 Compound 3.3
1.1 Extinction coefficient 
A stock solution of 3.3 (0.065 mM) in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl)
was prepared. A series of solutions of 0.01, 0.02, 0.03 and 0.04 mM was prepared 
from the stock solution and UV-visible spectra were recorded for these solutions in a 
1.0 cm pathlength cuvette. Ligand absorbances at the λmax of 452 nm were plotted 
against ligand concentrations and a linear fit (red line) was applied to obtain the 
extinction coefficient of (19.57 ± 0.24) × 103 dm3 mol-1 cm-1 (Figure A10.1).
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Figure A10.1 Absorbance for 3.3 as a function of concentration.
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1.2 Error margins for isothermal titration calorimetry of 3.3.
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Figure A10.2 Normalised Σdev2/dof for binding parameters of experiment (a).
Appendix
207
-5x10
5
-4x10
5
-3x10
5
-2x10
5
-1x10
5 0
1.0
1.5
2.0
2.5
3.0
No
rm
ali
se
d 
d
ev
2  /
 do
f
H
A1
 / cal mol
-1
0.0 7.0x10
7
1.4x10
8
2.1x10
8
2.8x10
8
3.5x10
8
4.2x10
8
0.8
1.0
1.2
1.4
1.6
1.8
2.0
2.2
2.4
2.6
2.8
3.0
No
rm
ali
se
d 
d
ev
2  /
 do
f
K
A1
 / M
-1
0.00 0.05 0.10 0.15 0.20
1.0
1.5
2.0
2.5
3.0
No
rm
ali
se
d 
d
ev
2  /
 do
f
n
A1
 / bp
-1
-6.0x10
3
-5.5x10
3
-5.0x10
3
-4.5x10
3
-4.0x10
3
-3.5x10
3
-3.0x10
3
-2.5x10
3
1.0
1.5
2.0
2.5
3.0
No
rm
ali
se
d 
d
ev
2  /
 do
f
H
B1
 / cal mol
-1
0.0 2.0x10
6
4.0x10
6
6.0x10
6
8.0x10
6
1.0x10
7
1.2x10
7
1.0
1.5
2.0
2.5
3.0
No
rm
ali
se
d 
d
ev
2  /
 do
f
K
B1
 / M
-1
0.65 0.70 0.75 0.80 0.85 0.90 0.95
1.0
1.5
2.0
2.5
3.0
No
rm
ali
se
d 
d
ev
2  /
 do
f
n
B1
 / bp
-1
Figure A10.3 Normalised Σdev2/dof for binding parameters of experiment (b).
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Figure A10.4 Normalised Σdev2/dof for dilution parameters.
A11 Compound 4.1
1.1 Extinction coefficient 
A stock solution of 4.1 (1.0 mM) in DMSO was prepared. Three series of solutions of 
0.025, 0.05, 0.075 and 0.1 mM were prepared from the stock solution and UV-visible 
spectra were recorded for these solutions in a 1.0 cm pathlength cuvette. Ligand 
absorbances at the λmax of 400 nm were plotted against ligand concentrations and a 
linear fit (red line) was applied to obtain the extinction coefficient of (13.6 ± 0.2) × 
103 dm3 mol-1 cm-1 (Figure A11.1).
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Figure A11.1 Absorbance for 4.1 as a function of concentration.
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A12 Compound 4.2
1.1 Extinction coefficient 
A stock solution of 4.2 (2.0 mM) in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl) was 
prepared. A series of solutions of 0.019, 0.029 and 0.039 mM was prepared from the 
stock solution and UV-visible spectra were recorded for these solutions in a 1.0 cm 
pathlength cuvette. Ligand absorbances at the λmax of 320 nm were plotted against 
ligand concentrations and a linear fit (red line) was applied to obtain the extinction 
coefficient of (19.63 ± 0.35) × 103 dm3 mol-1 cm-1 (Figure A12.1).
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Figure A12.1 Absorbance for 4.2 as a function of concentration.
1.2 Error margins for isothermal titration calorimetry of 4.2.
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Figure A12.2 Normalised Σdev2/dof for dilution parameters.
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Figure A12.3 Normalised Σdev2/dof for binding parameters.
A13 Compound 4.3
1.1 Extinction coefficient and UV-visible titrations of 4.3.
Stock solution of 4.3 (0.5 mM) in DMSO was prepared. Series solutions of (0.025, 
0.05 and 0.062 mM) in 50 vol-% DMSO-MOPS buffer (25 mM MOPS, pH 7.0, 50 
mM NaCl) were prepared from the stock solution and UV-visible spectra were 
recorded for these solutions in a 1.0 cm pathlength cuvette. Ligand absorbances at the 
λmax of 362 nm were plotted against ligand concentrations and a linear fit (red line) 
was applied to obtain the extinction coefficient of (13.51 ± 0.1) × 103 dm3 mol-1 cm-1 
(Figure A13.1).
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Figure A13.1 Absorbance for 4.3 as a function of concentration.
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A14 Sequence selectivity studies of 2.2 and 2.4-2.7
1.1 2.2 binding to (dAdT)12.(dAdT)12
The binding of 2.2 to (dAdT)12.(dAdT)12 was studied using UV-visible spectroscopy; 
the changes in absorption of 2.2 upon addition of (dAdT)12.(dAdT)12 were measured 
in buffer (25 mM MOPS pH 7.0 and 50 mM NaCl) at 25 °C (Figure A14.1).
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Figure A14.1 UV-visible spectra for 0.031 mM 2.2 upon addition of 0 – 0.26 mM 
(dAdT)12.(dAdT)12 in 25 mM MOPS pH 7.0, 50 mM NaCl, at 25°C.
Figure A14.1 shows a hypochromic shift in absorbance (at the λmax of 347 nm) and 
hyperchromic shift (at 390 nm) of 2.2 upon addition of (dAdT)12.(dAdT)12, this 
change in UV-visible absorption may occur as a result of geometrical distortion of 2.2
when it interacts with DNA, but it may also be a local medium effect.  
To quantify the affinity of 2.2 for (dAdT)12.(dAdT)12, the absorbances at 347 were 
plotted as a function of concentration of (dAdT)12.(dAdT)12 (Figure A14.2).
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Figure A14.2 Absorbance at 347 nm of a solution of 0.032 mM 2.2 (●) and of a 
solution of 0.020 mM 2.2 (■), as a function of (dAdT)12.(dAdT)12 concentration, in
buffer (25 mM MOPS pH 7.0, 50 mM NaCl), at 25 °C. The solid lines represent a 
global fit of a multiple independent sites model to the data.
The titration curves of Figure A14.2 were analysed globally in terms of a multiple 
independent binding sites models, which also takes ligand dilution into account, 
giving an equilibrium constant (Kbinding) of (13.86 ± 6.02) ×103 M-1 and a binding site 
size of (0.33 ± 0.10) base pairs. The obtained binding stoichiometry was small 
therefore the data were reanalysed at fixed binding site size of 3.0 base pairs. Because 
the fit did not reproduce the experimental data well, therefore we decided to reanalyse 
the data for a binding site size restricted to 1.0 base pair, giving an equilibrium 
constant (Kbinding) of (92.49 ± 19.97) ×103 M-1.
1.2 2.2 binding to (dGdC)12.(dGdC)12
The binding of 2.2 to (dGdC)12.(dGdC)12 was studied using UV-visible spectroscopy; 
the changes in absorption of 2.2 upon addition of (dGdC)12.(dGdC)12 were measured 
in buffer (25 mM MOPS pH 7.0 and 50 mM NaCl) at 25 °C (Figure A14.3).
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Figure A14.3 UV-visible spectra for 0.034 mM 2.2 upon addition of 0 – 0.33 mM 
(dGdC)12.(dGdC)12 in 25 mM MOPS pH 7.0, 50 mM NaCl, at 25°C.
Figure A14.3 shows a hypochromic shift in absorbance (at the λmax of 347 nm) and 
hyperchromic shift (at 390 nm) of 2.2 upon addition of (dGdC)12.(dGdC)12, this 
change in UV-visible absorption may occur as a result of geometrical distortion of 2.2
when it interacts with DNA, but it may also be a local medium effect.  
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To quantify the affinity of 2.2 for (dGdC)12.(dGdC)12, the absorbances at 347 were 
plotted as a function of concentration of (dGdC)12.(dGdC)12 (Figure A14.4).
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Figure A14.4 Absorbance at 347 nm of a solution of 0.051 mM 2.2 (●) and of a 
solution of 0.034 mM 2.2 (■), as a function of (dGdC)12.(dGdC)12 concentration, in
buffer (25 mM MOPS pH 7.0, 50 mM NaCl), at 25 °C. The solid lines represent a 
global fit of a multiple independent sites model to the data.
The titration curves of Figure A14.4 were analysed globally in terms of a multiple 
independent binding sites models, which also takes ligand dilution into account to the 
data, giving an equilibrium constant (Kbinding) of (15 ± 916) ×10-3 M-1 and a binding 
site size of (0.09 ± 5.7) ×10-6 base pairs. The obtained binding constant and 
stoichiometry were unreasonably small therefore the data were reanalysed at fixed 
binding site size 3.0 base pairs. Because the fit did not reproduce the experimental 
data well at n = 3, therefore the data were reanalysed at binding site size 1.0 base pair, 
giving an equilibrium constant (Kbinding) of (25.45 ± 5.85) ×103 M-1.
1.3 2.4 binding to (dAdT)12.(dAdT)12
The binding of 2.4 to (dAdT)12.(dAdT)12 was studied using UV-visible spectroscopy; 
the changes in absorption of 2.4 upon addition of (dAdT)12.(dAdT)12 were measured 
in buffer (25 mM MOPS pH 7.0 and 50 mM NaCl) at 25 °C (Figure A14.5).
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Figure A14.5 UV-visible spectra for 0.012 mM 2.4 upon addition of 0 – 0.44 mM 
(dAdT)12.(dAdT)12 in 25 mM MOPS pH 7.0, 50 mM NaCl, at 25°C.
Figure A14.5 shows a hypochromic shift in absorbance (at the λmax of 347 nm) and 
hyperchromic shift (at 390 nm) of 2.4 upon addition of (dAdT)12.(dAdT)12, this 
change in UV-visible absorption may occur as a result of geometrical distortion of 2.4
when it interacts with DNA, but it may also be a local medium effect.  
To quantify the affinity of 2.4 for (dAdT)12.(dAdT)12, the absorbances at 347 were 
plotted as a function of concentration of (dAdT)12.(dAdT)12 (Figure A14.6).
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Figure A14.6 Absorbance at 347 nm of a solution of 0.017mM 2.4 (●), Absorbance at 
347 nm of a solution of 0.012 mM 2.4 (■), as a function of (dAdT)12.(dAdT)12
concentration, in buffer (25 mM MOPS pH 7.0, 50 mM NaCl), at 25 °C. The solid 
lines represent a global fit of a multiple independent sites model to the data.
The titration curves of Figure A14.6 were analysed globally in terms of a multiple 
independent binding sites models, which also takes ligand dilution into account to the 
data, giving an equilibrium constant (Kbinding) of (0.03 ± 3.7) M-1 and a binding site 
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size of (0.08 ± 9.6) ×10-6 base pairs. The obtained binding parameters were 
unreasonable therefore the data were reanalysed at fixed binding site size 3.0 base 
pairs, giving an equilibrium constant (Kbinding) of (14.41 ± 3.12) ×103 M-1.
1.4 2.4 binding to (dGdC)12.(dGdC)12
The binding of 2.4 to (dGdC)12.(dGdC)12 was studied using UV-visible spectroscopy; 
the changes in absorption of 2.4 upon addition of (dGdC)12.(dGdC)12were measured 
in buffer (25 mM MOPS pH 7.0 and 50 mM NaCl) at 25 °C (Figure A14.7).
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Figure A14.7 UV-visible spectra for 0.012 mM 2.4 upon addition of 0 – 0.26 mM 
(dGdC)12.(dGdC)12 in 25 mM MOPS pH 7.0, 50 mM NaCl, at 25°C.
Figure A14.7 shows a hypochromic shift in absorbance (at the λmax of 347 nm) and 
hyperchromic shift (at 390 nm) of 2.4 upon addition of (dGdC)12.(dGdC)12, this 
change in UV-visible absorption may occur as a result of geometrical distortion of 2.4
when it interacts with (dGdC)12.(dGdC)12, but it may also be a local medium effect.  
To quantify the affinity of 2.4 for (dGdC)12.(dGdC)12, the absorbances at 347 were 
plotted as a function of concentration of (dGdC)12.(dGdC)12 (Figure A14.8).
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Figure A14.8 Absorbance at 347 nm of a solution of 0.022 mM 2.4 (●) and of a 
solution of 0.012 mM 2.4 (■), as a function of (dGdC)12.(dGdC)12 concentration, in
buffer (25 mM MOPS pH 7.0, 50 mM NaCl), at 25 °C. The solid lines represent a 
global fit of a multiple independent sites model to the data.
The titration curves of Figure A14.8 were analysed globally in terms of a multiple 
independent binding sites models, which also takes ligand dilution into account, 
giving an equilibrium constant (Kbinding) of (0.009 ± 1.54) M-1 and a binding site size 
of (0.04 ± 6.4) ×10-4 base pairs. The obtained binding parameters were unreasonably 
small therefore the data were reanalysed at fixed binding site size 3.0 base pairs, 
giving an equilibrium constant (Kbinding) of (8.05 ± 2.03) ×103 M-1.
1.5 2.5 binding to (dAdT)12.(dAdT)12
The binding of 2.5 to (dAdT)12.(dAdT)12 was studied using UV-visible spectroscopy; 
the changes in absorption of 2.5 upon addition of (dAdT)12.(dAdT)12 were measured 
in buffer (25 mM MOPS pH 7.0 and 50 mM NaCl) at 25 °C (Figure A14.9).
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Figure A14.9 UV-visible spectra for 0.018 mM 2.5 upon addition of 0 – 0.47 mM 
(dAdT)12.(dAdT)12 in 25 mM MOPS pH 7.0, 50 mM NaCl, at 25°C
Figure A14.9 shows a hypochromic shift in absorbance (at the λmax of 347 nm) and 
hyperchromic shift (at 390 nm) of 2.5 upon addition of (dAdT)12.(dAdT)12, this 
change in UV-visible absorption may occur as a result of geometrical distortion of 2.5
when it interacts with DNA, but it may also be a local medium effect.  
To quantify the affinity of 2.5 for (dAdT)12.(dAdT)12, the absorbances at 347 were 
plotted as a function of concentration of (dAdT)12.(dAdT)12 (Figure A14.10).
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Figure A14.10 Absorbance at 347 nm of a solution of 0.026mM 2.5 (●) and of a 
solution of 0.018 mM 2.5 (■), as a function of (dAdT)12.(dAdT)12 concentration, in
buffer (25 mM MOPS pH 7.0, 50 mM NaCl), at 25 °C. The solid lines represent a 
global fit of a multiple independent sites model to the data.
The titration curves of Figure A14.10 were analysed globally in terms of a multiple 
independent binding sites models, which also takes ligand dilution into account to the 
data, giving an equilibrium constant (Kbinding) of (25.61 ± 13.02) ×103 M-1 and a 
binding site size of (3.42 ± 1.07) base pairs. 
1.6 2.5 binding to (dGdC)12.(dGdC)12
The binding of 2.5 to (dGdC)12.(dGdC)12 was studied using UV-visible spectroscopy; 
the changes in absorption of 2.5 upon addition of (dGdC)12.(dGdC)12were measured 
in buffer (25 mM MOPS pH 7.0 and 50 mM NaCl) at 25 °C (Figure A14.11).
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Figure A14.11 UV-visible spectra for 0.025 mM 2.5 upon addition of 0 – 0.27 mM 
(dGdC)12.(dGdC)12 in 25 mM MOPS pH 7.0, 50 mM NaCl, at 25°C.
Figure A14.11 shows a hypochromic shift in absorbance (at the λmax of 347 nm) and 
hyperchromic shift (at 390 nm) of 2.5 upon addition of (dGdC)12.(dGdC)12, this 
change in UV-visible absorption may occur as a result of geometrical distortion of 2.5
when it interacts with (dGdC)12.(dGdC)12, but it may also be a local medium effect.  
To quantify the affinity of 2.5 for (dGdC)12.(dGdC)12, the absorbances at 347 were 
plotted as a function of concentration of (dGdC)12.(dGdC)12 (Figure A14.12).
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Figure A14.12 Absorbance at 347 nm of a solution of 0.033 mM 2.5 (●) and of a 
solution of 0.025 mM 2.5 (■), as a function of (dGdC)12.(dGdC)12 concentration, in
buffer (25 mM MOPS pH 7.0, 50 mM NaCl), at 25 °C. The solid lines represent a 
global fit of a multiple independent sites model to the data.
Appendix
219
The titration curves of Figure A14.12 were analysed globally in terms of a multiple 
independent binding sites models, which also takes ligand dilution into account to the 
data, giving an equilibrium constant (Kbinding) of (66.10 ± 52.89) ×104 M-1 and a 
binding site size of (12.8 ± 0.7) base pairs. The obtained stoichiometry was big 
therefore the data were reanalysed at fixed binding site size 3.0 base pairs, giving an 
equilibrium constant (Kbinding) of (9.30 ± 2.70) ×103 M-1.
1.7 2.6 binding to (dAdT)12.(dAdT)12
The binding of 2.6 to (dAdT)12.(dAdT)12 was studied using UV-visible spectroscopy; 
the changes in absorption of 2.6 upon addition of (dAdT)12.(dAdT)12 were measured 
in buffer (25 mM MOPS pH 7.0 and 50 mM NaCl) at 25 °C (Figure A14.13).
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Figure A14.13 UV-visible spectra for 0.010 mM 2.6 upon addition of 0 – 0.016 mM 
(dAdT)12.(dAdT)12 in 25 mM MOPS pH 7.0, 50 mM NaCl, at 25°C
Figure A14.13 shows a hypochromic shift in absorbance (at the λmax of 440 nm) of 2.6
upon addition of (dAdT)12.(dAdT)12, this change in UV-visible absorption may occur 
as a result of geometrical distortion of 2.6 when it interacts with DNA, but it may also 
be a local medium effect.  
To quantify the affinity of 2.6 for (dAdT)12.(dAdT)12, the absorbances at 440 were 
plotted as a function of concentration of (dAdT)12.(dAdT)12 (Figure A14.14).
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Figure A14.14 Absorbance at 440 nm of a solution of 0.010 mM 2.6 (●) and of a 
solution of 0.004 mM 2.6 (■), as a function of (dAdT)12.(dAdT)12 concentration, in
buffer (25 mM MOPS pH 7.0, 50 mM NaCl), at 25 °C. The solid lines represent a 
global fit of a multiple independent sites model to the data.
The titration curves of Figure A14.14 were analysed globally in terms of a multiple 
independent binding sites models, which also takes ligand dilution into account to the 
data, giving an equilibrium constant (Kbinding) of (5.04 ± 36.7) ×103 M-1 and a binding 
site size of (0.03 ± 0.22) base pair. The obtained binding site size was small therefore 
the data were reanalysed at fixed binding site size 3.0 base pairs. Because the fit did 
not reproduce the experimental data well, therefore we analysed the data again at 
lower stoichiometry n=1.0 base pair, giving an equilibrium constant (Kbinding) of 
(74.76 ± 76.62) ×104 M-1. Because equilibrium constants cannot be negative, we 
express the error margin as a confidence interval so that the equilibrium constant is 
74×104 [0 – 151×104]. 
1.8 2.6 binding to (dGdC)12.(dGdC)12
The binding of 2.6 to (dGdC)12.(dGdC)12 was studied using UV-visible spectroscopy; 
the changes in absorption of 2.6 upon addition of (dGdC)12.(dGdC)12were measured 
in buffer (25 mM MOPS pH 7.0 and 50 mM NaCl) at 25 °C (Figure A14.15).
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Figure A14.15 UV-visible spectra for 0.0048 mM 2.6 upon addition of 0 – 0.11 mM 
(dGdC)12.(dGdC)12in 25 mM MOPS pH 7.0, 50 mM NaCl, at 25°C.
Figure A14.14 shows a hypochromic shift in absorbance (at the λmax of 440 nm) of 2.6
upon addition of (dGdC)12.(dGdC)12, this change in UV-visible absorption may occur 
as a result of geometrical distortion of 2.6 when it interacts with (dGdC)12.(dGdC)12, 
but it may also be a local medium effect.  
To quantify the affinity of 2.6 for (dGdC)12.(dGdC)12, the absorbances at 347 were 
plotted as a function of concentration of (dGdC)12.(dGdC)12 (Figure A14.16).
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Figure A14.16 Absorbance at 440 nm of a solution of 0.0048 mM 2.6, as a function 
of (dGdC)12.(dGdC)12 concentration, in buffer (25 mM MOPS pH 7.0, 50 mM NaCl), 
at 25 °C. The solid lines represent a global fit of a multiple independent sites model to 
the data.
The titration curve of Figure A14.16 was analysed in terms of a multiple independent 
binding sites models, which also takes ligand dilution into account to the data, giving 
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unreasonably small binding parameters, therefore the data were reanalysed at fixed 
stoichiometry n=3 base pairs, giving an equilibrium constant (Kbinding) of (13.67 ± 
1.93) ×104 M-1.
1.9 2.7 binding to (dAdT)12.(dAdT)12
The binding of 2.7 to (dAdT)12.(dAdT)12 was studied using UV-visible spectroscopy; 
the changes in absorption of 2.7 upon addition of (dAdT)12.(dAdT)12 were measured 
in buffer (25 mM MOPS pH 7.0 and 50 mM NaCl) at 25 °C (Figure A14.17).
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Figure A14.17 UV-visible spectra for 0.018 mM 2.7 upon addition of 0 – 0.28 mM 
(dAdT)12.(dAdT)12 in 25 mM MOPS pH 7.0, 50 mM NaCl, at 25°C
Figure A14.17 shows a hypochromic shift in absorbance (at the λmax of 434 nm) of 2.7
upon addition of (dAdT)12.(dAdT)12, this change in UV-visible absorption may occur 
as a result of geometrical distortion of 2.7 when it interacts with DNA, but it may also 
be a local medium effect.  
To quantify the affinity of 2.7 for (dAdT)12.(dAdT)12, the absorbances at 434 were 
plotted as a function of concentration of (dAdT)12.(dAdT)12 (Figure A14.18).
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Figure A14.18 Absorbance at 434 nm of a solution of 0.023 mM 2.7 (●), and of a 
solution of 0.018 mM 2.7 (■), as a function of (dAdT)12.(dAdT)12 concentration, in 
buffer (25 mM MOPS pH 7.0, 50 mM NaCl), at 25 °C. The solid lines represent a 
global fit of a multiple independent sites model to the data.
The titration curves of Figure A14.18 were analysed globally in terms of a multiple 
independent binding sites models, which also takes ligand dilution into account to the 
data, giving an equilibrium constant (Kbinding) of (10.28 ± 2.56) ×104 M-1 and a 
binding site size of (2.53 ± 0.28) base pairs. 
1.10 2.7 binding to (dGdC)12.(dGdC)12
The binding of 2.7 to (dGdC)12.(dGdC)12 was studied using UV-visible spectroscopy; 
the changes in absorption of 2.7 upon addition of (dGdC)12.(dGdC)12were measured 
in buffer (25 mM MOPS pH 7.0 and 50 mM NaCl) at 25 °C (Figure A14.19).
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Figure A14.19 UV-visible spectra for 0.023 mM 2.7 upon addition of 0 – 0.21 mM 
(dGdC)12.(dGdC)12in 25 mM MOPS pH 7.0, 50 mM NaCl, at 25°C.
Figure A14.19 shows a hypochromic shift in absorbance (at the λmax of 434 nm) of 2.7
upon addition of (dGdC)12.(dGdC)12, this change in UV-visible absorption may occur 
as a result of geometrical distortion of 2.7 when it interacts with (dGdC)12.(dGdC)12, 
but it may also be a local medium effect.  
To quantify the affinity of 2.7 for (dGdC)12.(dGdC)12, the absorbances at 434 were 
plotted as a function of concentration of (dGdC)12.(dGdC)12 (Figure A14.20).
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Figure A14.20 Absorbance at 434 nm of a solution of 0.023 mM 2.7 (●) and of a 
solution of 0.018 mM 2.7 (■), as a function of (dGdC)12.(dGdC)12 concentration, in
buffer (25 mM MOPS pH 7.0, 50 mM NaCl), at 25 °C. The solid lines represent a 
global fit of a multiple independent sites model to the data.
The titration curves of Figure A14.20 were analysed globally in terms of a multiple 
independent binding sites models, which also takes ligand dilution into account to the 
data, giving an equilibrium constant (Kbinding) of (18.18 ± 3.07) ×104 M-1 and a binding 
site size of (4.23 ± 0.17) base pairs.
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A15 UV-visible titrations of compounds of 1, 8-naphthalimide derivatives.
Table A15.1 UV-visible titration of 0.066 mM 2.1 upon addition of 0 – 3.33 mM 
FSDNA in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl), at 25 °C.
[DNA]stock = 18.2 mM, [Ligand]stock = 2.68 mM
Cumulative 
added 
volume 
DNA (µL)
Added 
volume 
ligand
(µL)
Total 
volume
(µL)
[DNA]
(x10-6 M)
[ligand]
(x10-6 M)
A347 nm A390 nm
0 0 1950 0 0 0.027632 0.027265
0 50 2000 0 66.8 0.435931 0.062651
5 50 2005 45.2 66.7 0.421888 0.065224
25 50 2025 224.0 66.0 0.393847 0.07161
55 50 2055 485.7 65.0 0.363846 0.074315
100 50 2100 864.2 63.6 0.342365 0.07741
150 50 2150 1266.2 62.2 0.326849 0.079928
200 50 2200 1650 60.7 0.312306 0.082575
250 50 2250 2016.6 59.4 0.296543 0.078687
300 50 2300 2367.3 58.1 0.287934 0.078798
350 50 2350 2703.1 56.9 0.285368 0.080366
400 50 2400 3025 55.7 0.281174 0.082095
450 50 2450 3333.6 54.5 0.278086 0.082221
Table A15.2 UV-visible titration of 0.093 mM 2.1 upon addition of 0 – 5.18 mM 
FSDNA in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl), at 25 °C.
[DNA]stock = 18.2 mM, [Ligand]stock = 2.68 mM
Cumulative 
added 
volume 
DNA (µL)
Added 
volume 
ligand
(µL)
Total 
volume
(µL)
[DNA]
(x10-6 M)
[ligand]
(x10-6 M)
A347 nm A390 nm
0 0 1930 0 0 0.027786 0.024696
0 70 2000 0 93.6 0.585879 0.070846
5 70 2005 45.3 93.3 0.569883 0.076091
15 70 2015 135.1 92.9 0.548219 0.077928
30 70 2030 268.2 92.2 0.522634 0.082048
60 70 2060 528.6 90.8 0.491706 0.088094
90 70 2090 781.5 89.5 0.465975 0.087533
130 70 2130 1107.7 87.9 0.443814 0.090592
180 70 2180 1498.6 85.8 0.427986 0.093432
250 70 2250 2016.6 83.2 0.408061 0.09499
320 70 2320 2503.4 80.7 0.393432 0.096321
400 70 2400 3025 78.0 0.378822 0.096355
480 70 2480 3512.9 75.5 0.363442 0.095211
560 70 2560 3970.3 73.1 0.355825 0.097236
640 70 2640 4400 70.9 0.34475 0.095467
720 70 2720 4804.4 68.8 0.339971 0.096234
800 70 2800 5185.7 66.8 0.334898 0.097616
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Table A15.3 UV-visible titration of 0.068 mM 2.2 upon addition of 0 – 8.36 mM 
FSDNA in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl), at 25 °C.
[DNA]stock = 22.3 mM, [Ligand]stock = 2.74 mM
Cumulative 
added 
volume 
DNA (µL)
Added 
volume 
ligand
(µL)
Total 
volume
(µL)
[DNA]
(x10-6 M)
[ligand]
(x10-6 M)
A347 nm A390 nm
0 0 1950 0 0 0.023047 0.024788
0 50 2000 0 68.5 0.438953 0.073699
2 50 2002 22.2 68.4 0.43038 0.073409
7 50 2007 77.8 68.2 0.420197 0.07451
17 50 2017 188.0 67.9 0.413914 0.075619
40 50 2040 437.4 67.1 0.404602 0.077302
80 50 2080 858 65.8 0.392247 0.079189
140 50 2140 1459.5 64 0.376916 0.081599
200 50 2200 2028.1 62.2 0.367003 0.082486
300 50 2300 2910 59.5 0.349798 0.083922
400 50 2400 3718.3 57 0.338344 0.085076
500 50 2500 4462 54.8 0.330875 0.086397
600 50 2600 5148.4 52.6 0.32236 0.086989
700 50 2700 5784 50.7 0.311611 0.086807
800 50 2800 6374.2 48.9 0.302456 0.086982
900 50 2900 6923.7 47.2 0.295426 0.087238
1000 50 3000 7436.6 45.6 0.288329 0.086982
1100 50 3100 7916.4 44.1 0.285218 0.08744
1200 50 3200 8366.2 42.8 0.281465 0.087511
Table A15.4 UV-visible titration of 0.082 mM 2.2 upon addition of 0 – 2.64 mM 
FSDNA in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl), at 25 °C.
[DNA]stock = 22.3 mM, [Ligand]stock = 2.74 mM
Cumulative 
added 
volume 
DNA (µL)
Added 
volume 
ligand
(µL)
Total 
volume
(µL)
[DNA]
(x10-6 M)
[ligand]
(x10-6 M)
A347 nm A390 nm
0 0 1950 0 0 0.026612
7
0.026461
0 60 2010 0 82.6 0.528632 0.086833
5 60 2015 55.3 82.4 0.518901 0.088661
10 60 2020 110.4 82.2 0.510197 0.090665
20 60 2030 219.8 81.8 0.503451 0.091616
40 60 2050 435.3 81 0.49337 0.095019
60 60 2070 646.6 80.2 0.483417 0.09592
90 60 2100 956.1 79.1 0.470911 0.098251
120 60 2130 1256.9 78 0.465113 0.100438
150 60 2160 1549.3 76.9 0.45531 0.100619
180 60 2190 1833.6 75.8 0.451728 0.10177
210 60 2220 2110.4 74.8 0.442752 0.102961
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240 60 2250 2379.7 73.8 0.439894 0.10472
270 60 2280 2641.9 72.8 0.435165 0.105621
300 60 2310 2897.4 71.9 0.433254 0.107851
330 60 2340 3146.2 71 0.429683 0.108092
Table A15.5 UV-visible titration of 0.046 mM 2.2 upon addition of 0 – 0.72 mM 
FSDNA in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl), at 25 °C.
[DNA]stock = 7.91, [Ligand]stock = 1.34 mM
Cumulative 
added 
volume 
DNA (µL)
Added 
volume 
ligand
(µL)
Total
volume
(µL)
[DNA]
(x10-6 M)
[ligand]
(x10-6 M)
A347 nm A390 nm
0 0 2200 0 0 0.029406 0.022785
0 80 2280 0 46.8 0.314072 0.059182
5 80 2285 17.3 46.7 0.307997 0.059772
12 80 2292 41.4 46.6 0.303854 0.060504
22 80 2302 75.5 46.4 0.299293 0.060531
35 80 2315 119.5 46.1 0.295389 0.061557
55 80 2335 186.3 45.7 0.292525 0.063465
80 80 2360 268.1 45.2 0.28745 0.063971
110 80 2390 364 44.7 0.281788 0.063883
140 80 2420 457.6 44.1 0.276978 0.063784
170 80 2450 548.8 43.6 0.273351 0.064377
200 80 2480 637.9 43 0.269413 0.064734
230 80 2510 724.8 42.5 0.268436 0.065749
Table A15.6 UV-visible titration of 0.052 mM 2.3 upon addition of 0 – 6.14 mM 
FSDNA in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl), at 25 °C.
[DNA]stock = 22.3 mM, [Ligand]stock = 4.2 mM
Cumulative 
added 
volume 
DNA (µL)
Added 
volume 
ligand
(µL)
Total 
volume
(µL)
[DNA]
(x10-6 M)
[ligand]
(x10-6 M)
A347 nm A390 nm
0 0 1975 0 0 0.029048 0.025485
0 25 2000 0 52.53 0.634309 0.053235
3 25 2003 33.4 52.45 0.634005 0.054869
13 25 2013 144 52.19 0.626641 0.057612
40 25 2040 437.4 51.50 0.6127 0.059605
60 25 2060 649.8 51 0.60149 0.062083
90 25 2090 960.7 50.27 0.586068 0.063849
120 25 2120 1262.8 49.56 0.573232 0.066581
160 25 2160 1652.5 48.64 0.555958 0.069396
200 25 2200 2028.1 47.76 0.542371 0.071546
250 25 2250 2478.8 46.7 0.527193 0.073638
320 25 2320 3077.2 45.29 0.510831 0.07601
400 25 2400 3718.3 43.78 0.490403 0.077461
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480 25 2480 4318 42.36 0.471037 0.078498
560 25 2560 4880.3 41.04 0.456195 0.079494
660 25 2660 5535.5 39.50 0.440688 0.081973
760 25 2760 6143.3 38.07 0.427361 0.082559
860 25 2860 6708.6 36.73 0.417196 0.08361
960 25 2960 7235.6 35.49 0.409591 0.085206
1060 25 3060 7728.3 34.33 0.400954 0.086677
1160 25 3160 8189.7 33.25 0.392412 0.086923
1260 25 3260 8622.8 32.23 0.381338 0.087964
Table A15.7 UV-visible titration of 0.031 mM 2.3 upon addition of 0 – 6.34 mM 
FSDNA in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl), at 25 °C.
[DNA]stock = 22.3 mM, [Ligand]stock = 4.2 mM
Cumulative 
added 
volume 
DNA (µL)
Added 
volume 
ligand
(µL)
Total 
volume
(µL)
[DNA]
(x10-6 M)
[ligand]
(x10-6 M)
A347 nm A390 nm
0 0 1985 0 0 0.024765 0.024849
0 15 2000 0 31.52 0.392252 0.044218
5 15 2005 55.6 31.44 0.388775 0.046736
15 15 2015 166 31.28 0.383105 0.048289
35 15 2035 383.7 30.98 0.373997 0.05026
110 15 2110 1163 29.87 0.352394 0.055349
160 15 2160 1652.5 29.18 0.341403 0.057655
220 15 2220 2210.9 28.39 0.329947 0.05909
300 15 2300 2910 27.41 0.314648 0.061128
400 15 2400 3718.3 26.26 0.302757 0.063109
500 15 2500 4462 25.21 0.291742 0.064686
600 15 2600 5148.4 24.24 0.283571 0.066708
700 15 2700 5784 23.35 0.27809 0.06792
800 15 2800 6374.2 22.51 0.274685 0.069782
Table A15.8 UV-visible titration of 0.032 mM 2.4 upon addition of 0 – 2.84 mM 
FSDNA in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl), at 25 °C.
[DNA]stock = 22.3 mM, [Ligand]stock = 0.19 mM
Cumulative 
added 
volume 
DNA (µL)
Added 
volume 
ligand
(µL)
Total 
volume
(µL)
[DNA]
(x10-6 M)
[ligand]
(x10-6 M)
A347 nm A390 nm
0 0 1930 0 0 0.023888 0.02678
0 400 2330 0 32.61 0.333187 0.035034
5 400 2335 47.7 32.54 0.324713 0.036416
20 400 2350 189.8 32.34 0.30818 0.039172
40 400 2370 376.5 32.06 0.298684 0.041821
70 400 2400 650.7 31.66 0.286043 0.044659
110 400 2440 1005.7 31.14 0.277835 0.04702
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160 400 2490 1433.5 30.52 0.27249 0.050146
220 400 2550 1924.7 29.80 0.268203 0.053202
280 400 2610 2393.4 29.11 0.265103 0.056557
340 400 2670 2840.9 28.46 0.26055 0.059441
Table A15.9 UV-visible titration of 0.039 mM 2.4 upon addition of 0 – 2.80 mM 
FSDNA in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl), at 25 °C.
[DNA]stock = 22.3 mM, [Ligand]stock = 0.19 mM
Cumulative 
added 
volume 
DNA (µL)
Added 
volume 
ligand
(µL)
Total 
volume
(µL)
[DNA]
(x10-6 M)
[ligand]
(x10-6 M)
A347 nm A390 nm
0 0 1930 0 0 0.030842 0.02818
0 500 2430 0 39.09 0.397978 0.039056
5 500 2435 45.8 39.01 0.386899 0.040125
10 500 2440 91.4 38.93 0.373891 0.041094
20 500 2450 182.1 38.77 0.360386 0.042303
35 500 2465 316.7 38.53 0.350881 0.044647
55 500 2485 493.7 38.22 0.341798 0.049063
80 500 2510 711 37.84 0.337937 0.052284
110 500 2540 966.1 37.40 0.325524 0.052049
200 500 2630 1696.5 36.12 0.313236 0.057526
250 500 2680 2081.1 35.44 0.309597 0.060593
300 500 2730 2451.6 34.79 0.307366 0.063353
350 500 2780 2808.8 34.17 0.301015 0.064268
Table A15.10 UV-visible titration of 0.027 mM 2.5 upon addition of 0 – 2.64 mM 
FSDNA in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl), at 25 °C.
[DNA]stock = 22.3 mM, [Ligand]stock = 0.20 mM
Cumulative 
added 
volume 
DNA (µL)
Added 
volume 
ligand
(µL)
Total 
volume
(µL)
[DNA]
(x10-6 M)
[ligand]
(x10-6 M)
A347 nm A390 nm
0 0 1930 0 0 0.033529 0.028969
0 300 2230 0 26.90 0.320386 0.042414
5 300 2235 49.9 26.84 0.313233 0.044746
10 300 2240 99.5 26.78 0.304809 0.04707
20 300 2250 198.3 26.66 0.292607 0.052492
30 300 2260 296.1 26.54 0.28827 0.052277
50 300 2280 489.2 26.31 0.278384 0.055375
80 300 2310 772.6 25.97 0.268272 0.058643
110 300 2340 1048.7 25.64 0.263449 0.060291
150 300 2380 1406 25.21 0.253099 0.062493
200 300 2430 1836.2 24.69 0.249063 0.064686
250 300 2480 2248.9 24.19 0.244124 0.065632
300 300 2530 2645.4 23.71 0.245754 0.068818
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Table A15.11 UV-visible titration of 0.034 mM 2.5 upon addition of 0 – 3.12 mM 
FSDNA in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl), at 25 °C.
[DNA]stock = 22.3 mM, [Ligand]stock = 0.20 mM
Cumulative 
added 
volume 
DNA (µL)
Added 
volume 
ligand
(µL)
Total 
volume
(µL)
[DNA]
(x10-6 M)
[ligand]
(x10-6 M)
A347 nm A390 nm
0 0 1930 0 0 0.052546 0.031363
0 400 2330 0 34.33 0.406359 0.047333
5 400 2335 47.7 34.26 0.390551 0.050145
20 400 2350 189.8 34.04 0.362305 0.055136
30 400 2360 283.6 33.89 0.347741 0.05603
50 400 2380 468.6 33.61 0.33154 0.058862
80 400 2410 740.5 33.19 0.327251 0.064988
120 400 2450 1092.7 32.65 0.313787 0.066648
160 400 2490 1433.5 32.12 0.306317 0.069176
220 400 2550 1924.7 31.37 0.30214 0.071634
300 400 2630 2544.8 30.41 0.296365 0.074513
380 400 2710 3128.3 29.52 0.295583 0.077883
Table A15.12 UV-visible titration of 0.039 mM 2.6 upon addition of 0 – 0.172 
mM FSDNA in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl), at 25 °C.
[DNA]stock = 8.82 mM, [Ligand]stock = 0.453 mM
Cumulative 
added 
volume 
DNA (µL)
Added 
volume 
ligand
(µL)
Total 
volume
(µL)
[DNA]
(x10-6 M)
[ligand]
(x10-6 M)
A440 nm
0 0 1825 0 0 0.064903
0 175 2000 0 39.63 0.722703
5 175 2005 21.9 39.53 0.601699
10 175 2010 43.8 39.44 0.557855
15 175 2015 65.6 39.34 0.515106
20 175 2020 87.2 39.24 0.478175
25 175 2025 108.8 39.14 0.469029
30 175 2030 130.2 39.05 0.465279
35 175 2035 151.6 38.95 0.469551
40 175 2040 172.8 38.86 0.472086
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Table A15.13 UV-visible titration of 0.017 mM 2.6 upon addition of 0 – 0.11 mM 
FSDNA in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl), at 25 °C.
[DNA]stock = 0.882 mM, [Ligand]stock = 0.088 mM
Cumulative 
added 
volume 
DNA (µL)
Added 
volume 
ligand
(µL)
Total 
volume
(µL)
[DNA]
(x10-6 M)
[ligand]
(x10-6 M)
A440 nm
0 0 2000 0 0 0.026758
0 500 2500 0 17.7 0.314793
10 500 2510 3.5 17.62 0.298538
20 500 2520 6.9 17.55 0.285953
30 500 2530 10.4 17.49 0.272431
50 500 2550 17.2 17.35 0.25026
70 500 2570 24.0 17.21 0.232741
90 500 2590 30.6 17.08 0.22819
120 500 2620 40.3 16.88 0.223655
160 500 2660 53.0 16.63 0.215173
210 500 2710 68.3 16.32 0.207669
260 500 2760 83.0 16.03 0.206074
310 500 2810 97.2 15.74 0.204175
360 500 2860 110.9 15.47 0.202484
Table A15.14 UV-visible titration of 0.050 mM 2.7 upon addition of 0 – 2.42 mM 
FSDNA in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl), at 25 °C.
[DNA]stock = 8.82 mM, [Ligand]stock = 1.0 mM
Cumulative 
added 
volume 
DNA (µL)
Added 
volume 
ligand
(µL)
Total 
volume
(µL)
[DNA]
(x10-6 M)
[ligand]
(x10-6 M)
A434 nm
0 0 2375 0 0 0.026722
0 125 2500 0 50 0.576419
10 125 2510 35.1 49.80 0.534488
20 125 2520 69.9 49.60 0.500561
40 125 2540 138.8 49.21 0.455751
80 125 2580 273.3 48.44 0.42202
120 125 2620 403.7 47.70 0.381122
180 125 2680 592.1 46.64 0.352162
250 125 2750 801.4 45.45 0.333512
350 125 2850 1082.6 43.85 0.317715
450 125 2950 1344.8 42.37 0.306221
550 125 3050 1589.7 40.98 0.296742
650 125 3150 1819.1 39.68 0.28738
750 125 3250 2034.4 38.46 0.279759
850 125 3350 2236.8 37.31 0.273626
950 125 3450 2427.5 36.23 0.266191
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Table A15.15 UV-visible titration of 0.070 mM 2.7 upon addition of 0 – 3.91 mM 
FSDNA in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl), at 25 °C.
[DNA]stock = 8.82 mM, [Ligand]stock = 1.0 mM
Cumulative 
added 
volume 
DNA (µL)
Added 
volume 
ligand
(µL)
Total 
volume
(µL)
[DNA]
(x10-6 M)
[ligand]
(x10-6 M)
A434 nm
0 0 1860 0 0 0.041577
0 140 2000 0 70 0.790216
20 140 2020 87.2 69.30 0.679863
40 140 2040 172.8 68.62 0.607376
100 140 2100 419. 66.66 0.503345
150 140 2150 615.0 65.11 0.469667
200 140 2200 801.4 63.63 0.451018
300 140 2300 1149.9 60.86 0.426156
400 140 2400 1469.3 58.33 0.407444
600 140 2600 2034.4 53.84 0.379523
800 140 2800 2518.8 50 0.356633
1000 140 3000 2938.6 46.66 0.337084
1200 140 3200 3306 43.75 0.320481
1400 140 3400 3630.1 41.17 0.305826
1600 140 3600 3918.2 38.88 0.29323
Table A15.16 UV-visible titration of 0.055 mM 2.8 upon addition of 0 – 1.84 mM 
FSDNA in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl), at 25 °C.
[DNA]stock = 7.90 mM, [Ligand]stock = 1.29 mM
Cumulative 
added 
volume 
DNA (µL)
Added 
volume 
ligand
(µL)
Total 
volume
(µL)
[DNA]
(x10-6 M)
[ligand]
(x10-6 M)
A400 nm
0 0 2200 0 0 0.029839
0 100 2300 0 55.95 0.589737
100 100 2400 329.1 53.62 0.568852
200 100 2500 632 51.48 0.549938
300 100 2600 911.5 49.5 0.532331
400 100 2700 1170.3 47.66 0.514968
500 100 2800 1410.7 45.96 0.500165
600 100 2900 1634.4 44.37 0.488542
700 100 3000 1843.3 42.9 0.474469
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Table A15.17 UV-visible titration of 0.017 mM 2.9 upon addition of 0 – 1.17 mM 
FSDNA in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl), at 25 °C.
[DNA]stock = 7.90 mM, [Ligand]stock = 0.40 mM
Cumulative 
added 
volume 
DNA (µL)
Added 
volume 
ligand
(µL)
Total 
volume
(µL)
[DNA]
(x10-6 M)
[ligand]
(x10-6 M)
A445 nm
0 0 2200 0 0 0.025621
0 100 2300 0 17.65 0.202416
50 100 2350 168.0 17.27 0.199916
100 100 2400 329.1 16.91 0.197534
150 100 2450 483.6 16.57 0.195182
200 100 2500 632 16.24 0.193083
250 100 2550 774.5 15.92 0.190992
300 100 2600 911.5 15.61 0.189019
350 100 2650 1043.3 15.32 0.187018
400 100 2700 1170.3 15.03 0.185181
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A16 UV-visible titrations of a family of dendrimeric compounds.
Table A16.1 UV-visible titration of 0.030 mM 3.1 upon addition of 0 – 1.72 mM 
FSDNA in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl), at 25 °C.
[DNA]stock1 = 0.88 mM, [DNA]stock2 = 8.8 mM, [Ligand]stock = 0.24 mM
Cumulative 
added 
volume 
DNA (µL)
Added 
volume 
ligand
(µL)
Total 
volume
(µL)
[DNA]
(x10-6 M)
[ligand]
(x10-6 M)
A446 nm
0 0 1750 0 0 0.025593
0 250 2000 0 30 0.50648
2 250 2002 0.879 29.97 0.493582
5 250 2005 2.19 29.92 0.466583
10 250 2010 4.37 29.85 0.425542
17 250 2017 7.41 29.74 0.386106
25 250 2025 10.8 29.63 0.350095
35 250 2035 15.1 29.48 0.341056
55 250 2055 23.5 29.19 0.33125
3 250 2058 12.8 29.15 0.337398
10 250 2065 42.6 29.05 0.356346
30 250 2085 126.6 28.77 0.397427
60 250 2115 249.6 28.36 0.440075
120 250 2175 485.5 27.58 0.466323
200 250 2255 780.4 26.60 0.470562
300 250 2355 1121 25.47 0.467293
500 250 2555 1722.1 23.48 0.452551
Table A16.2 UV-visible titration of 0.030 mM 3.3 upon addition of 0 – 0.69 mM 
FSDNA in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl), at 25 °C.
[DNA]stock = 8.44 mM, [Ligand]stock = 0.065 mM
Cumulative 
added 
volume 
DNA (µL)
Added 
volume 
ligand
(µL)
Total 
volume
(µL)
[DNA]
(x10-6 M)
[ligand]
(x10-6 M)
A452 nm
0 0 1077 0 0 0.025038
0 923 2000 0 29.99 0.574101
5 923 2005 21 29.92 0.54774
10 923 2010 41.9 29.84 0.508703
15 923 2015 62.8 29.77 0.468969
20 923 2020 83.5 29.70 0.44068
25 923 2025 104.1 29.62 0.448753
30 923 2030 124.7 29.55 0.457968
35 923 2035 145.1 29.48 0.464445
40 923 2040 165.4 29.40 0.473138
50 923 2050 205.8 29.26 0.476097
60 923 2060 245.8 29.12 0.479285
70 923 2070 285.4 28.98 0.483075
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80 923 2080 324.6 28.84 0.485389
90 923 2090 363.4 28.70 0.486509
100 923 2100 401.9 28.56 0.487495
110 923 2110 440 28.43 0.487879
120 923 2120 477.7 28.29 0.488603
130 923 2130 515.1 28.16 0.487556
140 923 2140 552.1 28.03 0.486759
150 923 2150 588.8 27.90 0.486494
160 923 2160 625.1 27.77 0.485927
180 923 2180 696.8 27.52 0.485055
Table A16.3 UV-visible titration of 0.040 mM 3.4 upon addition of 0 – 0.18 mM 
FSDNA in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl), at 25 °C.
[DNA]stock = 0.84 mM, [Ligand]stock = 0.29 mM
Cumulative 
added 
volume 
DNA (µL)
Added 
volume 
ligand
(µL)
Total 
volume
(µL)
[DNA]
(x10-6 M)
[ligand]
(x10-6 M)
A454 nm
0 0 1724 0 0 0.024984
0 276 2000 0 40.02 0.576088
5 276 2005 2.1 39.92 0.572607
10 276 2010 4.1 39.82 0.569453
20 276 2020 8.3 39.62 0.567421
30 276 2030 12.4 39.42 0.567702
40 276 2040 16.5 39.23 0.569631
50 276 2050 20.5 39.04 0.567449
70 276 2070 28.5 38.66 0.567275
100 276 2100 40.1 38.11 0.558772
150 276 2150 58.8 37.22 0.55986
200 276 2200 76.7 36.38 0.515736
230 276 2230 87 35.89 0.495073
260 276 2260 97 35.41 0.472145
300 276 2300 110 34.8 0.418326
330 276 2330 119.5 34.35 0.390231
350 276 2350 125.7 34.05 0.377664
370 276 2370 131.7 33.77 0.376748
390 276 2390 137.7 33.48 0.379635
410 276 2410 143.5 33.21 0.380514
450 276 2450 155 32.66 0.381929
490 276 2490 166 32.14 0.37966
550 276 2550 182 31.38 0.374827
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Table A16.4 UV-visible titration of 0.040 mM 3.4 upon addition of 0 – 0.18 mM 
FSDNA in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl), at 25 °C.
[DNA]stock = 0.84 mM, [Ligand]stock = 0.29 mM
Cumulative 
added 
volume 
DNA (µL)
Added 
volume 
ligand
(µL)
Total 
volume
(µL)
[DNA]
(x10-6 M)
[ligand]
(x10-6 M)
A(454 –
530) nm
0 0 1724 0 0 0.001823
0 276 2000 0 40.02 0.542694
5 276 2005 2.1 39.92 0.536365
10 276 2010 4.1 39.82 0.530002
20 276 2020 8.3 39.62 0.519134
30 276 2030 12.4 39.42 0.502283
40 276 2040 16.5 39.23 0.484283
50 276 2050 20.5 39.04 0.463229
70 276 2070 28.5 38.66 0.429676
100 276 2100 40.1 38.11 0.377043
150 276 2150 58.8 37.22 0.318118
200 276 2200 76.7 36.38 0.289899
230 276 2230 87 35.89 0.29274
260 276 2260 97 35.41 0.304341
300 276 2300 110 34.8 0.314157
330 276 2330 119.5 34.35 0.324013
350 276 2350 125.7 34.05 0.330823
370 276 2370 131.7 33.77 0.334887
390 276 2390 137.7 33.48 0.34072
410 276 2410 143.5 33.21 0.342795
450 276 2450 155 32.66 0.345223
490 276 2490 166 32.14 0.344062
550 276 2550 182 31.38 0.342382
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A17 UV-visible titrations of miscellaneous compounds.
Table A17.1 UV-visible titration of 0.041 mM 4.1 upon addition of 0 – 0.25 mM 
FSDNA in deionised water, at 25 °C.
[DNA]stock = 1.93 mM, [Ligand]stock = 1.04 mM
Cumulative 
added 
volume 
DNA (µL)
Added 
volume 
ligand
(µL)
Total 
volume
(µL)
[DNA]
(x10-6 M)
[ligand]
(x10-6 M)
A394 nm
0 0 2400 0 0 0.028274
0 100 2500 0 41.68 0.32393
10 100 2510 7.6 41.51 0.304186
20 100 2520 15.3 41.34 0.317852
40 100 2540 30.3 41.02 0.33568
80 100 2580 59.8 40.38 0.347837
120 100 2620 88.3 39.77 0.358118
200 100 2700 142.9 38.59 0.367925
280 100 2780 194.3 37.48 0.364969
380 100 2880 254.6 36.18 0.360931
Table A17.2 UV-visible titration of 0.084 mM 4.1 upon addition of 0 – 0.28 mM 
FSDNA in deionised water, at 25 °C.
[DNA]stock1 = 0.193 mM, [DNA]stock2 = 1.93 mM, [Ligand]stock = 1.40 mM
Cumulative 
added 
volume 
DNA (µL)
Added 
volume 
ligand
(µL)
Total 
volume
(µL)
[DNA]
(x10-6 M)
[ligand]
(x10-6 M)
A394 nm
0 0 2350 0 0 0.026489
0 150 2500 0 84 0.467068
10 150 2510 0.76 83.66 0.466843
30 150 2530 2.2 83.0 0.466147
50 150 2550 3.7 82.35 0.442464
100 150 2600 7.4 80.76 0.441871
150 150 2650 10.9 79.24 0.407051
200 150 2700 14.2 77.77 0.371592
10 150 2710 21.3 77.49 0.428337
30 150 2730 35.3 76.92 0.430722
70 150 2770 62.7 75.81 0.455761
140 150 2840 108.7 73.94 0.464585
240 150 2940 170.6 71.42 0.48508
340 150 3040 228.5 69.07 0.485247
440 150 3140 282.7 66.87 0.475217
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Table A17.3 UV-visible titration of 0.01 mM 4.2 upon addition of 0 – 0.44 mM 
FSDNA in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl), at 25 °C.
[DNA]stock = 7.60 mM, [Ligand]stock = 2.0 mM
Cumulative 
added 
volume 
DNA (µL)
Added 
volume 
ligand
(µL)
Total 
volume
(µL)
[DNA]
(x10-6 M)
[ligand]
(x10-6 M)
A338 nm A320 nm
0 0 2000 0 0 0.032674 0.034264
0 10 2010 0 9.95 0.095902 0.231002
1 10 2011 3.7 9.94 0.098611 0.22531
2 10 2012 7.5 9.94 0.102374 0.223906
4 10 2014 15.0 9.93 0.106114 0.219161
6 10 2016 22.6 9.92 0.110148 0.215982
10 10 2020 37.6 9.90 0.116609 0.211459
15 10 2025 56.2 9.87 0.121613 0.206956
25 10 2035 93.3 9.82 0.128873 0.203655
40 10 2050 148.2 9.75 0.136158 0.202099
55 10 2065 202.4 9.68 0.140632 0.20151
85 10 2095 308.3 9.54 0.142368 0.199076
125 10 2135 444.9 9.36 0.145055 0.19918
Table A17.4 UV-visible titration of 0.014 mM 4.2 upon addition of 0 – 0.56 mM 
FSDNA in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl), at 25 °C.
[DNA]stock = 7.60 mM , [Ligand]stock = 2.0 mM
Cumulative 
added 
volume 
DNA (µL)
Added 
volume 
ligand
(µL)
Total 
volume
(µL)
[DNA]
(x10-6 M)
[ligand]
(x10-6 M)
A338 nm A320 nm
0 0 2000 0 0 0.034140 0.035223
0 15 2015 0 14.88 0.123671 0.318755
0.5 15 2015.5 1.8 14.88 0.12467 0.316741
1.5 15 2016.5 5.6 14.87 0.126793 0.311712
4 15 2019 15.0 14.85 0.133725 0.303991
8 15 2023 30.0 14.82 0.14444 0.296364
15 15 2030 56.1 14.77 0.156894 0.287784
25 15 2040 93.1 14.70 0.169268 0.281667
40 15 2055 147.9 14.59 0.179958 0.279563
70 15 2085 255.1 14.38 0.184334 0.273049
110 15 2125 393.7 14.11 0.188484 0.269579
160 15 2175 559.0 13.79 0.188726 0.265784
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Table A17.5 UV-visible titration of 0.02 mM 4.3 upon addition of 0 – 0.96 mM 
FSDNA in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl), at 25 °C.
[DNA]stock = 10.7 mM, [Ligand]stock = 0.5 mM
Cumulative 
added 
volume 
DNA (µL)
Added 
volume 
ligand
(µL)
Total 
volume
(µL)
[DNA]
(x10-6 M)
[ligand]
(x10-6 M)
A362 nm A390 nm
0 0 1920 0 0 0.038211 0.034337
0 80 2000 0 20 0.267499 0.150274
2 80 2002 10.6 19.98 0.259499 0.149548
4 80 2004 21.2 19.96 0.257543 0.153484
8 80 2008 42.4 19.92 0.252968 0.155526
15 80 2015 79.2 19.85 0.246963 0.158812
25 80 2025 131.4 19.75 0.245708 0.163802
45 80 2045 234.3 19.55 0.244132 0.167995
80 80 2080 409.6 19.23 0.241058 0.169113
120 80 2120 602.8 18.86 0.240878 0.16902
160 80 2160 788.8 18.51 0.239512 0.169497
200 80 2200 968.1 18.18 0.237382 0.168298
Table A17.6 UV-visible titration of 0.02 mM 4.3 upon addition of 0 – 0.5 mM 
FSDNA in buffer (25 mM MOPS, pH 7.0, 50 mM NaCl), at 25 °C.
[DNA]stock = 10.7 mM, [Ligand]stock = 0.5 mM
Cumulati
ve added 
volume 
DNA 
(µL)
Added 
volume 
ligand
(µL)
Total 
volume
(µL)
[DNA]
(x10-6 M)
[ligand]
(x10-6 M)
A362 nm A390 nm
0 0 1920 0 0 0.035040 0.033779
0 80 2000 0 20 0.263413 0.148956
0.5 80 2000.5 2.6 19.99 0.259557 0.148183
1 80 2001 5.3 19.99 0.255524 0.147416
2 80 2002 10.6 19.98 0.252617 0.14959
4 80 2004 21.2 19.96 0.248849 0.15051
6 80 2006 31.8 19.94 0.245508 0.152216
8 80 2008 42.4 19.92 0.245933 0.155936
13 80 2013 68.7 19.87 0.242976 0.159106
20 80 2020 105.4 19.80 0.242603 0.161735
35 80 2035 183.1 19.65 0.240558 0.167197
60 80 2060 310.1 19.41 0.238452 0.167174
100 80 2100 507.1 19.04 0.234535 0.164241
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